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Abstract 
 
A novel mosquito-specific family of leucine-rich repeat immune proteins (LRIMs) was recently 
identified in Anopheles gambiae, the major vector of malaria in Africa. The founding family 
members, LRIM1 and APL1C, form a heterodimer circulating in the mosquito hemolymph and 
mediate killing of malaria parasites through their interaction with the complement C3-like effector, 
TEP1. This PhD thesis investigated the role of the LRIM family in mosquito immunity. 
Transcriptional profiling demonstrated that different LRIMs show distinct responses to malarial, 
fungal, bacterial and viral infections as well as to blood feeding. Certain LRIMs are broadly induced 
whereas others respond specifically to particular immune challenges, suggesting that there is 
specificity within the LRIM family towards different infections. RNA interference-mediated gene 
silencing identified LRIM9 as a novel antagonist of the rodent malaria parasite, Plasmodium berghei, 
with a putative role in parasite melanisation. Silencing LRIM9 partially inhibits the activity of 
phenoloxidase, a key enzyme in the melanisation pathway, but does not affect tissue melanisation. 
Unlike the LRIM1/APL1C heterodimer, LRIM9 circulates as a monomer in the mosquito hemolymph 
and is not involved in antibacterial defence. As LRIM9 does not interact with TEP1 and is not 
involved in TEP1 activity against Plasmodium, its precise function in the mosquito immune system 
remains unclear. Importantly, LRIM9 is highly upregulated in female mosquitoes after blood feeding 
but does not function in mosquito reproduction.  
The findings reported in this thesis indicate that the LRIM family has diversified to respond to 
infections with different microbes that mosquitoes encounter in their blood feeding lifestyle. LRIM9 
is an important novel candidate for involvement in defence against malaria parasites. We 
hypothesise that LRIM9 is induced after blood feeding in anticipation of blood-borne infections, 
which is an original concept in mosquito immunity. 
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1 Introduction 
Mosquito-borne diseases 
Mosquitoes transmit numerous human and animal diseases with devastating consequences 
worldwide. These diseases are responsible for severe morbidity and mortality, especially in poorer, 
developing countries (Hill et al., 2005; Tolle, 2009; Weaver and Reisen, 2010). It is frequently young 
children, adolescents and pregnant women that are worst affected. As well as human suffering, 
death, ill health and disability have dramatic economic, political and social impacts. 
The mosquito life cycle makes it an ideal disease vector. Mosquitoes, which are Dipteran insects of 
the family Culicidae, are phenomenally successful and have colonised every continent except 
Antarctica (Reiter, 2001). There are approximately 3,500 species of mosquito and almost three-
quarters live in tropical or sub-tropical regions. Most adult female mosquitoes must feed on the 
blood of vertebrates to acquire nutrients for egg production (Attardo et al., 2005). The females use 
their elongated proboscis to pierce skin and inject saliva to facilitate feeding, which effectively 
disseminates protozoan parasites, viruses and nematode worms into their vertebrate host (Reiter, 
2001). For most of these pathogens, the mosquito represents an essential stage in their life cycle. 
Feeding behaviour varies between mosquito species, with some preferring to feed on humans 
(anthropophilic) and others preferring animals, including mammals, birds and even reptiles 
(zoophilic). Female mosquitoes lay their eggs on or close to water and the larval and pupal stages are 
entirely aquatic (Reiter, 2001). A female mosquito can lay eggs more than once in her life, producing 
between 50 and 500 eggs per reproductive cycle (Clements, 2000). The mosquito life cycle is rapid 
and takes only 15-20 days from egg to adult (McGavin, 2001). Female mosquitoes have a life span of 
2-4 weeks whereas males generally live for less than 10 days.  
Many mosquito-borne diseases are resurging due to the complex interplay of human activity, vector 
biology and environmental factors. Population growth and uncontrolled urbanisation have led to 
humans infringing on traditional mosquito habitats (Weaver and Reisen, 2010). Mosquitoes, such as 
Aedes aegypti, are becoming increasingly anthropophilic (attracted to humans) and adapted to living 
in close proximity to humans. In developing countries, poorly managed water storage and 
inadequate disposal of waste water contribute to expansions in mosquito populations (Kyle and 
Harris, 2008; Reiter, 2001; Tolle, 2009). For example, water storage vessels, plastic containers and 
discarded tyres provide plentiful mosquito breeding sites. Increased agriculture has also affected 
mosquito populations, with irrigated rice fields and cattle hoof-prints providing excellent larval 
habitats (Reiter, 2001). Climate change and global warming strongly impact on mosquito ecology, 
20 
 
behaviour, development and survival, which can affect disease transmission and the geographical 
range of mosquitoes (Reiter, 2001). 
The deadliest mosquito-borne disease is malaria, which exacts a devastating toll on developing 
countries. It is an acute febrile disease caused by protozoan Plasmodium parasites and transmitted 
to humans exclusively by infected female Anopheles mosquitoes. Plasmodium falciparum is the 
deadliest form of human malaria and Anopheles gambiae is its main African vector. According to the 
most recent figures from the World Health Organisation (WHO), 3.3 billion people were at risk of 
malaria in 2010, especially those in Sub-Saharan Africa (WHO, 2011b). There were approximately 
216 million malaria cases in 2010, with 81% in Africa and 13% in South East Asia. An estimated 
655,000 people died in the same year, although estimates vary from 537,000 and 907,000. 91% of 
these casualties were in Africa and 86% were children under 5 years of age. Pregnant women were 
also severely affected, with high rates of miscarriage and maternal death. 
The second most important mosquito-borne parasitic disease is lymphatic filariasis, which is a major 
cause of permanent disability worldwide (Manguin et al., 2010). Lymphatic filariasis is caused by 
filarial parasites, which are tissue-dwelling nematodes transmitted to humans during a mosquito 
blood meal (Tolle, 2009). Over 90% of human lymphatic filariasis cases are caused by the nematode 
Wuchereria bancrofti (Manguin et al., 2010). More than 70 species of mosquito are known vectors of 
W. bancrofti, including Culex (in urban areas), Anopheles (in rural areas of Africa and other areas) 
and Aedes (in the Pacific islands) (Manguin et al., 2010; WHO, 2012b). Following an infectious 
mosquito bite, the parasites invade the human lymphatic system, disrupt the immune system and 
cause abnormal enlargement of body parts, severe pain and disability. The most common chronic 
manifestations are lymphoedema, elephantiasis and hydrocele (tissue swelling, skin thickening and 
fluid accumulation, respectively) (WHO, 2012b). Legs and genital organs are commonly affected. 
Over 120 million people were infected and 40 million were incapacitated by the disease in 2010 
(WHO, 2012b). The socioeconomic impact of this disease is immense. WHO launched a Global 
Programme to Eradicate Lymphatic Filariasis (GPELF) in 2000, with the aim to eliminate the disease 
by 2020. This programme involves mass drug administration and morbidity management (WHO, 
2012b). 
Malaria and lymphatic filariasis are co-endemic in many parts of the tropics and concomitant human 
infections occur. In fact, many Anopheles mosquitoes are able to transmit both malaria parasites and 
filarial nematodes, including An. gambiae and Anopheles arabiensis in Africa (Muturi et al., 2008). 
Interactions between malaria parasites and filarial nematodes within the same mosquito are poorly 
understood. A recent study reported that filarial worms reduce the prevalence and intensity of 
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Plasmodium gallinaceum infections in dually infected Anopheles mosquitoes (Aliota et al., 2011). It is 
therefore possible that elimination of filarial parasites could inadvertently increase malaria 
transmission, which must be taken into careful consideration by the GPELF campaign. 
Many arthropod-borne viruses (arboviruses) are also transmitted by mosquitoes, especially Aedes 
and Culex. Of these, dengue virus (of the genus Flavivirus) is the most prevalent and potentially 
severe arbovirus, with half of the world’s population at risk (WHO, 2012a). The WHO currently 
estimates that there are 50-100 million infections every year, with 250,000-500,000 causing severe 
illness. Although many dengue cases are asymptomatic, symptomatic dengue is a debilitating febrile 
illness, which can develop into a life-threating complication called severe dengue (Kyle and Harris, 
2008). There are four distinct serotypes of dengue virus: DEN-1 to -4. Infection with one serotype is 
believed to result in life-long immunity to that particular serotype but not the others (WHO, 2012a). 
Furthermore, subsequent infections with different serotypes have an increased risk of progressing to 
severe dengue. This complexity has so far prevented the development of a successful vaccine. 
Worryingly, the incidence of dengue has been increasing dramatically and expanding geographically 
in the last 50 years (Kyle and Harris, 2008; WHO, 2011a). Population growth and uncontrolled 
urbanisation have been held largely responsible. Global travel has also spread dengue virus and its 
mosquito vectors to new locations. The primary dengue vector is Ae. aegypti, a previously forest-
dwelling mosquito that has become highly anthropophilic and well adapted to living in urban areas. 
Aedes albopictus is a secondary dengue vector. Many arboviruses are maintained in wild animals 
(known as enzootic amplification), but dengue virus has largely lost this ability (Weaver and Reisen, 
2010). 
Yellow fever is another flavivirus transmitted to humans by Ae. aegypti. Yellow fever is an acute 
haemorrhagic disease, which gets its name from the jaundice experienced by some sufferers (WHO, 
2012d). Even though an effective vaccine is available, the virus continues to cause a huge disease 
burden (Tolle, 2009). There are an estimated 200,000 cases each year, with 30,000 deaths. Yellow 
fever is a zoonotic disease that is sustained in a sylvatic cycle (also called forest or jungle cycle) 
involving monkeys, in which Ae. aegypti is not the main vector. Aedes africanus is the principle 
vector of the sylvatic cycle in Africa whereas Haemagogus mosquitoes take this role in the Americas. 
A potential threat is “spillover” transmission to humans or domestic animals when rural 
environments are invaded (Weaver and Reisen, 2010). Infected people carry the virus into villages 
and towns where Ae. aegypti spreads the virus through the population, resulting in urban outbreaks 
(Gould and Solomon, 2008). Interestingly, the virus cannot complete its developmental cycle in 
humans and domestic animals, which are incidental or dead-end hosts. 
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The Japanese encephalitis serogroup of flaviviruses includes Japanese encephalitis virus (JEV) and 
West Nile Virus (WNV). These viruses are zoonotic with avian hosts and are transmitted primarily by 
Culex mosquitoes. JEV is the most common cause of mosquito-borne encephalitites, with around 
50,000 infections every year (Weaver and Reisen, 2010). It is endemic to large parts of Asia and the 
Pacific but has shown widespread expansion in recent years (Erlanger et al., 2009). The disease often 
occurs in epidemics and can lead to permanent neurological damage. JEV is primarily transmitted by 
Culex tritaeniorhynchus, which breed in irrigated rice paddies, and its main reservoir is wading water 
birds. The virus is amplified in domestic pigs before spreading to humans and horses, which are 
dead-end hosts. Human population growth, intensified rice cultivation and increased pig rearing are 
all responsible for the rapid expansion of JEV (Erlanger et al., 2009). WNV can also cause severe 
neuroinvasive disease, although 80% of infections are asymptomatic (Tolle, 2009). Its primary vector 
is Culex pipiens and the virus has now spread across all continents, except Antarctica (Weaver and 
Reisen, 2010). Epidemics are rife across North America. WNV also causes severe illness and death in 
horses and corvid birds, such as crows and jays (Tolle, 2009). 
Chikungunya virus (CHIKV) and O’nyong-nyong virus (ONNV) are members of the Alphavirus family. 
CHIKV was once seen as a debilitating but seldom fatal disease, which manifests as fever and severe 
joint pain (Weaver and Reisen, 2010). However, over the last decade, CHIKV has spread 
geographically, its virulence has dramatically increased and there have been major epidemics (Tolle, 
2009); therefore, CHIKV is now classed as a dangerous emerging arbovirus. The virus no longer 
requires enzootic amplification (Weaver and Reisen, 2010). The primary CHIKV vector is Ae. aegypti 
but a recent amino acid mutation has enabled it to be transmitted effectively by Ae. albopictus, 
which has facilitated dissemination to new locations. It has been speculated that this mutation may 
be associated with increased virulence in the recent outbreaks. ONNV is unusual as it is the only 
arbovirus primarily transmitted by Anopheles mosquitoes (Waldock et al., 2012). ONNV was 
responsible for epidemics in East Africa in the 1960s and 1990s. 
It is interesting that different mosquitoes have become adapted to transmit different pathogens. 
Anopheles mosquitoes, the exclusive vectors of malaria parasites, are very poor transmitters of 
viruses. Aedes and Culex are excellent vectors of viral infection but do not transmit Plasmodium 
parasites. 
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Mosquitoes and malaria 
Plasmodium - the malaria parasite 
Of all the mosquito-borne diseases, malaria is by far the most devastating. Of the 172 species of 
Plasmodium parasites known to infect mammals, birds and reptiles, the vast majority are incapable 
of infecting humans (Baird, 2005). Only five species are known to cause human malaria: P. 
falciparum, Plasmodium vivax, Plasmodium malariae, Plasmodium ovale and Plasmodium knowlsei. 
Each parasite causes a debilitating acute febrile disease. P. falciparum and P. vivax are responsible 
for the vast majority of infections. P. falciparum causes the vast majority of severe malaria infections 
and is the main perpetrator of malaria mortality and morbidity (WHO, 2012c). The five parasites are 
endemic to different regions worldwide. P. falciparum is prevalent in sub-Saharan Africa, where the 
disease burden is strongest, whereas P. vivax is more common in South and Southeast Asia, the 
Western Pacific and Central and South America (Price et al., 2007; Tolle, 2009). The geographical 
range of P. vivax is wider because it can develop at lower temperatures (Greenwood et al., 2005). P. 
ovale is restricted to West Africa. P. knowlesi was traditionally described as a parasite of macaque 
monkeys but it also naturally infects humans in certain areas, like Malaysia (Singh et al., 2004). In the 
laboratory, rodent parasites Plasmodium berghei and Plasmodium yoelii are used as convenient 
models of malaria parasite infection. These naturally infect thicket rats in central Africa (Frech and 
Chen, 2011).  
Plasmodium parasites undergo a complex dual life cycle in the mosquito vector and the vertebrate 
host (Figure 1.1) (Wirth, 2002). Malaria transmission is reliant on successful completion of the 
parasite’s sexual developmental cycle in the mosquito. The mosquito is the parasite’s definitive host 
and an essential component of its life cycle whereas the vertebrate is a passage between 
mosquitoes (the intermediate host). The female mosquito ingests Plasmodium gametocytes upon 
blood feeding on an infected vertebrate. Based largely on studies in P. berghei (Sinden, 2002), within 
minutes of reaching the mosquito gut lumen, haploid male and female gametocytes leave their red 
blood cells and differentiate into gametes. Changes in temperature and exposure to mosquito-
derived xanthurenic acid initiate gametogenesis in P. berghei (Billker et al., 1998; Billker et al., 1997) 
and P. falciparum (Ghosh et al., 2010). The male gametocyte undergoes an extraordinary process, 
called exflagellation, during which eight haploid flagellated gametes are generated within minutes. 
In contrast, the female gametocyte becomes activated and transforms into the female gamete 
without undergoing DNA replication (Guttery et al., 2012). Within one hour (h) of blood feeding, the 
male gamete fertilises the female to form a diploid zygote, which undergoes meiosis and becomes 
tetraploid within the subsequent 3 h (Kuehn and Pradel, 2010). Over the next 5-18 h, each zygote 
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develops into a single motile, elongated tetraploid ookinete (Sinden, 2002). Between 19-36 h after 
feeding, ookinetes use gliding motility (via an actin/myosin motor) to migrate out of the blood meal 
(Aly et al., 2009). Ookinetes traverse the peritrophic matrix, which surrounds the blood bolus, and 
penetrate the midgut epithelium intracellularly, often passing through several cells (Zieler and 
Dvorak, 2000). Midgut invasion causes a significant change in epithelial cell morphology and results 
in apoptosis and expulsion of the invaded cell(s) by wound repair mechanisms (Han et al., 2000). In 
the space between the epithelial layer and the basal lamina, the ookinete develops into a spherical, 
sessile oocyst. The basal lamina, which coats the entire body cavity (hemocoel) of the mosquito, is 
believed to trigger the ookinete-to-oocyst transition (Aly et al., 2009; Vlachou et al., 2006). Over the 
next 12-18 days, the oocyst undergoes many internal mitotic divisions and generates thousands of 
haploid sporozoites. Upon maturation, the oocyst bursts to release these sporozoites into the 
hemolymph (mosquito blood). The motile sporozoites migrate to and invade the mosquito’s salivary 
glands, where they can be injected into a new vertebrate host upon the next blood feeding. 
When sporozoites enter the circulation of the vertebrate host, they travel rapidly to the liver and 
invade hepatocytes (Aly et al., 2009; Tolle, 2009). Sporozoites use a membrane-associated actin-
myosin motor to actively invade several hepatocytes before stopping in a final hepatocyte. A 
parasitophorous vacuole forms around the parasite for protection from the host cell. Within this 
vacuole, the sporozoite undergoes asexual reproduction (a process called schizony) producing a 
hepatic schizont that contains thousands of merozoites (Prudencio et al., 2006). The liver stage of 
infection is asymptomatic and lasts 5-6 days for P. falciparum and 10-14 days for P. vivax (although 
P. vivax can persist in the liver, as discussed later) (Tolle, 2009). After this incubation period, 
thousands of merozoites are released into the host bloodstream. The merozoites invade and 
develop within red blood cells (erythrocytes). Asexual blood stage parasites undergo many cycles of 
multiplication, which can produce up to 1013 merozoites per host (Greenwood et al., 2008). These 
asexual parasites are pathogenic and associated with the high fever, chills, headache and vomiting 
symptoms of a malaria infection. If not treated within 24 h, P. falciparum infections often progress 
to life-threatening disease. A proportion of merozoites develop into male and female gametocytes 
(sexual forms), which are not pathogenic but can be ingested by a blood feeding mosquito, 
spreading the disease.  
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Figure 1.1  The dual life cycle of Plasmodium parasites.  
Plasmodium parasites undergo asexual and sexual development in their vertebrate (a) and mosquito 
(b) hosts, respectively. A female mosquito becomes infected with Plasmodium gametocytes when 
blood feeding on an infected vertebrate. Inside the mosquito midgut, gametocytes differentiate into 
gametes that form a zygote upon fertilisation. The zygote develops into a motile ookinete, which 
traverses the peritrophic membrane (not shown) and penetrates the midgut epithelium intracellularly. 
In the space between the epithelial cells and the basal lamina, the ookinete develops into a sessile 
oocyst. Over the next two weeks, the oocyst undergoes many internal mitotic divisions and matures to 
release thousands of sporozoites into the hemolymph. The sporozoites migrate to the salivary glands 
and are injected into a naïve vertebrate host upon the next blood feeding. Inside the vertebrate host, 
the parasites travel to the liver and invade hepatocytes. The parasite asexually reproduces to form 
thousands of merozoites. These merozoites are released into the blood where they infect red blood 
cells and cause symptomatic disease. Some parasites differentiate into gametocytes that will continue 
the life cycle in the next mosquito host. Adapted from Wirth, 2002.  
 
There are interesting differences in the behaviours of the five Plasmodium parasites that infect 
humans. The increased virulence of P. falciparum can be partly explained because this species can 
generate more merozoites per hepatocyte, increasing the disease burden (Tolle, 2009). In addition, 
P. falciparum can invade red blood cells of all ages whereas P. vivax and P. ovale prefer to invade 
only immature red blood cells (reticulocytes). Unlike the other Plasmodium species, P. vivax and P. 
ovale cause characteristic relapses months after the original illness. A subset of P. vivax and P. ovale 
sporozoites remain dormant in the liver, as hypnozoites, for prolonged periods of time before 
developing into schizonts and causing recurrent malaria symptoms (Price et al., 2007). P. malariae 
can persist in the blood for several years if poorly treated (Schlitzer, 2007). 
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The Plasmodium parasite’s journey through the mosquito is a difficult and dangerous battle for 
survival, with the parasite population suffering substantial losses (Barillas-Mury and Kumar, 2005). 
Compared to the trillions of parasites in the human bloodstream, parasite numbers typically drop to 
single figures in the mosquito (Figure 1.2) (Vogel, 2010). The most important bottleneck in parasite 
numbers takes place in the mosquito midgut, with major parasite losses occurring during the 
gametocyte-to-ookinete and ookinete-to-oocyst transition (Alavi et al., 2003; Sinden, 1999). 
Remarkably, 90-99% of ookinetes are lost before becoming oocysts (Sinden, 2002). Although a blood 
meal can contain 105 gametocytes, as few as 1 to 5 oocysts usually develop. The mosquito innate 
immune system is largely responsible for eliminating the majority of invading ookinetes during the 
midgut stages of mosquito infection (Christophides et al., 2004). The second bottleneck occurs 
between release of sporozoites from the oocyst and invasion of the salivary glands, with only 20% of 
sporozoites completing the journey (Clements, 2012). Critically, Plasmodium parasites have evolved 
to cope with these population bottlenecks and even a single oocyst is sufficient to transmit malaria. 
Nevertheless, the parasite is extremely vulnerable in the mosquito host, which makes this an ideal 
time to control malaria – either by targeting the parasite or the mosquito. P. falciparum infections in 
wild mosquito populations are typically much lower than P. berghei infections in the laboratory 
(Tahar et al., 2002), which could facilitate control strategies. 
 
 
 
Figure 1.2  Changes in Plasmodium parasite population during its life cycle.  
The parasite undergoes two serious bottlenecks in population size during its passage through the 
mosquito. Whereas up to 10
13
 asexual blood stage parasites can be found in the human host, only a 
few thousand parasites will be ingested by the mosquito. Of these, as few as 1 to 5 oocysts develop, 
with the vast majority of parasites killed in the journey from the midgut lumen to the basal labyrinth. 
Parasite numbers are boosted when each oocyst releases thousands of sporozoites into the 
hemolymph. However, most sporozoites do not make it to the salivary glands and only 10-20 parasites 
are typically injected with each infectious mosquito bite (Sinden, 1999). Adapted from Vogel, 2010. 
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Anopheles – the mosquito vector 
Contrary to popular belief, the vast majority of mosquitoes are incapable of transmitting disease. 
Plasmodium parasites causing human malaria are only transmitted by mosquitoes of the genus 
Anopheles, and of the estimated 400 species of Anopheles mosquitoes, only about 40 are known to 
transmit malaria effectively so that they can be considered important vectors. Different Anopheles 
mosquitoes are the dominant vectors in specific geographic locations (Figure 1.3) (Kiszewski et al., 
2004; Sinka et al., 2012). An. gambiae is the major malaria vector in sub-Saharan Africa, where the 
global disease burden is highest. Anopheles culicifacies and Anopheles stephensi are important in 
India. Anopheles darlingi is the chief vector in South America. 
 
 
Figure 1.3  Global distribution of Anopheles malaria vectors, past and present.  
Dominant Anopheles species transmit malaria parasites in different regions of the world, as indicated 
by colour-coding. This map includes regions where malaria is no longer transmitted but was 
transmitted in the past, such as most of Europe and North America. From Sinka et al., 2012. 
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Vector competence, the capacity of mosquitoes to allow development of a particular parasite, is 
species and context specific (Sinden et al., 2004). Each mosquito species is usually only an efficient 
vector of a limited number of Plasmodium species (Blandin et al., 2004). Additionally, there are wide 
variations in vectorial capacity even within the same species. There are even intraspecific differences 
in susceptibility between mosquitoes of the same strain, shown by the wide range of oocyst 
intensities in experimental infections. The mechanisms of vector competence are not well 
understood (Blandin et al., 2004). Genetic, behavioural, ecology and immunity components are 
important determinants of vectorial capacity (Catteruccia, 2007). Refractory mosquitoes can inhibit 
or reduce the progress of the malaria parasite at one or more points in its complex life cycle (Sinden 
et al., 2004). Some mosquitoes are completely refractory to Plasmodium development, others are 
partially refractory and some mosquitoes are highly susceptible. Even in mosquitoes susceptible to 
Plasmodium development, the vast majority of parasites are still killed at the ookinete-to-oocyst 
transition. Mosquito behaviour also determines whether a species will transmit a particular 
Plasmodium parasite in natural settings. For example, host preference, feeding behaviour, resting 
behaviour and breeding sites all influence malaria transmission (Besansky et al., 1994). Geographical 
distribution is also important in determining whether a mosquito species can vector a particular 
parasite. 
Importantly, An. gambiae is a complex of seven closely related species and several incipient species 
that vary greatly in their ability to transmit malaria (Coetzee et al., 2000). The complex is officially 
called the An. gambiae Giles complex, named after the English entomologist George Michael James 
Giles. The seven species in the complex are An. gambiae sensu stricto (henceforth An. gambiae), An. 
arabiensis, Anopheles bwambae, Anopheles merus, Anopheles melas and Anopheles quadriannulatus 
Theobald species A and B. These species are morphologically indistinguishable but are genetically 
and behaviourally distinct. They are able to interbreed in the laboratory but hybrid males are sterile 
(Davidson, 1964). They were originally defined by polytene chromosome analysis but are now 
distinguished by PCR-based methods (Bass et al., 2007; Coluzzi et al., 2002; Fanello et al., 2002). 
Both An. gambiae and An. arabiensis are extremely efficient vectors of P. falciparum in sub-Saharan 
Africa and are sympatric across large regions. The other species are more localised malaria vectors: 
An. melas in West Africa, An. merus in East Africa and An. bwanbae in Uganda. Interestingly, An. 
quadriannulatus species A and B, endemic to southern Africa and Ethiopia, respectively, are 
considered to be zoophilic and thus non-vectors of human malaria (Habtewold et al., 2008; Hunt et 
al., 1998). 
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Furthermore, An. gambiae has a complicated population structure, with several subdivisions (Holt et 
al., 2002; Neafsey et al., 2010). It is composed of at least two incipient species, known as the M and 
S molecular forms, initially defined based on fixed differences in ribosomal DNA (Lawniczak et al., 
2010). M and S are morphologically identical at all life stages. M and S forms are sympatric across 
large parts of West and Central Africa but are partially reproductively isolated by assortative mating. 
Hybridisation still occurs and so there is gene flow between the forms. M and S differ in their larval 
breeding sites and reproductive behaviour. M and S forms are further subdivided into five 
chromosomal forms: Mopti (molecular form M), Savanna (S form), Bamako (S form), Bissau and 
Forest (Neafsey et al., 2010). This complexity poses significant challenges for malaria control 
(Lawniczak et al., 2010). 
 
Malaria control strategies 
Malaria is such a complex and widespread disease that an integrated approach, combining many 
strategies, must be taken to achieve eradication. Controlling the mosquito vector, employing 
antimalarial drugs and vaccines and developing new technologies are all important if we are to 
successfully fight this devastating disease. Thanks to a huge influx of new funding, notably from the 
Bill & Melinda Gates Foundation, the global malaria map is “shrinking” (Figure 1.4) (Feachem et al., 
2010). Thirty two countries on the borders of the malaria transmission zone, such as Algeria, Egypt 
and Mexico, are making good progress towards eliminating malaria. However, other countries, 
particularly those close to the equator, such as Nigeria, Sudan, India, Brazil and Indonesia, are still 
battling to control transmission. Despite progress, malaria elimination in sub-Saharan Africa is not 
possible with the current tools and novel control strategies are urgently required. As well as new 
tools and techniques, malaria control needs socioeconomic and infrastructural advances to be truly 
effective (Enayati and Hemingway, 2010). 
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Figure 1.4  World map of malaria transmission hotspots.  
Thanks to new funding and control efforts, the geographical regions affected by malaria are 
“shrinking”. Areas in green, such as much of Europe and Australia, have no malaria transmission. Areas 
in blue, such as Mexico and Algeria, are progressing towards eliminating the disease. However, 
countries at the central belt of malaria transmission close to the equator, shown in red, are still 
struggling to control the disease. From Feachem et al., 2010. 
 
Vector control 
Insecticides targeting the mosquito vector have played an important role in reducing the burden of 
malaria. Clearly, reducing the mosquito population can decrease malaria transmission. From 1955 to 
1969, a Global Malaria Eradication Program employed insecticides to significantly reduce the 
population at risk of malaria from 77% in 1900 to 55% in 1975 (Hay et al., 2004). Malaria was 
eradicated from North America and much of Europe by the 1970s. However, the program excluded 
sub-Saharan Africa because transmission was phenomenally high (Enayati and Hemingway, 2010). 
The campaign relied heavily on the organochloride insecticide DDT (dichlorodiphenyl-
trichloroethane), which was used for indoor residual spraying (IRS). IRS is the application of 
insecticides to the inside of human dwellings to kill resting mosquitoes. DDT delays the closure of 
voltage-gated sodium channels causing neurons to repetitively fire, resulting in paralysis and death. 
However, DDT is a persistent organic pollutant with the ability to bioaccumulate in food chains, 
poisoning predatory birds and other animals. DDT was subsequently banned, although it has 
recently been re-introduced in parts of Africa. The eradication campaign was abandoned in 1969 
because of technical, logistical, economic and political complications (Enayati and Hemingway, 
2010). 
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Today, both IRS and insecticide-treated nets (ITNs) are frequently used concurrently to reduce 
mosquito populations and malaria transmission. Modern IRS uses stable formulations of insecticides 
that last for 2 to 6 months before re-spraying is necessary (Enayati and Hemingway, 2010). ITNs are 
designed to prevent human-mosquito contact and therefore mosquito bites by covering humans 
whilst sleeping. A major improvement to ITNs was the development of long-lasting insecticide-
treated nets (LLINs), which provide protection for 3 to 5 years (Okumu and Moore, 2011). Since 
2005, there has been large-scale distribution of LLINs within sub-Saharan Africa to encourage wider 
coverage and usage, particularly in young children and pregnant women (Atieli et al., 2011). This has 
been organised by WHO and various partnerships, including Roll Back Malaria (RBM). Trials in Africa 
have demonstrated that LLINs and IRS reduce malaria morbidity and mortality (Akachi and Atun, 
2011; Atieli et al., 2011; Lengeler, 2004). 
However, LLINs and IRS alone are insufficient to eliminate malaria from high-transmission regions. 
Increased ownership of LLINs does not necessarily translate to increased coverage. A disadvantage 
of IRS and ITNs is that they only target endophilic (indoor-resting/biting) mosquitoes, allowing 
exophilic (outdoor-resting/biting) mosquitoes to continue transmitting disease. Persistent use of IRS 
and ITNs could even evolutionarily select for exophilic behaviour (Riehle et al., 2011). Another major 
problem is the development of insecticide resistance in mosquito populations. Vector control is 
currently extremely reliant on pyrethroids, a single class of insecticides (Ranson et al., 2011). 
Pyrethroids are the only class approved for use on ITNs and they are also widely used for IRS across 
Africa, largely because they have been shown to be non-toxic and efficacious (Zaim et al., 2000). 
Overuse of one particular insecticide selects for mosquitoes in the population with resistance 
phenotypes. Sadly, pyrethroid resistance is now widespread in An. gambiae in Africa. Like DDT, 
pyrethroids target voltage-gated sodium channels in mosquito neurons. Several methods of 
acquiring resistance have been documented, including target site alteration, metabolic resistance, 
penetration resistance and behavioural resistance (Ranson et al., 2011). In recent years, the 
frequency of resistance genes in An. gambiae has rapidly increased. One solution to combat 
resistance would be to use distinct insecticide classes for ITNs and IRS. For example, pyrethroid-
treated nets could be employed in combination with organophosphate or carbamate IRS (Okumu 
and Moore, 2011). Importantly, a recently established product development partnership, called the 
Innovative Vector Control Consortium, is researching and developing novel or altered insecticides to 
provide options for the future (Hemingway et al., 2006).  
Inventive new approaches to vector control are currently being investigated, including biological 
control agents. Biological control has many advantages over chemicals, including safety to humans 
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and non-target wildlife and lower risk of resistance development (Raghavendra et al., 2011). Instead 
of targeting adult mosquitoes, another way of reducing the vector population is to kill larvae. This 
could be advantageous for exophilic mosquito populations that avoid ITNs and IRS (Enayati and 
Hemingway, 2010). Predators have been successfully introduced into breeding sites to control 
anophelines, including larvivorous fish, such as Poecilia, Tilapia, Gambusia and Aphanius species 
(Haq and Yadav, 2011). Bacillus thuringiensis israelensis (Bti), a toxin-producing bacterium, has been 
used as an effective larvicide in Northern Europe (Christophides, 2005; Raghavendra et al., 2011). 
Other biological control agents targeting adults or larvae include entomopathogenic fungi, such as 
Beauveria bassiana (Blanford et al., 2005; Bukhari et al., 2010; Scholte et al., 2005). Nematodes and 
insect-killing viruses have also been proposed. These additional control measures are yet to be 
deployed on a large scale (Enayati and Hemingway, 2010). Natural plant phytochemicals have also 
been demonstrated to have larvicidal effects (Raghavendra et al., 2011). 
 
Antimalarial drugs 
Antimalarial drugs are used for both the prevention and treatment of malaria. There are only a 
handful of available antimalarials and most target the pathogenic asexual blood stages of 
Plasmodium. Several drugs have been employed worldwide for prophylaxis and treatment of malaria 
but these efforts are being undermined by the emergence of resistant parasites. Excessive usage of 
non-lethal drug levels, poor compliance, self-treatment and counterfeit drugs have fuelled the 
emergence and spread of resistance (Baird, 2005), resulting in treatment failure and increased 
mortality and morbidity (WHO, 2010). 
Various strategies have been utilised for the administration of antimalarial drugs. Chemoprophylaxis 
is successfully used by millions of non-immune people that travel to malaria regions for business or 
pleasure every year (Greenwood et al., 2005). For the inhabitants of endemic areas, 
chemoprophylaxis in children can significantly reduce malaria mortality and morbidity but this is 
difficult to sustain over prolonged periods, might encourage resistance and could prevent children 
from acquiring natural immunity (Greenwood, 2010). During pregnancy, intermittent preventative 
therapy (IPT) is the preferred approach. This involves the use of antimalarials two or three times 
during pregnancy to protect mother and baby. IPT has also been successfully employed in infants, 
with drugs administered at set points during their first year (Greenwood et al., 2005). In regions 
where malaria is very seasonal, vulnerable groups can be given antimalarials at intervals during the 
transmission season. Another approach is mass drug administration (MDA) in which entire 
populations are given drugs regardless of their disease status. This has been demonstrated to 
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facilitate the emergence of resistance and is not recommended for controlling malaria. MDA might, 
however, be useful for regions on the brink of malaria elimination (Greenwood, 2010). 
In the 1940s, chloroquine became the first-line antimalarial for uncomplicated malaria worldwide. 
This asexual blood stage drug was very effective, safe, inexpensive and fast-acting (Baird, 2005). 
However, resistance in P. falciparum became widespread and this drug can no longer be used in 
many countries. Nevertheless, chloroquine is still used against P. vivax in areas without resistance 
(WHO, 2010). Sulfadoxine-pyrimethamine was employed in the 1970s to target chloroquine-
resistant parasites but resistance also developed quickly. Mefloquine and quinine were then used, 
resulting in the appearance of multi-drug resistant parasites, especially in Southeast Asia (Eastman 
and Fidock, 2009). Subsequently, there was a global surge in malaria mortality and morbidity 
(Fidock, 2010). Primaquine is the only licensed tissue schizonticide available, which targets liver 
stage parasites (Baird, 2005; Schlitzer, 2007). It is the only classic drug capable of killing the 
hypnozoites of P. vivax and P. ovale (Enayati and Hemingway, 2010). Primaquine is also able to kill 
sexual blood stages (gametocytes), which prevents mosquito infection. However, safety concerns 
about this drug have limited its usage (Kiszewski, 2011). 
For the last decade, artemisinin-based combination therapies (ACTs) have been recommended as 
the best first-line treatment for P. falciparum malaria (WHO, 2010). Combination therapies exploit 
two drugs with different modes of action against the same parasite developmental stage (Baird, 
2005). Artemisinin is highly potent against the asexual blood stages, rapidly reducing parasitemia 
(Eastman and Fidock, 2009). It is also active against immature gametocytes, which reduces malaria 
transmission (Baird, 2005). However, artemisinin is promptly eliminated from the body and seven 
days of treatment would be required if the drug was used alone, which is deemed impractical. In 
combination with a slowly excreted blood schizonticide, like mefloquine, necessary treatment time is 
reduced to three days. Although combination therapies are more expensive, shorter treatment 
times increase patient compliance and slow the development of parasite resistance (Greenwood et 
al., 2005). Together with ITNs and IRS, ACTs have reduced malaria transmission in sub-Saharan Africa 
(Fidock, 2010). Worryingly though, artemisinin resistance in P. falciparum was recently reported in 
the Thai-Cambodia border (WHO, 2010). The WHO is battling to contain artemisinin resistance 
because few alternative antimalarials are available for the immediate future.  
Public-private partnerships, like the Medicines for Malaria Venture (MMV), are currently trying to 
discover and develop new antimalarial drugs (Enayati and Hemingway, 2010). Drugs against the 
sporozoites, liver stages and sexual blood stages are seriously lacking (Kiszewski, 2011; Mazier et al., 
2009). The development of high throughput screens of novel antimalarial drug candidates has been 
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a valuable step forward (Delves et al., 2012; Fidock, 2010). Unfortunately, drug development is a 
very slow process (Enserink, 2010). A key aim is to develop successful transmission blocking drugs 
that are effective against mature gametocytes and stop mosquitoes from being infected. The ideal 
antimalarial would require a single dose and target both asexual and sexual stages. Some promising 
candidates are currently undergoing development, such as Tafenoquine manufactured by 
GlaxoSmithKline (GSK) (Kiszewski, 2011; Schlitzer, 2007) and OX439 from MMV (Delves et al., 2012).  
 
Malaria vaccines 
A fully protective malaria vaccine has proven elusive. Hurdles to vaccine development have included 
lack of funding and the sheer complexity of the parasite biology and life cycle (Crompton et al., 
2010). Notably, the parasite naturally undergoes extensive antigenic variation and has many 
redundant proteins to evade the host immune response. To eliminate malaria with a vaccine, it 
would need to be almost 100% efficacious and given to the population at risk with very high 
coverage, which may be unattainable (Enayati and Hemingway, 2010). Therefore, a vaccine would 
need to be used in coordination with other malaria control strategies, like ITNs. 
The most clinically advanced malaria vaccine candidate by far is RTS,S, which is undergoing phase 3 
trials in seven African countries. It is the world’s first malaria vaccine candidate to reach large-scale 
phase 3 testing, which is the final stage of development before submission to the regulatory 
authorities (GlaxoSmithKline and PATH, 2012). GSK created RTS,S in 1987 and led its early 
development. In 2001, GSK went into a public-private partnership with the PATH Malaria Vaccine 
Initiative (MVI), supported by the Bill & Melinda Gates Foundation, to develop the vaccine for use in 
young children in Africa. RTS,S is a pre-erythrocytic (liver stage) subunit vaccine that targets the 
parasite’s circumsporozoite (CS) protein, the most prominent surface protein of the sporozoite. The 
vaccine is a recombinant protein combining part of P. falciparum CS protein with a hepatitis B virus 
surface antigen, which improves immunogenicity. It is administered with patented GSK adjuvant 
systems called AS01 or AS02. Together, this induces production of CS-specific antibodies and CD4+ T-
cells, which reduce the parasite’s ability to invade and develop within liver cells. The phase 3 trials 
are investigating vaccine efficacy, safety and immunogenicity in young babies and older infants 
(Agnandji et al., 2011). Early results met the modest expectations set by the phase 2 trials. The risk 
of clinical malaria and severe malaria were reduced by 56% and 47%, respectively, in older infants. 
Safety of the vaccine was also promising, with few adverse effects reported. The vaccine’s efficacy in 
young babies, its cost-effectiveness and longevity of the protective effect are yet to be determined. 
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Final results are not expected until 2014 but WHO has taken the unprecedented step of 
recommending the use of RTS,S in some African countries by 2015 (Tanne, 2011). 
Other vaccine candidates are being developed against every parasite life stage, with most targeting 
the pre-erythrocytic stages (Greenwood and Targett, 2011). Whole parasite immunisation, using 
sporozoites attenuated by irradiation or genetic manipulation, was one of the earliest vaccine 
attempts and has recently been revived (Hill, 2011). It is hoped this pre-erythrocytic vaccine could 
induce significantly higher levels of efficacy than RTS,S but product development is challenging. 
Vectored vaccines, usually delivered in a prime-boost regime, use viral vectors or plasmid DNA to 
deliver pre-erythrocytic or blood stage antigens to induce an immune response. Progress with 
developing asexual blood stage vaccines has been disappointing and improved target antigens are 
required. One challenge for the future is developing multicomponent vaccines against all life stages 
(Hill, 2011; Vogel, 2010). 
An exciting prospect for malaria control is the development of transmission blocking vaccines (TBVs), 
which prevent parasites infecting the mosquito vector. The aim would be to immunise humans with 
gametocyte, gamete, zygote or ookinete antigens so they produce antibodies which are transferred 
to the mosquito during blood feeding. These antibodies could prevent or reduce oocyst 
development in the mosquito gut and therefore malaria transmission (Crompton et al., 2010; Hill, 
2011). This is a logical approach as the parasite is at its most vulnerable inside the mosquito because 
it is present extracellularly and in small numbers (Figure 1.2) (Crompton et al., 2010). These vaccines 
are known as “community vaccines” because they would benefit the local population rather than the 
immunised individuals. The entire population would need to be vaccinated to block transmission, 
which could be logistically difficult. Early trials of TBV candidates have been very promising, with 
some blocking parasite development by 96% (Vogel, 2010). Interestingly, mosquito midgut antigens 
have also been proposed for use in TBVs. An aminopeptidase N (AgAPN1) in the An. gambiae midgut 
was recently identified as a putative ligand for ookinete invasion (Dinglasan et al., 2007). It was 
demonstrated that antibodies against AgAPN1 could significantly inhibit P. falciparum invasion in 
several mosquito species, which implies a conserved role for AgAPN1 in ookinete invasion. 
Therefore, a major advantage of mosquito-stage vaccines is they could be effective against more 
than one Plasmodium species, such as P. falciparum and P. vivax, which is unlikely to be true for 
other types of vaccines (Hill, 2011; Vogel, 2010). 
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Genetically modified mosquitoes 
Technological advances have led to the exciting prospect of exploiting genetically modified (GM) 
mosquitoes to control malaria transmission. Furthermore, this can also be applied to controlling 
arboviruses, like dengue and CHIKV (Alphey, 2009). Two different approaches are available: 
population suppression and population replacement. Population suppression aims to use GM 
mosquitoes to reduce mosquito numbers in natural populations. An important example is RIDL 
(release of insects with a dominant lethal), which is an advancement on the sterile insect technique 
(SIT). In SIT, mass-reared male insects are sterilised and released repeatedly into wild populations to 
mate with wild females. This results in few viable offspring and ultimately suppresses the population 
(Black et al., 2011). In RIDL, male GM mosquitoes are fertile but their female offspring are killed by a 
dominant lethal gene whereas male offspring pass the lethal gene on (Thomas et al., 2000). If 
sufficient numbers of males are released over a sustained period, this suppresses the local 
population. Expression of the lethal gene is conditional, usually in the absence of tetracycline, so 
females survive in the laboratory and are killed before release by withdrawing the drug. The 
conditional female-specific lethal gene removes any danger of accidental release and also the need 
to sterilise males. RIDL field trials using Ae. aegypti are ongoing (Alphey, 2009). It is believed that 
RIDL would be useful for suppressing isolated mosquito populations but not for large areas. 
Population replacement involves replacing the natural mosquito population with GM mosquitoes 
refractory to Plasmodium parasites (Catteruccia, 2007; Christophides, 2005). Sequencing of the An. 
gambiae genome (Holt et al., 2002) has helped identify mosquito effector genes that could be 
exploited for population replacement programs. The mosquito immune system is an excellent target 
for manipulation as it plays an important role in naturally refractory mosquito strains or species. For 
example, the mosquito immune system could be enhanced by overexpressing a Plasmodium 
antagonist (Christophides, 2005). To date, no single gene is capable of completely blocking 
Plasmodium development and so multiple genes would need to be targeted (Catteruccia, 2007). This 
would also reduce the likelihood of resistance emerging in the parasite population. 
Several examples of partially refractory GM mosquitoes have been created in the laboratory. 
Transgenic An. stephensi mosquitoes expressing the artificial peptide SM1 in the midgut significantly 
reduced capacity to transmit the rodent parasite, P. berghei (Ito et al., 2002). SM1 binds to the 
mosquito salivary gland and midgut epithelia, which inhibits parasite invasion. This was the first 
demonstration of stably transforming Anopheles mosquitoes to affect malaria transmission. In 
another study, ectopic overexpression of the antimicrobial peptide (AMP), cecropin A, in the An. 
gambiae midgut resulted in a 60% reduction in oocysts (Kim et al., 2004). An. stephensi have also 
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been engineered to express single-chain antibodies (scFvs), which significantly reduced P. falciparum 
infection levels (Isaacs et al., 2012; Isaacs et al., 2011). Expression of a synthetic antimalarial gene, 
Vida3, in the midgut of An. gambiae reduced rodent parasite P. yoelii infections by 85%, although 
results were inconsistent for P. falciparum (Meredith et al., 2011).  
A genetic drive system is necessary to spread a new trait into field populations of mosquitoes 
(Christophides, 2005). Various different gene drive systems have been proposed, with some tested 
in the laboratory. Examples include transposable elements, meiotic drive, intracellular symbionts like 
Wolbachia and homing endonucleases (Sinkins and Gould, 2006). Tight linkage between the gene 
drive system and the engineered gene(s) is essential to prevent recombination from separating 
them, resulting in spread of an “empty” drive (Alphey et al., 2002; Catteruccia, 2007; Christophides, 
2005). 
Practical implementation of GM mosquitoes for malaria control is challenging, with technical, ethical 
and safety issues to overcome (Catteruccia, 2007). It is vital to have a thorough understanding of the 
population structure, behaviour and ecology of the mosquito population being targeted 
(Christophides, 2005). Detailed knowledge of local malaria transmission dynamics is also essential. 
Altering the mosquito immune system may have fitness or survival costs, which must be investigated 
if the GM mosquito is to successfully mate with wild insects (Catteruccia, 2007). Also, all GM 
mosquito strategies are species-specific and can be complicated by the intricate population 
structure of the An. gambiae complex. 
An alternative approach to GM mosquitoes is paratransgenesis, the transformation of obligate insect 
symbionts. In a recent laboratory study, Pantoea agglomerans, a bacterial symbiont of Anopheles 
mosquitoes, was engineered to secrete anti-Plasmodium effector proteins (Bisi and Lampe, 2011). It 
remains to be determined whether this strategy is able to block malaria transmission in the field.  
 
Mosquito immunity 
The innate immune response is a powerful, fast-acting and primitive form of defence shared by all 
eukaryotes and is the sole defence mechanism of insects (Christophides et al., 2004). It is a broad 
defence system that allows organisms to quickly distinguish between self and infectious non-self to 
protect against infection (Michel and Kafatos, 2005). Once the danger is recognised, the signal is 
modulated, either amplified or dampened depending on its original intensity and the situation 
(Christophides et al., 2004). A diverse range of effector mechanisms, such as phagocytosis, lysis and 
melanisation are deployed to kill the invader. As well as detecting non-self, the innate immune 
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system can also be activated upon recognition of endogenous molecules released from injured or 
stressed cells, known as damage-associated molecular patterns (DAMPs) (Carta et al., 2009; Newton 
and Dixit, 2012). DAMPs, such as ATP, uric acid, DNA, heat-shock proteins and collagen, act as 
danger signals and trigger inflammatory responses to restore homeostasis. Unlike the adaptive 
immune response of vertebrates, innate immunity is largely independent of previous infections 
(Hoffmann, 2003; Meister et al., 2004). However, a memory-like response called “immune priming” 
has been reported in insects, whereby an initial challenge makes the immune system more 
responsive to subsequent challenges of the same or different type (Schmid-Hempel, 2005). This 
protection can be either generalised or pathogen-specific and persist for several weeks (Pham et al., 
2007). 
The An. gambiae innate immune response is a complex interplay between many effector 
mechanisms, including a complement-like system (Figure 1.5). Insect defence can be broadly divided 
into humoral and cellular reactions, although many immune molecules are shared between the two 
types of responses (Christophides et al., 2004). In humoral reactions, immune molecules are 
secreted into the hemolymph where they fight microbial invaders. Insects have an open circulatory 
system, which allows the hemolymph to bathe organs and tissues. The major immune tissues of 
insects are hemocytes (blood cells) and fat body, a diffuse organ analogous to the mammalian liver 
and adipose tissue. Cellular responses entail direct action by hemocytes, such as encapsulation and 
phagocytosis (Christophides et al., 2004). Some responses are acute and happen rapidly after 
infection, such as cellular responses or those involving immune effectors constitutively present in 
the hemolymph. Other responses are inducible and require activation of signalling pathways, 
resulting in induction of immune gene expression. Induction can also replace those molecules 
utilised in acute reactions. 
The fruitfly, Drosophila melanogaster, has been an invaluable model for studying the innate immune 
system (Lemaitre and Hoffmann, 2007). A great deal of our knowledge about An. gambiae immunity 
originally stemmed from studies in Drosophila. Mosquitoes and fruitflies are both Dipteran insects, 
which are believed to have separated approximately 250 million years ago (Waterhouse et al., 2007). 
Classical genetics, the use of mutants and morphological markers and genetic manipulation have 
been perfected in the fly. However, in recent years, An. gambiae has emerged as an alternative 
model system to study innate immunity. Furthermore, as a major malaria vector, An. gambiae is 
ideal for studying natural host-parasite interactions. 
The last decade or more has seen tremendous advances in the tools and techniques available to 
study the mosquito immune system. High throughput sequencing permitted the complete sequence 
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of the An. gambiae genome (Giles reference strain) to be published in 2002 (Holt et al., 2002) and 
further annotation continues. Comparative genomic analyses between An. gambiae and the well-
studied D. melanogaster have been exploited to identify candidate immunity genes (Christophides et 
al., 2002). The genomes of Ae. aegypti and Culex pipiens quinquefasciatus, two other vector 
mosquitoes, have also been sequenced, which allows for further genomic comparisons (Baton et al., 
2008). VectorBase has been developed as an online bioinformatic resource for analysing disease 
vector genomes and expression data (Lawson et al., 2009). Furthermore, genome sequencing of P. 
falciparum, P. vivax, P. yoelii and P. berghei has been successfully accomplished (Carlton et al., 2008; 
Carlton et al., 2002; Gardner et al., 2002; Hall et al., 2005).  
Cultured cell lines derived from An. gambiae hemocyte-like cells were generated for analysing gene 
function in vitro (Muller et al., 1999). Expressed Sequence Tag (EST) libraries constructed from these 
cell lines were used for the first An. gambiae microarray to analyse gene expression (Dimopoulos et 
al., 2002). An important advancement was the development of whole-genome An. gambiae 
microarray platforms, which allow genome-wide transcriptional profiling. Microarrays have 
facilitated the discovery of genes differentially expressed by various immune challenges (Dong et al., 
2006a; Marinotti et al., 2005; Vlachou et al., 2005). Recently, a high-density single nucleotide 
polymorphism (SNP) genotyping array has been employed to map genetic divergence between 
mosquitoes in a population or species (Lawniczak et al., 2010). 
Germline transgenesis of mosquitoes has been successfully implemented in An. stephensi 
(Catteruccia et al., 2000) and An. gambiae (Grossman et al., 2001). This allows overexpression of 
candidate genes to elucidate their immune function. Nevertheless, producing and maintaining 
transgenic mosquitoes is technically and logistically demanding (Baton et al., 2008). Transient gene 
silencing using RNA interference (RNAi) has become the preferred method for functional 
characterisation of candidate genes. RNAi can silence a target gene in the whole mosquito by 
microinjection of specific double-stranded (ds) RNA (Blandin et al., 2002). Rather than a complete 
knockout, RNAi can significantly “knockdown” expression of the gene. The dsRNA is taken up by cells 
where it is cleaved into small interfering RNA fragments (siRNA) that induce degradation of 
endogenous target mRNA. This technique can be effectively used for cultured cells by transfecting 
the dsRNA (Levashina et al., 2001). Simultaneous RNAi silencing of two or more genes can be used to 
investigate epistatic interactions. RNAi is a form of reverse genetics: investigating the phenotype 
associated with a known gene. It has been pivotal in the discovery and characterisation of many 
novel anti-Plasmodium effectors. Transgenic P. berghei constitutively expressing green fluorescence 
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protein (GFP) throughout its life cycle is an excellent tool for screening candidate genes for a role in 
Plasmodium infections (Franke-Fayard et al., 2004). 
Together, these powerful technological advances have transformed the study of molecular biology 
of the mosquito and enabled dissection of its innate immune system. Importantly, they led to the 
exciting discovery of a complement-like system in An. gambiae (Blandin et al., 2008), which will be 
discussed later in this Chapter. 
 
Figure 1.5  Schematic overview of innate immunity in An. gambiae.  
Plasmodium ookinetes invade the mosquito midgut epithelium (a) and some are killed by nitration of 
epithelial cells (b). The vast majority of parasites are killed and lysed in the basal labyrinth by the 
mosquito complement-like system (c), which involves the effector TEP1 and its interaction with 
LRIM1/APL1C (h). In certain mosquito genetic backgrounds, ookinetes are melanised by the activity of 
phenoloxidase (PO) (d). Toxic nitric oxide (NO) generated by midgut epithelial cells and possibly fat 
body cells kills some early oocysts (e). Surviving oocysts develop in the basal labyrinth and rupture after 
approximately two weeks to release thousands of sporozoites into the hemolymph (f). These 
sporozoites travel to and invade the mosquito salivary glands (g). Bacteria that invade the hemolymph 
through the cuticle or from the midgut are phagocytosed by hemocytes after opsonisation by TEP1, 
possibly in complex with LRIM1/APL1C (i). Antimicrobial peptides (AMPs), produced by the fat body, 
hemocytes and barrier epithelia, play an important role in microbial killing in the hemolymph (j). From 
Yassine and Osta, 2010. 
 
Pathogen recognition 
Insects have an array of pattern recognition receptors (PRRs) that detect and bind to conserved 
pathogen-associated molecular patterns (PAMPs) and trigger immune responses (Christophides et 
al., 2002). PAMPs are crucial to microbial physiology but rare or absent from higher organisms 
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(Michel and Kafatos, 2005). Examples include peptidoglycan (PGN), lipopolysaccharide (LPS) and β-
1,3 glucans, which are microbial cell wall or membrane components. The nature of Plasmodium 
PAMPs and how they are recognised by the mosquito is still unknown (Christophides et al., 2004). 
PRRs can be membrane bound, such as on the surface of hemocytes, or circulating in the 
hemolymph. Once a PRR has bound a PAMP, it can directly mediate microbial killing via phagocytosis 
and encapsulation or it can indirectly initiate killing by activating serine protease cascades in the 
hemolymph and intracellular signalling pathways (Warr et al., 2008). 
The PGN recognition protein (PGRP) family are the best studied insect PRRs (Christophides et al., 
2004). This family has central and diverse functions in triggering immune reactions, such as 
melanisation, phagocytosis and signal transduction (Christophides et al., 2002). There are two PGRP 
subfamilies: short (S) are secreted whereas long (L) are either transmembrane or intracellular. There 
are seven An. gambiae PGRP family members (three S and four L) compared to 13 in Drosophila 
(seven S and six L). PGRP-S proteins have amidase activity whereas PGRP-L proteins are catalytically 
inactive. PGRP-LC is essential for survival of gram-negative and gram-positive bacterial infections in 
An. gambiae (Meister et al., 2009). Like in Drosophila, An. gambiae PGRP-LC undergoes alternative 
splicing to form three isoforms with variant PGRP domains (LC1, LC2 and LC3) and different 
specificities (Christophides et al., 2002; Meister et al., 2009). 
Another established family of insect PRRs are the gram-negative bacteria binding proteins (GNBPs), 
which are known to bind to LPS and β-1,3 glucans (Christophides et al., 2002). Three GNBPs have 
been discovered in Drosophila and the family has expanded to six in An. gambiae. Different GNBPs 
have been demonstrated to aid mosquito survival during gram-negative and gram-positive bacterial 
infections (Warr et al., 2008). Several GNBP family members are also antagonists of P. falciparum 
and P. berghei. 
The C-type lectins (CTLs), which bind carbohydrates in a calcium-dependent manner, are also 
predicted to be PRRs (Christophides et al., 2004). There are 35 and 22 CTLs predicted in Drosophila 
and Anopheles, respectively (Christophides et al., 2002). CTLs have been implicated in innate 
immune reactions in various insects, including melanisation, cellular encapsulation and opsonisation 
(Ao et al., 2007; Jomori and Natori, 1992). In An. gambiae, CTL4 and CTLMA2 circulate in the 
hemolymph as a disulphide-bonded heterodimer and act as repressors of P. berghei ookinete 
melanisation (Osta et al., 2004a; Schnitger et al., 2009), although their role in P. falciparum 
infections is uncertain (Cohuet et al., 2006). The CTL4/CTLMA2 complex is also involved in defence 
against gram-negative bacteria (Schnitger et al., 2009). 
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Other potential insect PRR families include the Galectins (GALEs), the scavenger receptors (SCRs) and 
the fibrinogen-like domain immunolectins (known as FBNs or FREPs).  
 
Immune signalling pathways 
Five intracellular immune signalling pathways have been identified in Drosophila and these are also 
found in mosquitoes. The two best studied, Toll and Immune deficiency (Imd), are fundamental to 
the Drosophila innate immune response and evolved early in metazoan evolution (Hoffmann, 2003). 
The Toll and Imd pathways in insects are homologous to the Toll-like receptor (TLR) and Tumour 
necrosis factor (TNF) signalling pathways in vertebrates, respectively. In Drosophila, the Toll pathway 
chiefly responds to infections with fungi and gram-positive bacteria whereas Imd is mainly activated 
by gram-negative bacteria. There is, however, significant cross-talk between pathways, which can 
therefore act synergistically (Ferrandon et al., 2007; Lemaitre and Hoffmann, 2007). The Toll 
pathway is also critical for embryogenesis in Drosophila. In the Toll pathway, PRRs convey an 
immune signal to a transmembrane receptor, resulting in intracellular signalling which culminates in 
nuclear translocation of a nuclear factor-κB/reticuloendotheliosis (NF-κB/Rel) transcription factor. In 
the Imd pathway, transmembrane PRRs directly initiate intracellular signalling. Depending on the 
signal, the NF-κB/Rel transcription factor induces expression of a specific repertoire of immune 
genes, such as AMPs. Most AMPs are secreted, cationic effectors that kill microbes by binding to 
their lipid membranes and causing surface perturbation and cytoplasmic efflux (Broderick et al., 
2009; Christophides et al., 2004). Many AMPs are differentially active against particular pathogens. 
For example, Drosophila diptericin is mainly active against gram-positive bacteria, defensin against 
gram-positive bacteria and drosomycin against fungi (Lemaitre and Hoffmann, 2007). Some AMP 
genes, for example drosomycin, are activated to different extents by both the Toll and Imd pathways 
under diverse circumstances (Lemaitre and Hoffmann, 2007).  
In the Drosophila Toll pathway, the Lysine-type PGN of gram-positive bacteria is recognised by three 
circulating PRRs, PGRP-SA, PGRP-SD and GNBP1 (Figure 1.6) (Ganesan et al., 2011; Lemaitre and 
Hoffmann, 2007). GNBP3 detects β1,3-glucans from fungal cell walls (Ferrandon et al., 2007). All 
these recognition events converge on the Toll pathway via activation of the same protease, Modular 
Serine Protease (ModSP) (Ganesan et al., 2011). ModSP triggers a serine protease cascade which 
activates Spätzle processing enzyme (SPE), which directly cleaves pro-Spätzle and releases the active 
extracellular ligand, Spätzle. Virulence factors, produced by some bacteria and fungi, can also 
stimulate the Toll Pathway by activating the serine protease, Persephone, which converges on SPE, 
independently of ModSP. The negative regulator of Persephone, a serpin called Necrotic, can act to 
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dampen Toll signalling (Govind, 2008). Mature Spätzle binds to the transmembrane Toll receptor, 
inducing its homodimerisation (Lemaitre and Hoffmann, 2007). Toll signals via its intracellular Toll-
IL1 receptor (TIR) domain to recruit three intracellular Death-domain (DD) containing proteins, 
dMyD88, Tube and Pelle. The kinase Pelle is activated by auto-phosphorylation, which triggers the 
phosphorylation and degradation of the NF-κB/Rel inhibitor, IκB/Cactus. As a result, NF-κB/Rel 
transcription factors Dif and Dorsal, which are usually sequestered by Cactus, are released and 
translocate to the nucleus. Here they induce the expression of specific antimicrobial genes, such as 
drosomycin. Dorsal is important for developmental processes whereas Dif is essential in adult 
immunity (Ganesan et al., 2011). 
The Drosophila Imd pathway is triggered by the PRRs, PGRP-LC and PGRP-LE, which detect the DAP-
type PGN of gram-negative bacterial cell walls (Figure 1.6) (Ganesan et al., 2011). PGRP-LC is 
membrane bound whereas PGRP-LE is usually intracellular but a cleaved PGRP-domain only form can 
be extracellular. In the cytoplasm, PGRP-LE recognises tiny PGN fragments that have entered the cell 
or PGN from intracellular bacterial pathogens, such as Listeria monocytogenes. Upon direct binding 
of PGN, the receptors recruit the adaptor Imd. Imd interacts with dFADD which itself recruits the 
caspase Dredd, all via their DDs. Next, Dredd is proposed to bind Relish, an NF-κB/Rel transcription 
factor with a self-inhibitory ankyrin (ANK) repeat domain (Govind, 2008). Relish is phosphorylated by 
the IKKγ/β complex, which is itself believed to be activated by the TAK1-TAB2 complex in an Imd-
dependent manner (Ferrandon et al., 2007; Lemaitre and Hoffmann, 2007). Phosphorylated Relish is 
cleaved by Dredd, releasing its NF-κB/Rel domain from inhibition and allowing nuclear translocation. 
Relish stimulates the expression of a specific subset of genes, including diptericin. 
Comparative genomics has shown that the majority of Toll and Imd pathway components are highly 
conserved between D. melanogaster and An. gambiae (Christophides et al., 2002; Waterhouse et al., 
2007). In contrast, other immune genes are rapidly evolving (Waterhouse et al., 2007). There are 
most differences in recognition, modulation and effector molecules rather than signal transduction, 
which might reflect adaptation to different pathogens. As a blood feeding insect, An. gambiae is 
subjected to a diverse range of pathogens compared to Drosophila, which primarily feed on yeast 
and sugars (Dimopoulos, 2003). For example, of the seven AMP families present in Drosophila, only 
defensins (DEFs), cecropins (CECs) and attacins (ATTs) have been so far found in An. gambiae 
(Waterhouse et al., 2007). Mosquitoes have an additional AMP family called gambicins (GAMs). The 
Imd pathway PRR, PGRP-LE, is also absent in mosquitoes (Christophides et al., 2002). 
The precise mechanisms and functions of the Toll and Imd pathways in mosquitoes are still being 
investigated (Garver et al., 2008). In An. gambiae, REL1 (orthologue of Dorsal) and REL2 (orthologue 
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of Relish) are the NF-κB/Rel transcription factors in the Toll and Imd pathways, respectively 
(Christophides et al., 2004). Surprisingly, there is no orthologue of Dif in the An. gambiae genome 
(Christophides et al., 2002). An. gambiae REL2 undergoes alternative splicing to produce the full-
length isoform REL2-F and a shorter version, REL2-S, without the inhibitory ANK repeats and DD 
(Meister et al., 2005). Whereas Relish in Drosophila is specific to gram-negative bacteria, REL2-F and 
REL2-S are involved in defence against gram-positive and gram-negative bacteria, respectively. It 
therefore seems that REL2-S substitutes for the role of Dif. Like Drosophila, the An. gambiae Toll 
pathway is primarily active against fungi and gram-positive bacteria (Hillyer, 2010). In Ae. aegypti, 
the Toll pathway has been shown to control dengue virus infection (Xi et al., 2008) but the pathway 
does not affect ONNV infections in An. gambiae (Waldock et al., 2012).  
Both the Toll and Imd pathways have been implicated in defence against Plasmodium. Imd signalling 
and subsequent REL2-F activation limits the development of P. berghei oocysts in the An. gambiae 
midgut (Meister et al., 2005). REL2 regulates the expression of major Plasmodium antagonists and 
AMPs (Dong et al., 2011; Garver et al., 2009; Meister et al., 2005). Overexpression of REL2 causes 
increased expression of these anti-Plasmodium effectors, which almost completely blocks P. 
falciparum infection of An. stephensi (Dong et al., 2011). Furthermore, Caspar, a negative regulator 
of REL2, has been shown to control resistance to P. falciparum in the major malaria vectors, An. 
gambiae, An. stephensi and An. albimanus (Garver et al., 2009). The Toll pathway has also been 
suggested to play an anti-Plasmodium role. Several important effectors, like components of the 
complement-like pathway, are regulated by the Toll/REL1 pathway (Fraiture et al., 2009; Frolet et al., 
2006). Silencing Cactus, a negative regulator of REL1, renders An. gambiae mosquitoes almost 
refractory to P. berghei infections (Frolet et al., 2006). Interestingly, REL1 and REL2 were shown to 
be most efficient against P. berghei and P. falciparum, respectively, highlighting species specificity 
(Garver et al., 2009). Other immune signalling pathways in Drosophila and other insects are poorly 
characterised (Lemaitre and Hoffmann, 2007). The Janus kinase (JAK)/signal transducers and 
activators of transcription (STAT) pathway is essential for hematopoiesis in mammals and embryonic 
development in Drosophila (Christophides et al., 2004). It also plays an immunity role in insects but 
little is known about the mechanisms involved. The JAK/STAT pathway is involved in antiviral 
immunity in mammals, Drosophila and Ae. aegypti but does not have a major role in An. gambiae 
defence against ONNV (Steinert and Levashina, 2011; Waldock et al., 2012). Signalling by AgSTAT-A 
was recently reported to mediate a late-phase response against Plasmodium (Gupta et al., 2009). 
Next, the c-Jun N-terminal kinase (JNK) pathway plays a key role in the regulation of many 
developmental processes in Drosophila and has been proposed to regulate immune gene expression 
(Lemaitre and Hoffmann, 2007). JNK signalling is thought to be a branch of the Imd pathway as it is 
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triggered by TAK1 (Figure 1.6). Finally, the mitogen-activated protein kinase (MAPK)/p38 stress 
pathway has been implicated in the immune response of plants, Caenorhabditis elegans and 
mammals but its role in insects is unknown (Lemaitre and Hoffmann, 2007). 
 
Figure 1.6  Intracellular immune signalling pathways in Drosophila melanogaster.  
The Toll and Imd signalling pathways modulate expression of AMPs in Drosophila. In the fruitfly, the 
Toll pathway predominantly responds to fungal and gram-positive bacterial infections whereas the Imd 
pathway is largely activated by gram-negative bacteria. In the Toll pathway, PAMPs are recognised by 
soluble PRRs, including PGRP-SA, PGRP-SD, GNBP1 and GNBP3. As well as the serine protease 
Persephone, these PRRs converge on SPE, which cleaves and activates Spätzle. Spätzle binds to the 
transmembrane receptor, Toll, inducing its dimerisation. MyD88, Tube and Pelle are recruited, resulting 
in phosphorylation and degradation of the inhibitor, Cactus. The NF-κB/Rel transcription factors, Dif 
and Dorsal, are subsequently released and activate expression of immune genes, such as drosomycin. 
In the Imd pathway, the transmembrane PRR, PGRP-LC, directly binds to PAMPs and recruits 
intracellular adaptor, Imd. Imd interacts with dFADD and caspase Dredd. The Imd pathway NF-κB/Rel 
transcription factor, Relish, has a self-inhibitory ankyrin (ANK) domain. After phosphorylation by the 
IKKγ/β complex, Relish is cleaved by Dredd and relieved from inhibition. The Rel domain of Relish 
translocates to the nucleus and activates specific genes, such as diptericin. From Lemaitre and 
Hoffmann, 2007.  
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The mosquito complement-like system 
Thioester-containing protein 1 (TEP1) and Leucine-rich repeat immune protein 1 (LRIM1) were the 
first major Plasmodium antagonists identified by RNAi (Blandin et al., 2004; Osta et al., 2004a). 
Silencing TEP1 or LRIM1 results in a dramatic increase in P. berghei oocysts in the midgut of 
susceptible mosquitoes, which suggests that wild-type mosquitoes actively control parasite 
development in a TEP1-LRIM1 dependent manner. Another important anti-Plasmodium effector 
related to LRIM1 named Anopheles Plasmodium-responsive leucine-rich repeat 1 (APL1) was 
discovered shortly after (Riehle et al., 2006). In a survey of natural An. gambiae populations in West 
Africa, APL1 mapped to a genetic locus that controls resistance to P. falciparum. Silencing APL1 gives 
the same antagonistic phenotype with P. berghei as LRIM1 and TEP1 (Povelones et al., 2009; Riehle 
et al., 2006). Manual re-annotation revealed that the APL1 locus encompasses three independent 
yet closely related genes (APL1A, APL1B and APL1C); of these only APL1C is a P. berghei antagonist 
(Riehle et al., 2008) whereas all three paralogues have been implicated in defence against P. 
falciparum to varying degrees (Garver et al., 2012; Mitri et al., 2009). 
TEP1, LRIM1 and APL1C are core members of the mosquito complement-like pathway, which plays a 
vital role in the killing and disposal of pathogens, including Plasmodium parasites and bacteria 
(Blandin et al., 2008). Melanisation, lysis and phagocytosis are all effector mechanisms of the 
complement-like system. The mosquito complement-like pathway, particularly its biochemical 
regulation, is still largely uncharacterised (Povelones et al., 2011). Interestingly, LRIM1 and APL1C do 
not have identifiable orthologues in D. melanogaster (Waterhouse et al., 2007). Evidence suggests 
that the LRIM1/APL1C/TEP1 module is conserved in Ae. aegypti, as their orthologues are 
upregulated following infection with a life-shortening Wolbachia strain (Kambris et al., 2009). 
The TEPs are an important family of immune effectors, which are related to the vertebrate 
complement factors, C3, C4 and C5 and the universal protease inhibitors, α2-macroglobulins (α2Ms) 
(Christophides et al., 2004). There are 15 TEPs in An. gambiae compared to only six in Drosophila 
(Christophides et al., 2002). The highly reactive TE bond is exposed by proteolytic cleavage, either by 
a specific convertase protease complex or a general protease (Blandin and Levashina, 2004). Once 
proteolytically active, TEPs use their TE to covalently bind to pathogen surfaces, opsonising them for 
destruction (Levashina et al., 2001). Interestingly, nine Anopheles TEPs and two Drosophila TEPs lack 
the TE motif, which might suggest these TEPs have a regulatory role (Christophides et al., 2002). A TE 
motif is not essential for protein activity, as shown by vertebrate C5 complement factors. TEP family 
members are involved in anti-Plasmodium and antibacterial defence (Blandin and Levashina, 2004). 
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TEP1 displays considerable sequence, structural and functional similarities to C3, the central effector 
of the vertebrate complement system (Baxter et al., 2007; Levashina et al., 2001). Both are secreted 
glycoproteins with a conserved TE motif in comparable locations. The TE is sequestered and 
activated by cleavage in a protease-sensitive region of the protein (Baxter et al., 2007). TEP1 lacks 
the anaphylatoxin domain of C3, which triggers inflammatory responses in vertebrates. Vertebrate 
C3 is 180 kDa and composed of two chains, α and β, which are joined together by disulphide bridges. 
TEP1 circulates in the mosquito hemolymph as both the full length 165 kDa protein (TEP1-F) and a 
mature, proteolytically processed form (TEP1cut). The two parts of TEP1cut remain held together by a 
non-disulphide linkage and they can be separated by non-reducing SDS-PAGE into N- and C-terminal 
fragments (~75 kDa and ~85 kDa, respectively) (Levashina et al., 2001). The protease responsible for 
cleaving TEP1-F into mature TEP1cut is still undetermined. In vitro experiments have indicated that 
the TE bond, found in the C-terminal fragment, is not spontaneously activated by this cleavage 
(Fraiture et al., 2009). It is unknown how the TE of TEP1cut is activated in vivo and whether an 
additional cleavage is necessary. 
TEP1 engages in complement-like activity, including opsonisation. Upon proteolytic activation, 
vertebrate C3 proteins covalently bind to pathogen surfaces via their active TE bond and trigger a 
cascade of events that culminates in pathogen killing by phagocytosis or cell lysis (Levashina 2001). 
Likewise, TEP1cut covalently binds to the surface of bacteria and promotes their phagocytosis in a TE-
dependent manner (Levashina et al., 2001). Chemical inactivation of the TE bond with methylamine 
or TEP1 knockdown by RNAi impairs phagocytosis in vitro (Levashina et al., 2001). TEP1 knockdown 
also severely impairs phagocytosis of Escherichia coli (gram-negative bacteria) and Staphylococcus 
aureus (gram-positive bacteria) in adult mosquitoes (Moita et al., 2005).  
Plasmodium killing by Anopheles mosquitoes is mediated by direct binding of TEP1cut to the ookinete 
surface, which triggers parasite lysis or melanisation (Blandin et al., 2004). TEP1cut binds to parasites 
as they emerge from invaded midgut cells into the basal labyrinth, the space between the midgut 
epithelia and the basal lamina. The basal lamina is permeable to hemolymph proteins but not 
hemocytes. As mentioned earlier, silencing TEP1 substantially increases Plasmodium infection 
intensity. A C-terminal TEP1 antibody was used to demonstrate TEP1 localisation on the surface of P. 
berghei ookinetes 24 to 48 h after an infected blood meal. Using transgenic P. berghei, the vast 
majority of TEP1-labelled parasites had lost GFP expression and were therefore dead. Importantly, 
not all ookinetes were TEP1-labelled but more labelled ookinetes were observed in refractory 
mosquitoes compared to susceptible mosquitoes. Binding of TEP1 also proceeded faster in 
refractory mosquitoes. TEP1 has also been observed on the surface of oocysts but not sporozoites, 
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highlighting the specificity of TEP1-parasite interactions. It should be noted that some parasites are 
killed in a TEP1-independent manner as parasites can be detected without GFP expression or TEP1 
labelling. 
LRIM1 and APL1C are related proteins that possess leucine-rich repeat (LRR) domains, which are 
found in host defence proteins of many phyla. LRIM1 and APL1C circulate in the hemolymph as a 
disulphide-linked heterodimeric complex (Baxter et al., 2010; Povelones et al., 2011). Using an 
antibody against LRIM1 or APL1C, a high molecular weight band is detected by non-reducing western 
blot that resolves into the predicted monomers under reducing conditions (Povelones et al., 2009). 
Upon silencing of LRIM1, APL1C is not secreted in vivo, and vice versa (Fraiture et al., 2009; 
Povelones et al., 2009). This suggests that complex formation is obligatory and occurs prior to 
secretion. The crystal structure of the LRIM1/APL1C heterodimer was recently solved, revealing that 
it is held together by a single intermolecular disulphide bond between conserved cysteine residues 
(Baxter et al., 2010). This has been confirmed with mutational analyses (Baxter et al., 2010; 
Povelones et al., 2011). 
The LRIM1/APL1C complex interacts with TEP1cut in the hemolymph, stabilising this processed form, 
maintaining it in circulation and promoting its localisation to parasite surfaces (Figure 1.7) (Fraiture 
et al., 2009; Povelones et al., 2009; Volohonsky et al., 2010). This interaction was demonstrated 
when the LRIM1/APL1C complex was able to co-immunoprecipitate endogenous TEP1cut from the 
conditioned media of mosquito hemocyte-like cells (Povelones et al., 2009). His-tagged TEP1 
injected into the mosquito hemocoel was also able to pull-down LRIM1 and APL1C (Fraiture et al., 
2009). Furthermore, the complex prevents TEP1cut from non-specifically reacting with self-tissues 
(Fraiture et al., 2009). RNAi-mediated depletion of LRIM1 or APL1C causes a significant decrease in 
levels of TEP1cut but not TEP1-F in the hemolymph (Fraiture et al., 2009; Povelones et al., 2009). 
Immunofluorescence staining showed that TEP1cut is deposited on mosquito tissues, such as the 
abdominal epidermis, in the absence of LRIM1/APL1C (Fraiture et al., 2009). Levels of TEP1cut in the 
hemolymph can be rescued by injection of recombinant LRIM1/APL1C (Baxter et al., 2010). 
Interestingly, the LRIM1/APL1C complex is still detected in the hemolymph after TEP1 knockdown, 
demonstrating that LRIM1/APL1C stability is not dependent on TEP1. Silencing of LRIM1 or APL1C 
completely abolishes binding of TEP1cut to P. berghei ookinetes and subsequent TEP1-mediated 
killing (Fraiture et al., 2009; Povelones et al., 2009). Therefore, TEP1 malfunction seems to be largely 
responsible for the increased parasite load observed upon LRIM1 or APL1C knockdown (Osta et al., 
2004a; Riehle et al., 2006). Furthermore, silencing TEP1, LRIM1 or APL1C in An. quadriannulatus 
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transforms this refractory mosquito into a highly susceptible Plasmodium vector (Habtewold et al., 
2008). 
 
Figure 1.7  Proposed roles of TEP1, LRIM1 and APL1C in the complement-like system of An. gambiae. 
Full-length TEP1 (TEP1-F) is constitutively cleaved in the mosquito hemolymph by an unknown 
protease. Cleavage generates TEP1-N and TEP1-C fragments, which remain together as a two-chain 
molecule called TEP1cut. The LRIM1/APL1C complex binds to TEP1cut, which stabilises TEP1cut and 
maintains it in circulation. This LRR complex is proposed to direct TEP1cut to pathogen surfaces during 
infection. During P. berghei infection, TEP1cut is released from the LRIM1/APL1C complex by an 
unknown mechanism, possibly via another protein. TEP1cut binds to the ookinete surface and promotes 
its destruction. When LRIM1 and/or APL1C are silenced by RNAi, TEP1cut reacts with mosquito tissues 
and is unable to localise to parasite surfaces. This results in increased survival of live oocysts. Adapted 
from Volohonsky et al., 2010.  
 
It is not clear whether the LRIM1/APL1C complex is able to recognise pathogen surfaces to control 
the specificity of TEP1 binding (Fraiture et al., 2009). One hypothesis is that TEP1 is released from 
the LRIM1/APL1C complex in close proximity to pathogens, which mediates activation of its TE bond 
and binding to the pathogen surface. To complicate matters, the LRIM1/APL1C complex was recently 
demonstrated to interact only with TEP1cut possessing an inactive TE in vitro, although the relevance 
of this in vivo is unknown (Baxter et al., 2010). The authors speculated that TEP1cut (with an inactive 
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TE) might act as a TEP1 convertase, activating free TEP1 molecules close to pathogen surfaces, under 
the regulation of LRIM1/APL1C. In addition to TEP1, the LRIM1/APL1C complex has been 
demonstrated to interact with other TEP family members in vitro (Povelones et al., 2011). The 
complex captured the N- and C-terminal fragments of TEP3, the C-terminal fragment of TEP4 and the 
N-terminal fragment of TEP9 from the conditioned media of mosquito hemocyte-like cells. As the 
LRIM1/APL1C complex is reported to interact with TEP1 with a 1:1 stoichiometry (Baxter et al., 
2010), it seems probable that LRIM1/APL1C forms independent complexes with each of these TEPs 
in response to different infections (Povelones et al., 2011).  
Basal immunity is an interesting concept related to the mosquito complement-like system and 
antiparasitic responses (Blandin et al., 2008; Frolet et al., 2006). It has been hypothesised that pre-
formed immune components are permanently circulating in the hemolymph, ready for rapid action 
against invading pathogens. TEP1, LRIM1 and APL1C are all expressed and secreted by hemocytes 
(Levashina et al., 2001; Pinto et al., 2009). Under normal conditions, the complement components, 
TEP1, LRIM1 and APL1C, are constitutively expressed under regulation of REL1 and REL2 (Fraiture et 
al., 2009; Frolet et al., 2006). TEP1, LRIM1 and APL1C are present in the hemolymph bathing the 
basal labyrinth poised to attack malaria parasites as they emerge through invaded cells (Blandin et 
al., 2008). Parasite invasion induces expression of these genes to replenish proteins utilised during 
the infection. Thus, acute response reactions play an important role in An. gambiae whereas 
Drosophila is highly dependent on inducible reactions. The role of constitutively expressed immune 
effectors in Drosophila is unclear. 
The role of the LRIM1/APL1C/TEP1 module in defence against the deadliest human parasite, P. 
falciparum, remains uncertain. Most functional studies to date have used the rodent parasite, P. 
berghei, as a convenient laboratory model. However, P. berghei is naturally transmitted by 
Anopheles dureni and is unlikely to encounter the very anthropophilic An. gambiae in the wild 
(Cohuet et al., 2006). TEP1 has been shown to limit P. falciparum infections in An. gambiae (Dong et 
al., 2006a; Garver et al., 2012), although it remains undetermined whether TEP1 binds to P. 
falciparum ookinetes (Yassine and Osta, 2010). It was recently demonstrated that LRIM1 and APL1C 
are P. falciparum antagonists in an infection intensity-dependent manner (Garver et al., 2012). 
Silencing LRIM1 or APL1C was found to significantly increase P. falciparum oocyst levels at medium 
and low infection intensities, respectively. Therefore, LRIM1 and APL1C are likely to play a context-
specific role in P. falciparum defence, correlating well with the discovery of APL1C in a P. falciparum 
resistance island (Riehle et al., 2006). The dependence on infection intensity explains why earlier 
studies reported that LRIM1 or APL1C knockdown in An. gambiae has no influence on P. falciparum 
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infections (Cohuet et al., 2006; Mitri et al., 2009). The varied impact of the LRIM1/APL1C/TEP1 
module could highlight vector-parasite co-evolution and immune evasion by the parasite, 
presumably to enhance its transmission. Interestingly, LRIM1, APL1C and TEP1 are also antagonists 
of P. yoelii in An. gambiae, which is partially refractory to this rodent parasite, but not in An. 
stephensi, a natural vector of P. yoelii (Jaramillo-Gutierrez et al., 2009). It is possible that parasites in 
their natural vectors (P. falciparum in An. gambiae and P. yoelii in An. stephensi) have evolved to 
evade the LRIM1/APL1C/TEP1 pathway. In agreement, a recent study reported that the TEP1 
pathway is unable to kill some sympatric strains of P. falciparum (Molina-Cruz et al., 2012). 
Alternatively, in line with the TEP1 convertase hypothesis discussed above, the putative TEP1 
convertase could be under different regulation in specific contexts, which might explain why LRIM1 
and APL1C exhibit a stronger phenotype with P. berghei than P. falciparum (Marois, 2011). 
 
Melanisation and lysis 
Melanisation is an important innate immune response exclusive to arthropods, which involves the 
production and deposition of melanin on invading pathogens and parasites (Christensen et al., 
2005). It is sometimes referred to as melanotic encapsulation because the invader is encased in a 
melanin-containing capsule (Clements, 2012). In addition to immunity, melanisation plays a critical 
role in many invertebrate physiological processes, such as egg chorion hardening, cuticle 
sclerotisation and wound healing (Hillyer, 2010). Melanisation can be deployed against a variety of 
pathogens, including bacteria, fungi and Plasmodium parasites. However, the reaction is highly 
specific and only elicited against certain species or strains of pathogens. Melanisation often results 
in pathogen death but the killing mechanism is uncharacterised. It has been hypothesised that 
pathogens are killed by oxidative damage from cytotoxic intermediates or by starvation (Christensen 
et al., 2005; Hillyer, 2010). Melanisation is also utilised to dispose of pathogens killed by an 
independent mechanism (Blandin et al., 2004).  
Melanisation is controlled by the enzyme, phenoloxidase (PO), which catalyses fundamental steps in 
the synthesis of melanin, a brown-black polymeric macromolecule (Christensen et al., 2005; 
Clements, 2012; Hillyer, 2010). The biochemical pathway of melanin synthesis in mosquitoes has not 
been fully elucidated (Clements, 2012). The putative pathway begins with the hydroxylation of 
phenylalanine into tyrosine. PO catalyses the hydroxylation of tyrosine to dopa and then the 
oxidation of dopa to dopaquinone, which is non-enzymatically converted to dopachrome (Hillyer, 
2010). Dopachrome is converted to 5,6-dihydroxyindole by dopachrome conversion enzyme (DCE). 
5,6-dihydroxyindole is oxidised to indole-5,6-quinone by PO and then cross-linked with hemolymph 
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proteins to form eumelanin. In an alternative pathway, dopa can produce dopamine via the action of 
dopa decarboxylase (DDC), which PO and other enzymes convert into melanin. Silencing either DCE 
or DDC impairs pathogen melanisation, highlighting the importance of both pathways (Hillyer, 2010). 
PO is activated by a cascade of serine proteases and regulated by protease inhibitors and cofactors 
(Figure 1.8) (Cerenius and Soderhall, 2004). POs are synthesised as inactive precursors called 
prophenoloxidases (PPOs), which undergo limited proteolysis by a PPO-activating enzyme (PPAE) 
(Cerenius and Soderhall, 2004; Christensen et al., 2005). The An. gambiae genome encodes nine 
putative PPOs, with only one possessing a Drosophila orthologue (Christophides et al., 2002). Most 
PPOs lack a signal peptide and are thought to be released into the hemolymph via lysis of activated 
hemocytes rather than secretion (Castillo et al., 2006). It is hypothesised that each PO has a specific 
or primary function, such as in larvae or in adults after blood feeding (Christensen et al., 2005; 
Clements, 2012). PPAEs are also maintained as zymogens that are activated by an upstream cascade 
of extracellular serine proteases following infection or injury. This cascade modulates the initial 
signal, either amplifying a “danger signal” or dampening a false alarm (Christophides et al., 2004). 
Recognition events triggering melanisation are poorly understood but β-1,3-glucan-recognition 
proteins have been implicated (Christensen et al., 2005). As the quinone intermediates of the 
melanisation pathway are highly reactive and toxic, the process must be tightly regulated in both 
location and time to protect the host. Serpins (SRPNs), a family of irreversible serine protease 
inhibitors, prevent excessive or inappropriate PO activation (Cerenius and Soderhall, 2004). Different 
SRPNs inhibit both the serine protease cascade and PPAEs. 
The clip-domain serine proteases and serine protease homologues (CLIPs) are an important family 
responsible for modulating and regulating melanisation. CLIPs possess a compact disulphide-bridged 
structure called the clip-domain, and a protease domain. After activation by proteolytic cleavage, 
the protein structure resembles a paperclip (Christophides et al., 2004). The precise function of the 
clip domain is unclear but it is believed to be important for regulating and localising the activity of 
the protease domain. There are five subfamilies of CLIPs in mosquitoes: A, B, C, D and E. Most CLIPB, 
D and C subfamily members have protease activity whereas CLIPA and E members are non-catalytic 
serine protease homologues (SPHs). CLIPBs are chiefly responsible for PPAE activation. They are 
sequentially cleaved in a proteolytic cascade, which culminates in the activation of PPAE and PPO. In 
contrast, CLIPAs are important positive and negative regulators of melanisation, sometimes acting as 
cofactors to help activate PO (Volz et al., 2006). There are predicted to be 10 CLIPAs and 17 CLIPBs in 
the An. gambiae genome (Christophides et al., 2002). 
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Figure 1.8  The prophenoloxidase activating system in arthropods.  
Melanisation pathways in arthropods are triggered when PRRs detect microbial PAMPs or in response 
to injury. A cascade of serine proteases sequentially activate each other, culminating in cleavage and 
activation of PPAE. Active PPAE cleaves prophenoloxidase into active phenoloxidase. Phenoloxidase 
catalyses the major steps in melanin production, which generates cytotoxic intermediates, such as 
quinones. Melanin is deposited on pathogen surfaces as a killing or clearance mechanism. The process 
is tightly controlled by SRPN inhibitors and serine protease homologues (SPHs). Some PPAEs require 
SPHs to activate phenoloxidase. Adapted from Cerenius and Soderhall, 2004. 
 
Melanisation is involved in the killing and clearance of Plasmodium parasites, but its role varies 
considerably between mosquito and parasite strains. Ookinetes are melanised once they have 
invaded the mosquito midgut and reached the basal labyrinth (Collins et al., 1986). Curiously, killed 
melanised parasites persist in the midgut tissues for the remainder of the mosquito’s life but do not 
influence mosquito survival (Blandin et al., 2004). Certain mosquito genetic backgrounds are capable 
of blocking Plasmodium infection due to highly efficient melanisation. Such melanotic refractoriness 
is a complicated phenomenon requiring the coordinated function of a several genes, including TEP1 
(Blandin et al., 2004). The most famous example of melanotic refractoriness to Plasmodium infection 
is the L3-5 strain of An. gambiae. The L3-5 strain was genetically selected in the laboratory from An. 
gambiae G3, a susceptible strain colonised in Gambia in 1975 (Collins et al., 1986). L3-5 mosquitoes 
melanise virtually all invading ookinetes of various strains of rodent, primate, human and avian 
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parasites. This strain is almost completely refractory to the primate parasite Plasmodium cynomolgi, 
the rodent parasite P. berghei and allopatric (non-African) isolates of P. falciparum, P. vivax and P. 
ovale. Normal G3 mosquitoes are susceptible to all these parasites. Interestingly, L3-5 mosquitoes 
fail to melanise co-indigenous strains of human malaria parasites. It was recently shown that certain 
P. falciparum strains are able to evade TEP1-mediated antiparasitic responses to survive in the L3-5 
strain (Molina-Cruz et al., 2012). Genetic mapping found that three quantitative trait loci (QTLs), 
named Pen1, Pen2 and Pen3, are responsible for melanisation in L3-5 (Zheng et al., 1997). The 
contribution of each QTL varies depending on the parasite species (Zheng et al., 2003). Interestingly, 
the L3-5 strain has elevated levels of reactive oxygen species (ROS) (Kumar et al., 2003). Another 
example is a genetically selected strain of Anopheles dirus, a human malaria vector from Southeast 
Asia, which is completely refractory to the African rodent parasite, P. yoelii nigeriensis (Somboon et 
al., 1999; Wen-Yue et al., 2007). This refractory strain is capable of melanising ookinetes 
immediately after midgut invasion and fully encapsulated oocysts have also been observed. 
Interestingly, the same strain is fully susceptible to infections with P. falciparum and P. vivax, which 
both naturally infect An. dirus. Both these examples highlight the importance of host-pathogen co-
evolution. It is likely that parasites have evolved to manipulate and evade the immune responses of 
their natural mosquito hosts. 
The melanisation cascade in An. gambiae is poorly characterised but some major players have been 
identified. RNAi-mediated gene silencing has been used to determine the effect on P. berghei 
melanisation. Interestingly, phenotypes can vary considerably depending on the mosquito genetic 
background (Volz et al., 2006). Injection of abiotic Sephadex beads has also been utilised to test for 
genes influencing melanisation (Paskewitz et al., 2006; Warr et al., 2006). Plasmodium-refractory 
and susceptible strains of An. gambiae can both melanise beads, with a stronger response in 
refractory mosquitoes. CLIPB3, CLIPB4, CLIPB8 and CLIPB17 promote parasite melanisation whereas 
CLIPA2, CLIPA5 and CLIPA7 inhibit parasite melanisation (Volz et al., 2006). CLIPB4 and CLIPB8 are 
also involved in promoting bead melanisation (Paskewitz et al., 2006). CLIPA8, a non-catalytic SPH, is 
essential for PO activation and is a key regulator of both ookinete and bacterial melanisation in An. 
gambiae (Schnitger et al., 2007; Volz et al., 2006). This suggests there is overlap in the genetic 
modules regulating responses to both pathogens. There are 18 predicted SRPNs in An. gambiae and 
most of these possess inhibitory activity (Suwanchaichinda and Kanost, 2009). Knockdown of SRPN2 
results in the formation of spontaneous melanotic pseudotumours that reduce mosquito life span 
(Michel et al., 2005). Silencing SRPN2 also strongly interferes with P. berghei midgut invasion 
because it usually inhibits parasite lysis and melanisation. SRPN6 in An. gambiae also inhibits 
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parasite melanisation and potentially promotes parasite lysis (Abraham et al., 2005). The 
organisation of these genes in the melanisation cascade is yet to be elucidated. 
Two potential An. gambiae pathogen recognition proteins of the CTL family are repressors of 
melanisation. CTL4 and CTLMA2 circulate as a disulphide-linked heterodimer in the hemolymph 
(Schnitger et al., 2009). Silencing either CTL results in a dramatic rise in melanised P. berghei 
ookinetes and decrease in live oocysts in the mosquito midgut (Osta et al., 2004a). The 
CTL4/CTLMA2 complex has been linked to the mosquito complement-like pathway and the 
promotion of parasite lysis. Silencing LRIM1, APL1C or TEP1 simultaneously with CTL4 in susceptible 
mosquitoes reverses the CTL4 phenotype with P. berghei, indicating these genes are epistatic to 
CTL4 (Osta et al., 2004a). Therefore, melanisation observed in CTL4 knockdown mosquitoes depends 
on LRIM1/APL1C/TEP1 function. Melanisation has been proposed as the killing mechanism in 
susceptible mosquitoes after CTL4 knockdown (Volz et al., 2006). CTL4 and CTLMA2 knockdown had 
no effect on P. falciparum development when sympatric field isolates were used to infect An. 
gambiae (Cohuet et al., 2006). The CTL4/CTLMA2 complex plays a key role in defence against gram-
negative bacteria in An. gambiae (Schnitger et al., 2009). Interestingly, CTL4 and CTLMA2 do not 
influence melanisation of Sephadex beads (Warr et al., 2006). 
Melanisation is an effector mechanism of the complement-like cascade: TEP1, LRIM1 and APL1C all 
influence melanisation. It has been hypothesised that binding of the LRIM1/APL1C/TEP1 complex to 
pathogens initiates the melanisation cascade (Warr et al., 2006). Both LRIM1 and TEP1 are required 
for the melanisation of Sephadex beads (Warr et al., 2006). Silencing LRIM1, APL1C or TEP1 can 
reverse the refractory L3-5 phenotype, abolishing parasite melanisation and making the mosquito 
susceptible to P. berghei infection (Blandin et al., 2004; Povelones et al., 2009). Therefore, it has 
been suggested that TEP1-mediated parasite killing (or damage) by an undetermined mechanism is a 
prerequisite for melanisation in L3-5 (Blandin et al., 2004). Melanisation in L3-5 is thought to be a 
clearance mechanism of dead or damaged parasites (Blandin et al., 2004; Volz et al., 2006). 
The wide variability in the capacity of An. gambiae individuals to transmit Plasmodium parasites has 
been largely attributed to polymorphisms in the TEP1 gene, which is exceptionally polymorphic 
(Blandin et al., 2009; Obbard et al., 2008). Interestingly, there are two distinct alleles of TEP1 called 
TEP1s and TEP1r, which seem to be associated with susceptible and refractory mosquitoes, 
respectively (Blandin et al., 2004; Molina-Cruz et al., 2012). TEP1r has been associated with L3-5 
mosquitoes (Blandin et al., 2004). The predicted TEP1s and TEP1r proteins share 93% identity and 
96% similarity, with differences concentrated in one region close to the TE motif (Baxter et al., 
2007). TEP1r has been shown to be more efficient at parasite killing (Blandin et al., 2009). It has been 
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hypothesised that TEP1r has a more reactive TE bond, which accelerates binding kinetics and 
efficiency (Baxter et al., 2007; Blandin et al., 2004). 
The significance of melanisation in the mosquito immune response, including P. falciparum defence 
in the field, is still under investigation. Melanisation can negatively impact reproductive fitness and 
the toxic intermediates pose serious danger to the host (Whitten et al., 2006). Anopheles 
punctulatus uses melanisation to kill invading filarial worms (Aliota et al., 2011). However, 
melanisation is not essential for mosquito survival of bacterial infections and melanised bacteria are 
rarely observed in An. gambiae adults (Schnitger et al., 2007). Indeed, it has been suggested that 
melanisation might increase the effectiveness of other immune reactions, as seen in Drosophila 
(Schnitger et al., 2007; Tang et al., 2006). Melanised P. falciparum ookinetes are observed in field-
caught An. gambiae mosquitoes although this is quite rare. Nevertheless, in one study in Tanzania, 
90% of field-captured An. gambiae were able to melanise Sephadex beads prior to blood feeding 
(Schwartz and Koella, 2002). Furthermore, APL1C maps to a Plasmodium resistance island on 
chromosome 2L with significant effects on P. falciparum melanisation (Riehle et al., 2006), which 
suggests a role for the complement-like pathway in melanisation in field populations.  
Recent studies in Ae. aegypti have suggested that immune melanisation and tissue melanisation 
have independent mechanisms of PPO activation (Zou et al., 2010). It is unknown whether this is also 
true for An. gambiae. However, CLIPA8 is critical for pathogen melanisation but is not required for 
wound melanisation (Schnitger et al., 2007), which implies the existence of distinct mechanisms in 
An. gambiae.  
In addition to melanisation, lysis is a related Plasmodium-killing or clearance mechanism (Blandin et 
al., 2008). The term lysis was first adopted to account for the dramatic killing and subsequent 
disappearance of the vast majority of invading parasites. These “missing” parasites in wild-type 
mosquitoes become apparent as live oocysts in the midgut upon RNAi-mediated knockdown of 
particular effectors, like LRIM1. Both lysis and melanisation play an important role in refractory 
mosquitoes, such as An. gambiae L3-5 strain and An. quadriannulatus (Collins et al., 1986; 
Habtewold et al., 2008). Upon TEP1 binding, dead or dying ookinetes appear morphologically 
deformed (Blandin et al., 2004). Ookinetes undergoing lysis exhibit organelle disintegration, 
cytoplasmic vacuolation and membrane blebbing (Whitten et al., 2006). An example of a lytic 
refractory An. gambiae strain is SUAF2, a laboratory selected line that lyses all P. gallinaceum 
parasites as they traverse the midgut epithelium (Vernick et al., 1995). As with melanisation, it is still 
undetermined whether lysis is predominantly a mechanism of killing or a means to clear dead or 
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dying parasites. It has been proposed that parasites are killed by TEP1 via an unidentified mechanism 
and then cleared by lysis (Blandin et al., 2004). 
The underlying mechanism of lysis is very poorly understood. It is unknown whether TEP1 binding 
recruits a membrane attack complex akin to the vertebrate complement system. The TEP1r allele 
has been linked to more efficient lysis of parasites (Blandin et al., 2009). CLIPB14 and CLIPB15 
promote P. berghei lysis in susceptible and refractory mosquitoes (Volz et al., 2005). In addition to 
inhibiting melanisation, SRPN6 promotes parasite lysis (Abraham et al., 2005).  
 
Cellular immunity 
As well as humoral defences, mosquitoes exhibit a range of cellular innate immune responses 
mediated by hemocytes, which act as immunosurveillance cells (Hillyer, 2010). Hemocytes also play 
a crucial role in humoral responses by producing immune proteins, such as PRRs, melanisation 
components and AMPs (Hillyer, 2009; Pinto et al., 2009). Mosquitoes possess an open circulatory 
system whereby hemolymph bathes all internal tissues and organs. Some hemocytes circulate in the 
hemolymph whereas most are found attached to visceral surfaces, such as the tracheae, Malpighian 
tubules and the basal surface of the midgut (Blandin and Levashina, 2007). Hemocyte abundance 
progressively decreases with mosquito age, which has been linked to increased susceptibility to 
septic infection (Castillo et al., 2006). Interestingly, a brief rise in circulating hemocytes is observed 
following blood feeding, which could represent mobilisation of sessile hemocytes or increased 
hematopoiesis. Three types of hemocytes have been identified in mosquito larvae, pupae and 
adults: granulocytes, oenocytoids and prohemocytes. Granulocytes are by far the most abundant 
whereas oenocytoids and prohemocytes usually account for less than 10%. Oenocytoids 
constitutively express PPO for the melanisation cascade, which is stored in the cytoplasm and 
released when the cell is activated and lysed upon immune challenge. Prohemocytes are small 
progenitors of granulocytes (Blandin and Levashina, 2007).  
Phagocytosis is the engulfment of pathogens by circulating hemocytes, which results in their killing 
and degradation (Michel and Kafatos, 2005). It is triggered by PRRs that opsonise pathogens and 
induce intracellular signalling cascades, resulting in actin-dependent internalisation of the invader 
(Christophides et al., 2004). Granulocytes are the only insect hemocyte capable of phagocytosis 
(Castillo et al., 2006). The phagocytic response is very rapid and can occur within 5 minutes of 
exposure to microorganisms. As the infection advances, the granulocytes increase in size as they 
engulf hundreds of invaders (Hillyer, 2010). Apoptotic bodies and melanised pathogens can also be 
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cleared by phagocytosis (Clements, 2012; Osta et al., 2004b). Interestingly, distinct molecular 
mechanisms are believed to control phagocytosis of gram-negative and gram-positive bacteria. The 
uptake of gram-negative bacteria is faster and more efficient than gram-positive bacteria, with more 
gram-negative bacteria engulfed per cell (Blandin and Levashina, 2007). Inactivation of phagocytosis 
components results in rapid bacterial accumulation within 8 h of infection (Moita et al., 2005). 
However, similar to melanisation, blocking phagocytosis does not usually compromise mosquito 
survival during bacterial infection. This suggests that, although phagocytosis plays an important role 
in the early stages of infection, the powerful repertoire of AMPs take over once they have been 
induced.  
The potential role of phagocytosis in Plasmodium defence remains unclear. Direct contact between 
ookinetes and hemocytes is prevented by the basal lamina. Therefore, phagocytosis by hemocytes is 
not involved in ookinete killing or clearance of dead ookinetes (Blandin and Levashina, 2007). 
Sporozoites are the only parasite stage that circulates freely in the hemolymph. Between 80 and 
90% of sporozoites are cleared before reaching the salivary glands but the mechanisms responsible 
are unknown. Phagocytosis of Plasmodium sporozoites is observed in vivo but it is not believed to 
make a substantial contribution to sporozoite clearance in An. gambiae (Hillyer et al., 2007). It has 
been hypothesised that phagocytosis of a small number of sporozoites could trigger systemic 
immune signalling and other antiparasitic defences, such as lysis. 
Several major players involved in phagocytosis in An. gambiae have been identified by RNAi and a 
semiquantitative in vivo assay (Moita et al., 2005). TEP1 is essential for promoting phagocytosis of 
gram-negative and gram-positive bacteria (Levashina et al., 2001; Moita et al., 2005). TEP1 opsonises 
bacterial surfaces in a TE-dependent manner, reminiscent of vertebrate complement factors. In 
contrast, LRIM1 has been demonstrated to be involved in phagocytosis of gram-negative not gram-
positive bacteria (Moita et al., 2005). As LRIM1 and APL1C form an obligate complex, it can be 
assumed that APL1C is also important for gram-negative bacterial phagocytosis. Presumably, 
LRIM1/APL1C delivers TEP1cut to the surface of gram-negative bacteria. It is not known whether TEP1 
has a different partner for gram-positive bacteria. Other hemolymph proteins, TEP3 and TEP4, have 
also been implicated in efficient bacterial phagocytosis. TEP3 is involved with only gram-negative 
bacteria whereas TEP4 is important for both gram-types (Moita et al., 2005). Three intracellular 
molecules, CED2, CED5 and CED6, had a strong effect on phagocytosis of both gram-types. These 
CED proteins are homologues of components of the apoptotic and necrotic cell removal pathways in 
C. elegans. PGRP-LC, the transmembrane PRR of the Imd pathway, is important for gram-negative 
bacterial phagocytosis. Putative transmembrane receptors, lipoprotein receptor-related protein 
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(LRP) and β2-integrin (BINT2), also affect bacterial phagocytosis of both gram-types and gram-
negative bacteria, respectively. Finally, the Down syndrome cell adhesion molecule (Dscam), a 
hypervariable immunoglobulin-like transmembrane receptor, significantly affects phagocytosis of 
both gram-negative and gram-positive bacteria (Dong et al., 2006b). 
Two partially redundant phagocytosis pathways have been proposed in An. gambiae, with each 
involving hemolymph proteins, transmembrane receptors and intracellular molecules (Blandin and 
Levashina, 2007; Moita et al., 2005). The pathways are named CED5 and CED6 after their main 
intracellular component. Epistasis experiments assigned TEP4, BINT2 and CED2 as putative 
components of the CED5 pathway (Moita et al., 2005). Likewise, TEP1, TEP3, LRIM1 and LRP are 
predicted to be in the CED6 pathway. 
Cellular encapsulation is deployed against pathogens too large for engulfment, such as parasitoid 
eggs and nematodes (Clements, 2012; Michel and Kafatos, 2005). It involves aggregation of 
hemocytes around the invader to form a multi-layered capsule (Osta et al., 2004b). The invader is 
then isolated, immobilised and subsequently killed by asphyxiation, oxidation or the deposition of 
melanin. The mechanisms leading to cellular encapsulation are not well understood. 
 
Local epithelial immunity 
The mosquito’s first line of defence against infection is the presence of structural barriers, such as 
the cuticle and the midgut (Meister et al., 2004). Barrier epithelia, such as the gut and reproductive 
tract, are constantly exposed to both indigenous and environmental microbes and are major 
potential routes of infection (Broderick et al., 2009). As well as being a physical barrier, epithelial 
cells mount powerful immune responses against microorganisms, such as secretion of AMPs. Local 
epithelial responses play an important role in the substantial loss of ookinetes during midgut 
invasion (Vlachou and Kafatos, 2005). Nevertheless, as barrier epithelia have to accommodate native 
microbiota, there must be a compromise between immune activation and tolerance (Broderick et 
al., 2009). 
The peritrophic matrix is a thick acellular chitinous membrane that coats the lumenal side of the 
midgut epithelium after blood ingestion (Whitten et al., 2006). Matrix components, such as chitin 
proteins and proteoglycans, are secreted by midgut epithelial cells during feeding and are 
polymerised within 24 h (Cirimotich et al., 2010; Meister et al., 2004). The peritrophic matrix is 
expelled after blood digestion and re-synthesised upon subsequent blood meals (Rodrigues et al., 
2010). The matrix forms a physical barrier around the blood bolus, preventing midgut bacteria and 
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vertebrate blood cells from coming into direct contact with the epithelia. Nevertheless, malaria 
parasites have chitinases to digest the membrane and continue their journey through the mosquito 
(Clements, 2000). 
Midgut epithelial cells play an active role in anti-Plasmodium defence by forming actin-based 
cytoplasmic protrusions during midgut invasion. It was reported that ookinetes emerging from the 
basal side of invaded midgut cells were covered by a specialised epithelial structure named a “hood” 
(Vlachou et al., 2004). The hood was thought to be an actin-based lamellipodia protrusion extended 
by the invaded cell to envelope the parasite. Previously, similar structures had been observed in the 
SUAF2 lytic refractory strain of An. gambiae (Vernick et al., 1995). In agreement with these findings, 
microarray analysis of midgut epithelial responses to P. berghei invasion discovered that the largest 
functional class upregulated encodes actin- and microtubule-cytoskeleton reorganisation proteins 
(Vlachou et al., 2005). Furthermore, silencing WASP, an important regulator of cytoskeleton 
dynamics, increases the intensity of P. berghei and P. falciparum infections (Mendes et al., 2008; 
Vlachou et al., 2005). It was therefore hypothesised that WASP-mediated cytoskeleton 
reorganisation contributes to Plasmodium killing. An independent study reported an “organelle-free 
actin zone” (AZ) at the base of midgut epithelial cells, partially surrounding dead or dying ookinetes 
in both susceptible and refractory mosquitoes (Shiao et al., 2006). In contrast to the previous 
reports, the AZ was reported to derive from epithelial cells adjacent to the invaded cell. 
Interestingly, AZ formation was associated with melanised parasites in the L3-5 refractory strain of 
An. gambiae and both were dependent on TEP1. Instead of parasite killing, these authors speculated 
that AZ formation was involved in clearance of dead or dying parasites. 
An important mosquito defence is the production of ROS, which has been shown to modulate 
bacterial and Plasmodium infections (Molina-Cruz et al., 2008). ROS, such as superoxide anion and 
hydrogen peroxide, are generated as by-products of mitochondrial respiration or in response to 
pathogens (DeJong et al., 2007; Molina-Cruz et al., 2008). Production of ROS is massively increased 
in response to an uninfected blood meal and exacerbated further by Plasmodium infection (Kumar 
et al., 2003; Molina-Cruz et al., 2008). Hemocytes and epithelial cells both contribute to ROS 
generation. As ROS are highly reactive and toxic, insects protect themselves by producing 
detoxification enzymes, including superoxide dismutase (SOD), catalase and peroxidase (Clements, 
2012). SOD converts superoxide anion into hydrogen peroxide, which is less toxic (DeJong et al., 
2007). Both catalase and peroxidase convert hydrogen peroxide to water and oxygen. Detoxification 
enzymes are induced in midgut epithelial cells and fat body 24 h after blood feeding to reduce global 
ROS levels. However, as ROS are toxic to Plasmodium, catalase expression is specifically suppressed 
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in P. berghei-infected midguts, which keeps local hydrogen peroxide levels high and reduces parasite 
numbers (Molina-Cruz et al., 2008). Silencing catalase by RNAi significantly decreases P. berghei 
infection by lysis. Interestingly, L3-5 mosquitoes are in a chronic state of oxidative stress, which is 
intensified by blood feeding, resulting in increased ROS in the hemolymph and promoting 
melanisation (Kumar et al., 2003). This is probably due to a systemic deficiency in ROS detoxification. 
Dietary supplements of antioxidants in L3-5 can lower ROS levels and inhibit melanisation (Kumar et 
al., 2003). Mosquitoes with higher systemic ROS levels are also better at surviving bacterial 
infections (Molina-Cruz et al., 2008). ROS have also been shown to act as a signalling molecule in the 
JNK, NF-κB and MAPK pathways (Jaramillo-Gutierrez et al., 2010; Surachetpong et al., 2011). 
Nevertheless, cumulative exposure to ROS is detrimental to mosquito fecundity and longevity, so 
there must be a trade-off between immunity and physiology (DeJong et al., 2007).  
In a related defence mechanism, nitric oxide (NO), generated by NO synthase (NOS), also plays a role 
in anti-Plasmodium responses (Luckhart et al., 1998). Like ROS, NO is extremely toxic and reactive. 
Ookinetes induce tyrosine nitration in invaded midgut epithelial cells, which ultimately triggers 
apoptosis of these individual cells. NOS is induced in invaded midgut cells upon P. berghei and P. 
falciparum infection (Han et al., 2000; Luckhart et al., 1998). Parasite molecules, such as hemozoin 
and glycosylphosphatidylinositol (GPI), have been proposed to trigger this induction (Akman-
Anderson et al., 2007; Lim et al., 2005). NOS generates NO, which is readily converted into nitrites 
and other reactive nitrogen species. After a short time delay, epithelial peroxidases are induced and 
these use nitrites and hydrogen peroxide to generate nitrogen dioxide, which mediates tyrosine 
nitration (Kumar et al., 2004; Oliveira Gde et al., 2012). Invaded cells, expressing elevated NO levels 
and undergoing extensive nitration, are “budded off” into the midgut lumen via a purse-string 
mechanism that maintains epithelial integrity (Han et al., 2000; Kumar et al., 2004). NO is important 
for limiting parasite infections and the administration of NOS inhibitors promotes parasite 
development (Luckhart et al., 1998). Plasmodium invasion is said to trigger a “time bomb” as the 
parasite has a limited opportunity to traverse the cell safely before nitrogen dioxide is produced 
(Han et al., 2000; Kumar et al., 2004). The observed lateral movement between epithelial cells might 
be a parasite escape strategy. In susceptible mosquitoes, the time delay between NOS and 
peroxidase induction allows many ookinetes to exit the epithelial cell before nitration takes place 
(Kumar et al., 2004). As hydrogen peroxide levels are constitutively higher in L3-5 mosquitoes, 
accelerated nitration might contribute to refractoriness. Upregulation of NOS has been implicated in 
natural refractoriness within An. culicifacies sibling species (Vijay et al., 2011). One exciting 
hypothesis is that epithelial nitration modifies or damages ookinetes, which facilitates their 
recognition by the mosquito complement-like system and promotes TEP1-mediated lysis (Oliveira 
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Gde et al., 2012). Furthermore, the STAT pathway, via AgSTAT-A, has been reported to activate NOS 
transcription and mediate a late-phase antiparasitic response, which reduces the survival of early 
oocysts (Gupta et al., 2009). In addition to antagonising Plasmodium infections, NO is crucial for 
hemocyte-mediated immune responses against bacteria (Hillyer and Estevez-Lao, 2010). 
Finally, the mosquito midgut microbiota plays a key role in activating epithelial immunity and 
limiting Plasmodium infections. Mosquito guts harbour a diverse community of commensal bacteria 
encompassing a variety of genera and species (Dong et al., 2009). Gram-negative bacteria of the 
class Proteobacteria and family Enterobacteriaceae are most predominant (Cirimotich et al., 2011b). 
Common genera include Enterobacter, Microbacterium, Sphingomonas, Serratia, Chryseobacterium, 
Asaia and Pseudomonas (Dong et al., 2009). These endogenous bacteria are involved in the 
maintenance of host physiology, including metabolism and immune homeostasis. Blood feeding 
causes dramatic proliferation of the midgut microbiota, apparently due to the increase in nutrient 
availability (Cirimotich et al., 2010; Kumar et al., 2010). Bacterial levels can rise to 107 colony-forming 
units (CFU) per mL of blood by 24 h post blood feeding, returning to normal within 3 to 5 days 
(Cirimotich et al., 2010; Wang et al., 2011). Bacterial species composition changes drastically after 
blood feeding as well as between larvae, pupae and adults (Wang et al., 2011). Interestingly, 
bacterial load and species composition varies considerably between individual mosquitoes, which 
might contribute to susceptibility and refractoriness to Plasmodium infection (Cirimotich et al., 
2010). For instance, gram-negative bacteria usually inhibit parasite development more strongly than 
gram-positive bacteria.  
Gut bacteria can indirectly affect Plasmodium infections by priming the basal immune response. 
Mosquitoes cleared of their natural microbiotic flora by antibiotics are more susceptible to 
Plasmodium infections (Dong et al., 2009; Meister et al., 2009). This can be reversed by re-
introducing bacteria into antibiotic-treated mosquitoes. Co-feeding bacteria and P. falciparum 
parasites reduces oocyst numbers, suggesting the inhibitory effect occurs before the oocyst stage 
(Dong et al., 2009). The mosquito immune response constitutively controls bacterial load in the 
midgut. Besides defending against systemic bacterial infections, PGRP-LC signalling controls the size 
of midgut bacterial populations, including their proliferation after blood feeding (Meister et al., 
2009). This signalling modulates infections with P. berghei and field isolates of P. falciparum. 
Silencing PGRP-LC increases P. berghei and P. falciparum oocyst intensities, but only in the presence 
of normal midgut flora. Known Plasmodium effectors, such as TEP1, are elevated in control 
mosquitoes compared to antibiotic-treated mosquitoes (Dong et al., 2009). The majority of 
mosquito immune responses are active against both bacteria and parasites, so it is unsurprising that 
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responses mounted against endogenous bacteria can modulate Plasmodium infections (Cirimotich et 
al., 2010). Furthermore, particular midgut bacterial isolates have been shown to reduce 
susceptibility to dengue virus in Ae. aegypti by activating the mosquito immune system (Ramirez et 
al., 2012). It has been proposed that the mosquito’s basal immune response is primed by previous 
encounters with bacteria, even as larvae. A recent study described a mechanism of innate immune 
memory in adult mosquitoes involving bacteria-mediated hemocyte differentiation (Rodrigues et al., 
2010). Bacterial exposure triggered an increase in granulocytes that persisted for the mosquito’s life 
span and enhanced antibacterial responses upon re-challenge. This immune priming indirectly 
suppressed Plasmodium development. 
To prevent the proliferation of midgut bacteria after blood feeding from over-stimulating epithelial 
immunity, a cross-linked protein network is formed between the peritrophic matrix and midgut 
epithelial cells (Kumar et al., 2010). Dityrosine bonds are catalysed by immunomodulatory 
peroxidase (IMPer), which is secreted by epithelial cells in response to blood feeding, and dual 
oxidase (Duox), a transmembrane protein that produces hydrogen peroxide. The dityrosine network 
renders the gut less permeable to soluble immune elicitors and prevents activation of epithelial 
immunity. This shields the midgut microbiota from antibacterial responses but also protects 
Plasmodium parasites by preventing NOS induction. Immune responses are only elicited when 
parasites breach the peritrophic matrix and the dityrosine barrier. Silencing IMPer or Duox strongly 
elicits NOS production and dramatically reduces parasite survival.  
Gut bacteria have also been shown to directly interfere with Plasmodium development. In a recent 
study, an Enterobacter species was isolated from wild Zambian mosquito populations (Cirimotich et 
al., 2011a). When introduced into laboratory-reared An. gambiae and An. stephensi, this bacterium 
rendered mosquitoes almost refractory to P. falciparum development. This was independent of the 
mosquito Imd pathway as knockdown of PGRP-LC, Imd or REL2 failed to rescue parasite 
development. It was elucidated that the Enterobacter species was directly inhibiting parasite 
development in the mosquito midgut lumen by generating ROS. Furthermore, bacterial proliferation 
after blood feeding has been proposed to stimulate NOS induction in the midgut (Luckhart et al., 
1998). Commensal bacteria may also prevent parasite interactions with the mosquito epithelium, 
such as physically blocking receptors for invasion (Cirimotich et al., 2011b). 
Wolbachia, an intracellular bacterial symbiont of many insects, has been stably introduced into Ae. 
aegypti and inhibits infections with Plasmodium, dengue, CHIKV and filarial nematodes (Bian et al., 
2010; Hoffmann et al., 2011; Kambris et al., 2009; Moreira et al., 2009; Walker et al., 2011). The 
disease vectors Ae. aegypti and Anopheles species do not naturally harbour Wolbachia (Moreira et 
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al., 2009). In stably infected Ae. aegypti, Wolbachia primes the immune response by inducing 
constitutive upregulation of immune genes, such as TEPs, CLIPs and PGRPs (Kambris et al., 2009). 
Transient somatic Wolbachia infections of An. gambiae have shown comparable effects, including 
induction of TEP1 and LRIM1 (Kambris et al., 2010) and inhibition of P. falciparum infections (Hughes 
et al., 2011). Wolbachia has been proposed as a novel malaria control strategy, especially as 
infections can shorten the mosquito life span (McMeniman et al., 2009). However, Wolbachia has 
yet to be stably introduced into An. gambiae, which remains a significant hurdle to overcome. 
 
The LRIM family 
Bioinformatic searches discovered a novel mosquito-specific family of proteins related to LRIM1 and 
APL1C, using their shared structural features (Povelones et al., 2009; Waterhouse et al., 2010). To 
date, 24 members of this LRR immune protein (LRIM) family have been identified in An. gambiae 
(Table 1.1). Orthologues of most LRIMs and additional homologous proteins were discovered in the 
available genomes of mosquitoes, Ae. aegypti and C. quinquefasciatus, which have 29 and 30 LRIMs, 
respectively (Waterhouse et al., 2010). However, no LRIM-related genes were found in other 
organisms, including Drosophila, the honeybee and body louse. Each LRIM member shares a distinct 
genomic organisation and protein domain architecture, which distinguishes them from the larger 
superfamily of LRR genes. The majority of LRIM genes are composed of a small exon and intron 
followed by a larger exon encoding most of protein. Typical LRIM proteins comprise a signal peptide, 
LRR motifs, a conserved pattern of cysteines and a coiled-coil domain. LRR domains are often 
involved in pattern recognition whereas coil-coils are generic protein-protein interaction domains. 
Both the LRR domain and coiled-coil can tolerate high levels of sequence variation, which makes 
them flexible in their binding properties but hinders the discovery of ancestral LRIM-like genes in 
other organisms (Povelones et al., 2009; Waterhouse et al., 2010). The LRIM members have been 
grouped into four subfamilies based on variations to this core structure (Figure 1.9, Table 1.1). Two 
of these subfamilies are classified by the number of LRR domains: Long (10 to 13 LRRs) and Short (6 
or 7 LRRs). There are 6 Long LRIMs, including LRIM1 and APL1C, and 9 Short LRIMs in An. gambiae. 
Transmembrane LRIMs, with 3 members in An. gambiae, contain a C-terminal transmembrane 
region and are predicted to be membrane localised with the majority of the protein extracellular. In 
Transmembrane LRIMs, one of the cysteines in a conserved cysteine pair has been substituted with a 
tyrosine. Coil-less LRIMs possess all the characteristic LRIM features but lack the coiled-coil domain, 
which may affect how these proteins are organised into complexes and interact with other proteins. 
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There are 6 Coil-less LRIMs in An. gambiae. Apart from Transmembrane LRIMs, the other subfamilies 
are believed to be secreted into the hemolymph. 
 
 
 
 
 
 
 
Figure 1.9  The four LRIM subfamilies.  
A typical LRIM family member is comprised of a signal peptide, leucine-rich repeat (LRR) motifs, a 
conserved pattern of cysteine residues and a coiled-coil domain. The coiled-coil domain is often split 
into two parts. The family is divided into four subfamilies with different variations of this typical 
structure. The Short LRIMs have 6 or 7 LRR motifs whereas the long LRIMs have 10 to 13. 
Transmembrane LRIMs have a C-terminal transmembrane region and one cysteine in a conserved 
cysteine pair has been replaced with a tyrosine. Coil-less LRIMs lack the C-terminal coiled-coil domain 
but meet all the other LRIM selection criteria. Adapted from Waterhouse et al., 2010. 
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Table 1.1  The LRIM family in An. gambiae. 
Subfamily 
Gene ID or genomic 
location 
LRIM name Alternative name(s) 
Long 
AGAP006348 LRIM1  
AGAP007036 APL1A APL1, LRIM2 
AGAP007035 APL1B APL1, LRIM2 
AGAP007033 APL1C APL1, LRIM2, LRRD19 
AGAP007037 LRIM3  
AGAP007039 LRIM4 LRRD5 
Short 
2R:17513769-4965 LRIM5  
AGAP006327 LRIM6  
AGAP007457 LRIM7 LRRD17 
AGAP007454 LRIM8A  
AGAP007456 LRIM8B LRRD4, LRRd-1 
AGAP007453 LRIM9  
AGAP007455 LRIM10 LRRD9 
AGAP007034 LRIM11  
AGAP005496 LRIM12  
Transmembrane 
AGAP007045 LRIM15  
3R: 317336-9560 LRIM16A AGAP007758 
3R: 322657-4842 LRIM16B AGAP007758 
Coil-less 
AGAP005693 LRIM17 APL2, LRRD7 
AGAP010675 LRIM18  
AGAP011117 LRIM19  
AGAP002542 LRIM20  
AGAP005744 LRIM26  
2R: 17512465-3625 LRIM27  
 
The LRIM family in An. gambiae currently has 24 members, each belonging to one of four subfamilies: 
Long, Short, Transmembrane and Coil-less. Adapted from Povelones et al., 2009 and Waterhouse et al., 
2010. Refer to these papers for references of alternative names. 
 
 
The LRR is a structural motif of 20-30 amino acids with a distinctive consensus sequence rich in 
hydrophobic leucine residues (Bella et al., 2008). This 11-residue sequence is typically LxxLxLxxNxL 
(where x is any amino acid), although leucine and asparagine residues can be replaced with other 
hydrophobic residues. Most LRIM LRRs are 24 amino acids in length, although some LRIMs have an 
unusually short 19-residue LRR (Waterhouse et al., 2010). An LRR domain is composed of two or 
more repeats in tandem and forms a curved solenoid or “horseshoe” shape. This versatile shape has 
a high surface area that is ideal for protein-protein interactions (Kobe and Kajava, 2001; 
Padmanabhan et al., 2009). LRIMs with many LRR motifs are predicted to form extended arcs 
whereas Short LRIMs are likely to have shallow curves (Waterhouse et al., 2010). The concave side of 
an LRR domain is usually a parallel β-sheet, with each LRR motif providing a single strand (Bella et al., 
2008). The convex side is composed of various secondary helical structures, including α-helices and 
polyproline II helices. Ligand binding sites are typically found on the concave surface, with some LRR 
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proteins able to interact with multiple structurally unrelated ligands (Bell et al., 2003). LRR domains 
are typically flanked by N- and C-terminal structures called “caps”, which protect the hydrophobic 
core (Bell et al., 2003; Kobe and Kajava, 2001). In extracellular proteins, these flanking regions are 
often cysteine-rich and form stabilising intramolecular disulphide-bonds (Bella et al., 2008; 
Buchanan and Gay, 1996). Most LRIMs have a leucine-rich leader sequence that precedes the LRR 
domain (Waterhouse et al., 2010). 
Proteins with LRR domains have known roles in host defence in many phyla and mediate recognition 
of a diverse array of PAMPs. Mammalian innate immunity uses LRR-containing extracellular Toll-like 
receptors (TLRs) and intracellular Nod-like receptors (NLRs) to mediate pathogen recognition 
(Istomin and Godzik, 2009; Sirard et al., 2007). The LRR domains of different TLRs specifically interact 
with a vast range of ligands, including bacterial flagellin, LPS and peptidoglycan (Bell et al., 2003). 
Activation of TLRs and NLRs results in inflammatory responses (Wilmanski et al., 2008). Insect Toll 
transmembrane receptors, which are critical for intracellular immune signalling, also contain 
extracellular LRRs but do not directly interact with PAMPs (Christophides et al., 2002). LRR-
containing proteins are also crucial in plant host defence. Plant NB-LRRs function analogously to the 
mammalian adaptive immune system by recognising specific pathogen-encoded effectors 
(Padmanabhan et al., 2009). Jawless vertebrates, such as lamprey and hagfish, possess a repertoire 
of variable lymphocyte receptor (VLR) antibodies generated by combinatorial assembly of LRR gene 
segments (Guo et al., 2009; Han et al., 2008; Herrin et al., 2008). Like LRIM1/APL1C, VLR antibodies 
are secreted as disulphide-bonded multimeric complexes (Herrin et al., 2008). 
Structure-function analyses recently elucidated that LRIM1 and APL1C have a distinct modular 
organisation (Figure 1.10) (Povelones et al., 2011). The LRIM1/APL1C crystal structure and in vitro 
mutational analyses revealed that the conserved cysteines are important for heterodimer formation 
(Baxter et al., 2010; Povelones et al., 2011). Homologous cysteines in LRIM1 and APL1C form a single 
disulphide bond to stabilise the complex. This bond might also act as a hinge to release TEP1 at 
pathogen surfaces (Povelones et al., 2011). Additional conserved cysteines form two intramolecular 
disulphide bonds that are probably involved in protein folding and maybe even formation of a C-
terminal cap. LRIM1 and APL1C are not secreted upon mutation of any of these additional cysteines. 
The coiled-coil regions of LRIM1 and APL1C are essential for the complex to interact with TEP1 and 
other TEP cargoes. Both LRIM1 and APL1C have coiled-coil regions split into two parts. The most C-
terminal part of the coiled-coil also plays a role in regulating the specificity of LRIM1/APL1C 
heterodimerisation. The function of the LRR domain is still undetermined but it is hypothesised to be 
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involved in activation of LRIM1/APL1C/TEP complexes. The LRR domain may directly recognise 
pathogen surfaces or it may interact with other immune receptors. 
 
Figure 1.10  Functional modules of the LRIM1/APL1C complex.  
LRIM1 and APL1C are believed to contain three distinct modules. The coiled-coil domain is required for 
interaction with effector proteins, such as TEP1, TEP3, TEP4 and TEP9. The conserved cysteine residues 
form a disulphide bond to stabilise the LRIM1/APL1C complex and intramolecular bonds to ensure 
correct protein folding. The LRR domain is predicted to function in pathogen recognition and activation 
of the LRIM1/APL1C/TEP complex. From Povelones et al., 2011. 
 
Many LRIMs have 1:1:1 orthologues in An. gambiae, Ae. aegypti and C. quinquefasciatus (Figure 
1.11) (Povelones et al., 2009). Interestingly, several LRIMs are encoded within tight genomic clusters. 
Comparison of orthologous genomic regions between the three sequenced mosquitoes has revealed 
evidence of local gene shuffling and duplication (Waterhouse et al., 2010). A cluster of Short LRIMs 
found in all three mosquitoes comprises LRIM7, LRIM8, LRIM9 and LRIM10. LRIM8 has duplicated in 
An. gambiae (LRIM8A and LRIM8B) whereas LRIM10 has duplicated in Ae. aegypti (LRIM10A and 
LRIM10B). In An. gambiae, APL1A, APL1B and APL1C were previously annotated as a single gene 
(APL1 or LRIM2) (Riehle et al., 2006) but are actually three distinct genes derived from recent 
duplications (Riehle et al., 2008). There are also three LRIM2 genes in C. quinquefasciatus but only 
one in Ae. aegypti (Povelones et al., 2009). An. gambiae APL1A, APL1B and APL1C cluster with LRIM3 
and LRIM11 on chromosome 2L, in close proximity to LRIM4. This synteny is partially retained in Ae. 
aegypti and C. quinquefasciatus. LRIM16 has duplicated in An. gambiae and LRIM16A and LRIM16B 
are clustered together on chromosome 3R. 
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Figure 1.11  Phylogenetic relationships between LRIMs in three mosquito species.  
Phylogenetic trees demonstrating the relationships between LRIM family members in An. gambiae (Ag, 
red), Ae. aegypti (Ae, yellow) and C. quinquefasciatus (Cq, blue). Long (A), Short (B), Transmembrane 
(C) and Coil-less (D) subfamilies are shown. Predicted orthologous groups are shown in shaded ovals. 
White dots indicate bootstrap values of >70%. From Povelones et al., 2009. 
 
We hypothesise that the LRIM family has diversified to recognise different microbes that mosquitoes 
encounter, including human pathogens. It is unclear whether the LRIM family represents an 
adaptation to the hematophagous lifestyle of mosquitoes. With their versatile LRR domains, LRIMs 
are predicted to be pathogen recognition proteins. Apart from LRIM1 and APL1C (members of the 
Long subfamily), the other LRIM members have not been well characterised to date. Preliminary 
analyses have implicated certain LRIMs in innate immunity, as discussed further in Chapter 4 (Aguilar 
et al., 2005b; Dong et al., 2006a; Marinotti et al., 2005; Mitri et al., 2009; Vlachou et al., 2005). It is 
not known whether these LRIMs function in the same biochemical cascade as LRIM1/APL1C and 
TEP1 or if they have unique specificity and protein partners. Meta-analysis of all extant microarray 
data suggests some family members are transcriptionally co-regulated and present in clusters 
distinct from LRIM1, APL1C and TEP1 (Maccallum et al., 2011). 
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2 Aims and Objectives 
 
The overall aim of this PhD thesis was to investigate the role of the LRIM family in An. gambiae 
immunity. This is a mosquito-specific family that is hypothesised to be involved in defence against 
blood-borne pathogens. The founding members, LRIM1 and APL1C, form a heterodimer and play 
important roles in defence against Plasmodium parasites and bacteria (Garver et al., 2012; Moita et 
al., 2005; Osta et al., 2004a; Riehle et al., 2006). However, the other 22 LRIMs in An. gambiae were 
largely uncharacterised at the start of this project. The reason for the huge expansion of LRIMs in 
mosquitoes was unknown and it was unclear whether different LRIMs function specifically against 
distinct pathogens. 
The first objective was to transcriptionally profile all LRIMs to determine their responses to various 
immune challenges, including blood feeding and infections with Plasmodium, bacteria, fungi and 
virus. There is known to be a correlation between gene expression and protein function, although 
this is not true for all genes. Therefore, this profiling would determine whether there is 
transcriptional specificity in the family towards different pathogens and provide important clues to 
the immune function of the LRIMs. If certain LRIMs are transcriptionally co-regulated, this could 
highlight novel functional relationships or interactions. The next aim was to silence uncharacterised 
LRIMs using RNAi and investigate the resulting phenotypes during infections with the rodent malaria 
parasite, P. berghei. This simple screen would identify novel Plasmodium antagonists in the family, 
similar to LRIM1 and APL1C.  
The next objective was to biochemically and phenotypically characterise interesting candidates from 
the transcriptional and RNAi screens to provide further insights into their function in An. gambiae 
immunity. This would include investigating their roles in melanisation and during bacterial infections. 
Another objective was to investigate whether formation of LRIM complexes (similar to the 
LRIM1/APL1C heterodimer) is a general characteristic of LRIM family members and which structural 
features govern complex formation. A representative from each LRIM subfamily would be expressed 
in insect cell lines to monitor expression levels, protein mobility and complex formation. If LRIM 
complexes are identified, mutational analyses would be performed to identify the amino acid 
residues responsible for complex formation. Furthermore, antibodies would be raised against the 
most promising candidate LRIMs to investigate their behaviour in the mosquito hemolymph after 
different immune challenges. 
The final objective was to attempt to identify other mosquito proteins interacting with candidate 
LRIMs. This would indicate whether these LRIMs function in known immune pathways. In particular, 
72 
 
as the LRIM1/APL1C complex interacts with the complement C3-like effector TEP1 (Fraiture et al., 
2009; Povelones et al., 2011; Povelones et al., 2009), it was planned to investigate whether any 
other LRIMs are linked to the mosquito complement-like system. 
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3 Materials and Methods 
 
3.1 Mosquito experiments 
Mosquito rearing 
An. gambiae (susceptible strains Ngousso, Yaoundé, G3 and Keele and refractory strain L3-5) adult 
mosquitoes were maintained as previously described (Sinden et al., 2002). G3 is a long-term 
laboratory strain that was colonised from field collections in The Gambia in 1975 and L3-5 was 
selected from G3 (Collins et al., 1986). The Keele strain was produced in 2005 at Keele University, 
UK, by interbreeding four strains of An. gambiae (Hurd et al., 2005). Yaoundé was established from 
the Yaoundé region of Cameroon in 1988 (Tchuinkam et al., 1993). Ngousso was colonised in 2006 
from the urbanised Ngousso district of Yaoundé, Cameroon (Boissiere et al., 2012). As the most 
recently colonised strain, Ngousso was used for the majority of experiments, unless mentioned 
otherwise. Briefly, adult mosquitoes were maintained at 28 oC, 80% humidity in a 12 h light/dark 
cycle and provided with 10% sugar solution. For gene knockdown experiments, mosquitoes were 
used 0-2 days after emergence. Mosquitoes were 3-6 days old at the time of blood feeding. For 
experimental purposes, mosquitoes were kept in netted pots of 60-80 mosquitoes. 
RNAi-mediated gene silencing 
Female mosquitoes were anaesthetised under carbon dioxide (CO2) and injected intrathoracically 
with dsRNA using a Nanoject II injector (Drummond Scientific). For single gene knockdown 
experiments, mosquitoes were injected with 69 nL dsRNA at 3 µg/µL. GFP (non-specific dsRNA) and 
LRIM1 were used as negative and positive controls, respectively. To knockdown two genes 
simultaneously (“double knockdowns”), 138 nL of pooled dsRNA was injected per mosquito and 
controls were injected with 138 nL of dsGFP. Knockdown efficiency was monitored by quantitative 
real-time PCR (qRT-PCR) 4-5 days post injection.  
Hemolymph collection 
Prior to hemolymph collection, mosquitoes were briefly anaesthetised using CO2 and kept on ice. 
Groups of 10 mosquitoes were positioned with their ventral side up on a glass plate chilled on ice. 
Fine scissors were used to cut the proboscis of all 10 mosquitoes. Forceps were used to gently 
squeeze the thorax and a clear drop of hemolymph was collected by capillary action into a pipette 
tip containing 5 µL 2X non-reducing Lane Marker sample buffer (Pierce) and transferred immediately 
to an Eppendorf tube. Hemolymph was collected from between 20-90 mosquitoes per group and the 
final sample volume was adjusted to 1 mosquito/µL (or 1.5 mosquitoes/µL for CLIPA8 western blots 
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to increase protein abundance). For gene knockdown experiments, hemolymph was collected 4 days 
after dsRNA injection. Hemolymph was snap frozen on dry ice and stored at -80 oC prior to analysis. 
Uninfected blood feeding 
After being deprived of sugar for 2-6 h, female mosquitoes were permitted to feed on a terminally 
anaesthetised uninfected (“naïve”) Theiler’s original (TO) or CD1 mouse (Harlan, UK). Non blood fed 
mosquitoes were removed between 3 and 48 h, when the blood meal is visible through the 
abdominal cuticle.  
For human blood feeding, an artificial membrane feeding system was utilised. Briefly, compacted 
human red blood cells were washed twice with phosphate buffered saline (PBS) and resuspended in 
human AB serum at a 1:1 ratio. Perspex membrane feeders were warmed to 37 oC via connection to 
a water bath. Parafilm was stretched across the bottom of the feeders to provide a compartment for 
introduction of human blood with a 24 Gauge blunt needle (500 µL per feeder). Each feeder was 
rested on top of a pot of mosquitoes and they were allowed to feed for 30 min.  
P. berghei infection 
Female mosquitoes were allowed to feed on a mouse infected with the P. berghei CONGFP strain (a 
transgenic parasite constitutively expressing GFP (Franke-Fayard et al., 2004)), as previously 
described (Osta et al., 2004a). An uninfected (naïve) mouse was used as a control. Infected and 
control mosquitoes were stored at 19 oC, the optimum temperature for P. berghei development. 
For gene knockdown experiments, mosquitoes were infected with P. berghei 3-4 days after dsRNA 
injection and parasite load was quantified 7-10 days later. Midguts were dissected into PBS, fixed in 
4% formaldehyde for 30-60 min, washed three times in PBS and mounted on glass slides in 
Vectashield (Vector Labs). Live oocysts and melanised ookinetes were counted by direct microscopic 
observation using a Leica DMR microscope. Photographs were taken with a Zeiss digital camera and 
AxioVision software. Both infection intensity and prevalence (the percentage of guts with at least 
one oocyst or melanised parasite) were analysed.  
P. yoelii infection 
As described for P. berghei, female mosquitoes were allowed to feed on mice infected with the 
transgenic GFP-P. yoelii yoelii 17X strain (Ono et al., 2007). Infected mosquitoes were stored at 25 oC, 
along with control mosquitoes fed on uninfected blood. 
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P. falciparum infection 
Female G3 mosquitoes were fed on P. falciparum gametocyte cultures (NF-54 strain) using an 
artificial membrane feeding system, as previously described (Jaramillo-Gutierrez et al., 2009), by Dr 
Alvaro Molina-Cruz at the NIH. Mosquitoes were fed on the same blood without gametocytes as a 
control. Infected and control mosquitoes were stored at 27 oC.  
Fungal spore challenge 
B. bassiana spores were extracted from 3-week old cultures on malt agar plates, washed, 
resuspended and quantified by Dr Fanny Turlure (as described in Fanny Turlure, PhD thesis, 2010). 
The stock of B. bassiana spores was stored at -80 oC and, on the day of each experiment, it was 
serially diluted in PBS so that 69 nL would equate to 100 spores. Female mosquitoes were injected 
intrathoracically with 69 nL of the spore dilution. For the fungal time courses, control mosquitoes 
were injected with sterile PBS and uninjected mosquitoes were used as “time zero”.  
Bacterial infections 
Ampicillin-resistant E. coli OP-50 and tetracycline-resistant S. aureus were cultured overnight in 
Luria-Bertani (LB) broth at 37 oC. Overnight cultures were re-cultured at 1/50 or 1/100 dilution (for S. 
aureus and E. coli, respectively) for 2-3 h until the optical density at 600 nm (OD600) reached 0.7-0.8, 
which is indicative of logarithmic growth phase. Harvested cells were washed three times with 
sterile PBS and then resuspended in PBS to give an OD600 of 0.4 (Schnitger et al., 2009). Female 
mosquitoes were injected with 69 nL of this final bacterial suspension (approximately 10,000-20,000 
bacteria per mosquito). Bacterial viability was confirmed by plating onto agar at 1/10,000 dilution 
and incubating at 37 oC overnight (30-100 colonies expected). For bacterial time courses, control 
mosquitoes were injected with sterile PBS and uninjected mosquitoes were used as “time zero”.  
Injection of bioparticles 
Bioparticles are heat- or chemically-killed bacteria, usually fluorescently labelled, which can be used 
to provoke an immune response without the complication of bacterial proliferation. E. coli (K-12 
strain) and S. aureus (Wood strain, without protein A) fluorescein-labelled bioparticles (Invitrogen) 
were resuspended in sterile PBS to 20 mg/mL. Female mosquitoes were intrathoracically injected 
with 69 nL of bioparticle suspension (equating to approximately 400,000 bioparticles). 
Bacterial proliferation assay 
Female mosquitoes were injected with dsRNA and, 4 days later, were inoculated with 69 nL viable 
ampicillin-resistant E. coli (OD600 of 0.4). After 24 h, three to five batches of 10 mosquitoes per 
dsRNA treatment were surface-sterilised with 70% ethanol, washed twice with sterile PBS, 
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homogenised and plated on ampicillin-agar at 1/10 dilution. After an overnight incubation at 37 oC, 
colonies were counted and CFU per mosquito calculated. This protocol was adapted from Schnitger 
et al., 2009. As controls, 10 mosquitoes from each dsRNA-treatment were not injected with bacteria 
and were surface-sterilised and plated to check for bacterial contamination.  
Bacterial survival assay 
4 days after injection of dsRNA, female mosquitoes were inoculated with 69 nL viable ampicillin-
resistant E. coli (OD600 of 0.4). The number of dead mosquitoes was monitored daily for 10 days. In 
one experiment, mosquitoes were blood fed on a naïve mouse 24 h prior to bacterial inoculation. 
Antibiotic treatment 
Newly emerged mosquitoes were treated daily with a cocktail of antibiotics (10 U/mL penicillin, 10 
µg/mL streptomycin and 15 µg/mL gentamicin) in their 10% sugar solution for 4 days prior to blood 
feeding. To test the efficacy of antibiotic treatment, cohorts of 5 mosquitoes were collected after 5 
days of treatment, surface-sterilised in 70% ethanol and rinsed in sterile molecular biology grade 
water. Mosquitoes were homogenised in LB broth, plated at 1/100 dilution onto LB agar and 
incubated at 27 oC for 2 days. 
Phenoloxidase activity assay 
Genes of interest were silenced by RNAi in female mosquitoes 4 days prior to the assay. 1 mL of 
overnight cultures of E. coli and S. aureus were pelleted and washed twice with 1X PBS. Pellets were 
resuspended in PBS and suspensions were diluted to OD600 of 0.5. Equal volumes of E. coli and S. 
aureus suspensions were mixed together and 69 nL injected into at least 90 mosquitoes per gene 
knockdown. After 4-5 h, hemolymph was collected from 90 mosquitoes per gene knockdown into 45 
µL PBS supplemented with 2X protease inhibitors without EDTA (Roche). Each hemolymph sample 
was divided into 5 µL and 40 µL portions for protein quantification and the phenoloxidase assay, 
respectively. Samples were snap frozen and stored at -80 oC; they were used immediately after 
thawing. Each hemolymph sample was quantified using the Coomassie Plus (Bradford) Assay kit 
(Thermo Scientific) and the manufacturer’s Micro Microplate Protocol (working range = 1-25 µg/µL). 
The samples were adjusted to equal protein concentration in a total volume of 40 µL and the same 
volume of hemolymph collection buffer was used for a blank. In a 96-well plate, the 40 µL samples 
were mixed with 120 µL of 3 mg/mL L-3,4-dihydroxyphenylalanine (L-DOPA). The assay plate was 
covered with foil and OD490 was read immediately at kinetic intervals of 10 min for a total of 90 min. 
This assay measures dopachrome production by phenoloxidase. 
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Tissue melanisation assay 
Female mosquitoes were injected with dsRNA and were allowed to feed on an anaesthetised naïve 
mouse 3 days later. Approximately 24 h post blood feeding, mosquito thoraxes were pricked 
multiple times with a sterile needle. The needle was sterilised with 70% ethanol between each 
mosquito. Live mosquitoes were examined for tissue melanisation 24 h after injury. To this end, 
mosquitoes were anaesthetised using CO2 and immobilised by removal of their wings and legs. 
Immobilised mosquitoes were lined up on their sides on a glass slide and a large coverslip was 
secured on top using adhesive putty. Thoraxes were observed using a Leica DMR microscope and 
photographs were taken with a Zeiss digital camera and AxioVision software. This protocol was 
adapted from Schnitger et al., 2007. 
Viral challenge 
ONNV infectious clones (5'-ONNVic-eGFP) were produced by Dr Joanna Waldock from African green 
monkey kidney (VERO) cells (Waldock et al., 2012). VERO cells were grown in Minimum Essential 
Medium (MEM) supplemented with 10% fetal bovine serum (FBS), L-glutamine, non-essential amino 
acids, penicillin/streptomycin and fungizone (amphotericin B). Second passage 5'-ONNVic-eGFP (1.73 
x 108 plaque-forming units (PFU)/mL) was used for the viral time courses. For viral injection, female 
mosquitoes were injected with 69 nL of virus (11,937 PFU/mosquito) and control mosquitoes were 
injected with conditioned media from uninfected VERO cells. For blood feeding, 69 µL of virus was 
mixed with 465.5 µL human red blood cells and 465.5 µL human AB serum and female mosquitoes 
were fed using a membrane feeder. Assuming a mosquito ingests 1 µL during a blood meal, each 
mosquito was infected with the same viral titre as via injection. Control mosquitoes were fed on 
uninfected blood from the same batch. Untreated mosquitoes were used for “time zero”. Virally 
infected mosquitoes were double-contained in a 28 oC incubator to prevent escape. After 6 days, 
entire guts from remaining ONNV blood fed mosquitoes were dissected to determine infection 
prevalence. Standard plaque assays were performed on individual mosquitoes 6 days after ONNV 
injection to determine viral titre, as described in Waldock et al., 2012. 
Mosquito fecundity experiment 
Upon emergence, mosquitoes were permitted to mate in a large cage for 3 days before being 
injected with dsRNA. Female mosquitoes were fed on an anaesthetised naïve mouse 3 days after 
injection. After 48 h, a random sample of mosquitoes was dissected to examine blood meal digestion 
and ovary development. 72 h after blood feeding, individual females were carefully placed in 50 mm 
petri dishes on top of wet filter paper (0.1% salt water). They were stored in darkness at 27 oC for 24 
h to encourage oviposition. Female mosquitoes were then removed and the number of eggs laid was 
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counted by direct observation under a dissecting microscope. The egg dishes were half-filled with 
0.1% salt water, dusted with fish food and returned to 27 oC for 3 days to allow hatching. Gentle 
movement of the dishes and the addition of drops of salt water were used to encourage hatching. 
Larvae were counted by direct observation under a dissecting microscope. 
 
3.2 Molecular biology techniques 
dsRNA synthesis 
Primers were designed for 150-500 bp regions of each gene of interest, with 5' T7 promoter 
sequences, using the e-RNAi online software (Horn and Boutros, 2010). Primer sequences are shown 
in Appendix Table 9.1. RNAi probes were checked to ensure no significant sequence homology with 
other An. gambiae genes. Gene fragments were amplified by Polymerase Chain Reaction (PCR) using 
An. gambiae cDNA or plasmid template and purified using the QIAquick PCR Purification kit (Qiagen). 
The amplicons were analysed by agarose gel electrophoresis and NanoDrop (Thermo Scientific) to 
verify size and concentration, respectively. dsRNA was synthesised from the gene fragments using 
the MegaScript T7 kit (Ambion), according to manufacturer’s guidelines. dsRNA was purified using 
the RNeasy Mini kit (Qiagen), eluting twice in 30 µL RNase-free water, and adjusted to 3 µg/µL. 
Purified dsRNA was stored at -80 oC until use. 
RNA extraction and cDNA synthesis 
Total RNA was extracted from 10 whole mosquitoes collected per sample and the TRIzol Reagent 
(Invitrogen) was used, according to manufacturer’s instructions. Briefly, mosquitoes were 
homogenised in 200 µL TRIzol before a further 800 µL TRIzol was added (1 mL total volume). After 
removing debris by centrifugation, 200 µL chloroform was added to extract RNA from genomic DNA 
and protein. RNA was precipitated using 480 µL isopropanol. The RNA pellet was washed with 70% 
ethanol and resuspended in 90 µL RNase-free water. Total RNA was treated with DNase using Turbo 
DNA-free kit (Ambion) to remove genomic DNA contamination. cDNA was synthesised from 1 µg 
RNA using either SuperScript II or SuperScript III kits with oligo(dT)12-18 primers (Invitrogen), 
according to manufacturer’s instructions.  
For transcriptional time courses, 10 adult mosquitoes were collected at 24, 48 or 72 h post challenge 
(except day 1, 3 and 6 for viral time courses) and untreated mosquitoes were used as “time zero”. 
For other mosquito life stages, 10 larvae or pupae were collected per sample, surface-sterilised with 
70% ethanol, washed twice with water and RNA was extracted in 1 mL TRIzol, as above. For midgut 
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RNA extraction, 20 guts were used per sample in a total volume of 600 µL TRIzol, with other reagent 
volumes reduced accordingly. 
qRT-PCR analysis 
The ABI Prism 7500 Fast Real-Time PCR System was used with Fast SYBR Green Master Mix (Applied 
Biosystems) to perform qRT-PCR, according to manufacturer’s instructions. All qRT-PCR samples 
were analysed in duplicate, using 1 µL of 1/10 dilution of cDNA per reaction. The ribosomal “house-
keeping” gene S7 was used as the endogenous reference to normalise samples according to the 
amount of total cDNA added to the reaction. Gene expression was quantitated relative to a 
calibrator control sample (e.g. untreated mosquitoes, dsGFP-treated mosquitoes). If the efficiency of 
target gene amplification was approximately equal to the efficiency of S7 amplification, the 
Comparative CT (∆∆CT) Method was used (refer to User Bulletin #2). Otherwise, the Relative 
Standard Curve Method was used and standard curves were prepared from serially diluted cDNA 
(pooled cDNA from each sample or dsGFP-treated mosquito cDNA for knockdown experiments). 
Primers were designed using Primer3 online software (Rozen and Skaletsky, 2000) and optimised 
according to User Bulletin #5. Refer to Appendix Table 9.2 for qRT-PCR primer sequences. 
NanoString analysis 
NanoString nCounter Gene Expression Analysis (NanoString Technologies, Inc.) is a high-throughput 
digital technology for determining gene expression from total RNA, as described in detail in Chapter 
4 (Fortina and Surrey, 2008; Geiss et al., 2008). Gene-specific probes were designed and 
manufactured by NanoString Technologies Inc. to cover 100 bp of coding sequence (Appendix Table 
9.3). For each gene, a capture and a reporter probe (~50 bp each) were used to target the 100 bp 
region. Total RNA samples (after DNase-treatment) were diluted to 100 ng/µL and shipped on dry ice 
for NanoString analysis. Raw data was first normalised using positive “spike-in” controls to account 
for assay based variation and subsequently normalised using the mosquito reference gene, S7, to 
account for differences in total RNA abundance. 
Cloning LRIMs into pIEx-10 expression vector 
The LRIM9 open reading frame, without the endogenous signal peptide, was amplified by PCR, 
initially from genomic DNA using gLRIM9 forA and tLRIM9 revA primers followed by LRIM9 LIC for 
and LRIM9 LIC rev primers (Appendix Table 9.4). The open reading frames of LRIM4, LRIM17 and 
LRIM15, without the endogenous signal peptides, were amplified by PCR from cDNA template using 
primers in Table 9.4. The resulting products were cloned into the pIEx-10 insect expression plasmid 
using the Enterokinase/Ligase-independent cloning (Ek/LIC) system (Novagen), according to 
manufacturer’s instructions. This plasmid incorporates a mouse IgM signal peptide, an N-terminal 
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Strep-tag and a C-terminal His-tag. pIEx-10-LRIM9, -LRIM4 and -LRIM17 were transformed into 
NovaBlue GigaSingles competent cells (Novagen) and pIEx-10-LRIM15 was transformed into SURE 
competent cells (Stratagene), which reduce unwanted rearrangement events. Plasmid DNA from one 
sequence-verified clone per LRIM was prepared using the HiSpeed Plasmid Midi kit (Qiagen). 
Cloning TEP3 and TEP4 C-terminal fragments into pET-41a(+) expression vector 
C-terminal fragments of TEP3 and TEP4 were cloned into pET-41a(+) expression vector (Novagen), 
which incorporates an N-terminal GST-tag, with the aim of raising antibodies against the purified 
fragments after expression in E. coli. C-terminal fragments were amplified by PCR from existing 
plasmid templates (see Appendix Table 9.4 for primers) and cloned into pET-41a(+) using the Ek/LIC 
system (Novagen). pET41a(+)-TEP3 and -TEP4 were transformed into NovaBlue GigaSingles cells, 
sequence verified and re-transformed into BL21-pLysS competent cells (Novagen), which are 
isopropyl β-D-1-thiogalactopyranoside (IPTG) inducible and optimised for protein expression. 
Site-directed mutagenesis 
A cysteine (TGC) to serine (AGC) missense mutation at position 535 in LRIM4 was generated using 
the QuikChange II Site-Directed Mutagenesis protocol (Stratagene), according to manufacturer’s 
instructions. The following PAGE-purified primers were used:  
 C535S for  5'-gcagctgaccaagagcacctcgaccgt-3'  
 C535S rev  5'-acggtcgaggtgctcttggtcagctgc-3' 
 
3.3 Protein analysis and cell culture 
Maintenance of insect cell lines 
Spodoptera frugiperda (Lepidoptera)-derived Sf9 cells were cultured in serum-free Sf-900 medium 
(Gibco). Sua4.0 cells, derived from minced neonate An. gambiae larvae (Muller et al., 1999), were 
cultured in Schneider’s medium (Gibco) supplemented with 10% heat-inactivated FBS, 10 U/mL 
penicillin and 10 µg/mL streptomycin. All insect cells were maintained at 27 oC in 75 cm2 flasks and 
were split by diluting 1/10 in fresh media every 7 days. 
Transfection of cultured cells 
Sf9 and Sua4.0 cells were seeded at 1x106 and 3x106 cells in 2 mL of medium per well, respectively, in 
6-well plates. Cells were transfected with 2 µg plasmid DNA, using a GFP-expressing plasmid as a 
control. Escort IV (Sigma-Aldrich) and Effectene (Qiagen) were used to transfect Sf9 and Sua4.0 cells, 
respectively, according to manufacturers’ instructions. For one well, the following volumes of 
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reagents were used: 4 µL Escort IV (for Sf9 cells) or 100 µL EC buffer, 3.2 µL Enhancer and 10 µL 
Effectene (for Sua4.0 cells). The day after transfection, Sf9 media was replaced with fresh Sf-900 
whereas Sua4.0 cells were washed (to remove serum) and placed in 2 mL serum-free Schneider’s 
medium. Conditioned media were collected after 3-4 days and filtered using a 0.45 µM syringe filter 
to remove cells and debris. Samples were stored at 4 oC (protected from light) and used within 7 
days. 
LRIM9 peptide antibodies 
Rabbit polyclonal antibodies were raised against the following peptides by Eurogentec using the 
“Super Speedy” 28 day immunisation programme: 
 Peptide 70: NH2-CDYARRLEVASEPSAK-COOH (the real C-terminus with an ectopic cysteine) 
 Peptide 71: NH2-DSDGTLLDKSTDGTDC-COOH (amino acids 269-284; between LRRs and 
coiled-coil) 
Antibodies were affinity purified by Eurogentec and then verified by western blotting analysis of 
conditioned media from cultured cells and hemolymph (see below for details). 
LRIM9 whole protein antibody 
A Sf9 cell line stably expressing LRIM9 was produced by Dr Lavanya Bhagavatula by co-transfecting 
pIEx-10-LRIM9 and the pIE1-neo selection plasmid (Novagen), following the manufacturer’s protocol. 
Over 2 L of LRIM9-containing conditioned medium was collected and 0.22 µM sterile-filtered. LRIM9 
was purified from the media using a His Trap FF column on an ÄKTA purifier (fast protein liquid 
chromatography or FPLC; GE Healthcare), according to the manufacturer’s protocol. 
LRIM9 protein was analysed by Coomassie staining, concentrated using Amicon Ultra Centrifugal 
filter units (Millipore) and quantified by Bradford assay. 214 µg of purified LRIM9 was sent to 
Eurogentec for immunisation of two guinea pigs (named 59 and 60). Pre-immune serum (PPI) was 
collected from each animal before immunisation, as a control for antibody specificity. A large bleed 
(GP) and final bleed (SAB) were collected 3 weeks and 4 weeks, respectively, after immunisation. 
Antisera from both animals were characterised. SAB from guinea pig 59 at 1/500 dilution (in 3% milk) 
produced the strongest signal and was chosen for use in subsequent experiments. 
Western blot analysis of hemolymph or conditioned media 
Proteins were separated on an 8% SDS-PAGE gel before transfer to a PVDF membrane using a Trans-
Blot SD Semi-Dry Transfer Cell (Bio-Rad). Non-reduced samples were prepared in Lane Marker 
sample buffer (Pierce) without heating. Reduced samples were prepared by adding tris(2-
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carboxyethyl)phosphine (TCEP) solution (Pierce) to non-reduced samples to a final concentration of 
25 mM and heating at 95 oC for 5 min. Membranes were blocked with PBS containing 3% milk and 
0.05% Tween-20 and probed at room temperature for 1 h (or overnight at 4 oC) with primary 
antibody. Primary antibodies were used at the following dilutions: guinea pig α-LRIM9 (1/500), 
rabbit α-LRIM1-w (1/1000), rabbit α-LRIM2-300 (for APL1C; 1/2000), rabbit α-SRPN3 (1/1000), rabbit 
C-terminal α-TEP1 (1/1000), mouse α-CLIPA8 monoclonal (1/50) and mouse α-Strep-tag (1/1000). 
PBS-Tween containing 3% bovine serum albumin (BSA) was used as blocking buffer for α-Strep-tag. 
Membranes were washed three times with PBS-Tween and incubated with horseradish peroxidise 
(HRP)-conjugated rabbit secondary antibody for 1 h at room temperature. α-rabbit (1/12,000), α-
guinea pig (1/10,000) and α-mouse (1/12,000) secondary antibodies (Promega) were used, diluted in 
blocking buffer. Finally, blots were washed three times with PBS-Tween. For detection of the His-tag, 
blots were blocked with 3% BSA and probed for 1 h at room temperature with HRP-conjugated His 
probe (1/5000 dilution; Pierce), without the need for a secondary antibody. For visualisation, 
Western Lightning Chemiluminescence Reagent Plus (Perkin-Elmer) was applied and the ChemiDoc 
XRS+ System with Image Lab software (Bio-Rad) was used. Protein abundance was measured semi-
quantitatively using Image Lab software, normalising to the SRPN3 loading control. 
A MiniBlotter (Immunectics) was used to test the new LRIM9 antibodies, according to 
manufacturer’s guidelines. This allows multiple antibody dilutions to be tested on the same western 
blot. Antibody concentration and blocking buffer were optimised accordingly. 
Immunolocalisation of TEP1 
Mosquito midguts were dissected in ice-cold PBS 27-30 h after a P. berghei infected blood meal 
(Povelones et al., 2009). Micro-dissection scissors were used to cut along the length of the midgut 
and the bloodmeal was gently removed from the midgut epithelium. The epithelia were fixed in 4% 
formaldehyde for 45 min, washed three times in PBS for 15 min and permeabilised for 10 min in PBS 
with 0.05% Triton X-100. They were blocked for 30 min in PBS-Triton supplemented with 3% BSA and 
then incubated overnight at 4 oC with rabbit α-TEP1 antibody (diluted 1/500 in blocking buffer). After 
three more washes with PBS-Triton, midgut epithelia were incubated with an Alexa Fluor 546 
conjugated goat α-rabbit secondary antibody (Molecular Probes) at 1/1500 dilution in blocking 
buffer. The epithelia were washed three more times with PBS-Triton; the second 15 min wash was 
supplemented with 1 µg/µL DAPI (Boehringer Mannheim). Finally, they were mounted on glass slides 
in Vectashield. 4-7 midguts were analysed for each gene knockdown using the Leica DMR 
fluorescent microscope. One representative photograph (comprised of Alexa, GFP and DAPI 
channels) was taken per gut using the 40X objective. Green (live, GFP-labelled) and red (dead, TEP1-
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labelled) parasites were counted manually from the photographs, labelling each “counted” parasite 
with a brush mark in Adobe Photoshop to reduce error. 
Purification of His-tagged proteins from conditioned media 
Sua4.0 cells were transfected with pIEx-10-GFP, -LRIM1, -APL1C and either -LRIM9 or -LRIM4. 
Conditioned media were collected after 3.5 days and analysed by western blot using the His probe. 
Depending on the abundance of each His-tagged protein, between 400 µL and 1 mL of conditioned 
media were supplemented with 0.05% Triton X-100 in a Protein LoBind tube (Eppendorf). 50 µL of 
1:1 slurry of Talon Metal Affinity Resin (Clontech) in PBS was added to each sample. Samples were 
gently agitated for 1 h at room temperature before centrifugation for 2 min at 2500 rpm and 
removal of the supernatant. Beads were washed with 500 µL Talon wash buffer (50 mM NaH2PO4, 
300 nM NaCl, 10 mM imidazole) containing 0.05% Triton X-100. A further 500 µL Talon wash buffer 
(without Triton) was added to the beads and the entire solution was transferred to a 
Microcentrifuge spin column in a 2 mL collection tube (Pierce). Beads were washed five times with 
Talon wash buffer, centrifuging for 2 min at 2500 rpm each time. The column was transferred to a 
clean Protein LoBind tube and beads were incubated for 10 min with 35 µL 2X non-reducing Lane 
Marker sample buffer (Pierce). Eluates were recovered by centrifugation and samples were stored at 
-20 oC prior to western blot analysis. 
 
3.4 Statistical analysis and further data analysis 
Statistical analyses were performed using GraphPad Prism 5 software, unless otherwise noted. P. 
berghei infection intensity (number of oocysts or melanised ookinetes) was analysed by the Mann 
Whitney U-test whereas prevalence was analysed by Fisher’s exact test. However, if prevalence was 
zero for one gene knockdown, the Wilcoxon signed-rank test was used instead, which compares a 
median to a hypothetical value (i.e. 0.0). Bacterial survival assays were analysed using the Log-rank 
(Mantel-Cox) test. Bacterial proliferation assays were analysed using Meta-Analysis (Comprehensive 
Meta-Analysis, Biostat). 
Log2-transformed NanoString transcriptional data was analysed using Cluster 2.11 and Treeview 
(Eisen Laboratory). Average data for each time course was used to create a heat map and individual 
biological replicates were used to hierarchically cluster the genes tested (see Chapter 4). 
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3.5 VectorBase gene identifiers 
For the LRIM family, refer to Table 1.1. 
TEP1, AGAP010815; TEP2, AGAP008366; TEP3, AGAP010816; TEP4, AGAP010812; TEP5, 
AGAP010818; TEP6, AGAP010814; TEP8, AGAP010831; TEP9, AGAP010830; TEP10, AGAP010819; 
TEP12, AGAP008654; TEP13, AGAP008407; TEP14, AGAP008368; TEP15, AGAP008364; S7, 
AGAP010592; CTL4, AGAP005335; CLIPA8, AGAP010731; Polyubiquitin, AGAP001971. 
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4 Transcriptional and functional analysis of the LRIM 
family 
 
4.1 Background 
The LRIMs are a novel mosquito-specific protein family recently discovered in An. gambiae 
(Povelones et al., 2009; Waterhouse et al., 2010). The family shares characteristic protein domain 
architecture and LRIMs have been divided into four subfamilies: Long, Short, Transmembrane and 
Coil-less. The founding members, LRIM1 and APL1C, form a heterodimer and function in the 
mosquito complement-like pathway (Blandin et al., 2008; Povelones et al., 2011). The LRIM1/APL1C 
complex binds to and stabilises the complement-like effector, TEP1, delivering it to Plasmodium 
surfaces, which results in parasite killing, lysis and melanisation (Fraiture et al., 2009; Povelones et 
al., 2009). The LRIM1/APL1C complex also plays a key role in bacterial defence and phagocytosis 
(Moita et al., 2005). Apart from LRIM1 and APL1C, the other 22 LRIMs in An. gambiae have been 
poorly characterised to date. Microarray analyses have revealed expression changes in certain An. 
gambiae LRIMs after blood feeding, Plasmodium invasion and other immune challenges (Aguilar et 
al., 2005a; Dong et al., 2006a; Marinotti et al., 2005; Vlachou et al., 2005). For example, LRIM4, 
LRIM8B, LRIM10 and LRIM17 were shown to be upregulated in the An. gambiae midgut during P. 
falciparum infection (Dong et al., 2006a). LRIM10 was also highly induced in the midgut after P. 
berghei invasion (Vlachou et al., 2005) whereas LRIM8B was also downregulated by infection with 
Salmonella typhimurium, a gram-negative bacterium (Aguilar et al., 2005b). A few novel LRIMs have 
been putatively described as Plasmodium antagonists. The Coil-less LRIM17 was reported to 
antagonise infections with P. berghei and P. falciparum (Dong et al., 2006a; Garver et al., 2012), 
although this has not been supported by other studies (Riehle et al., 2006). The Long APL1A has 
been demonstrated to influence the prevalence of P. falciparum infections but not the infection 
intensity (Mitri et al., 2009). The Long APL1B was recently shown to influence P. falciparum oocyst 
levels at medium infection intensities (Garver et al., 2012).  
The importance of LRIM1 and APL1C in the mosquito immune response led to the hypothesis that 
the LRIM family has expanded and diversified in mosquitoes to provide protection against different 
pathogens they encounter. To determine whether there is specificity in the LRIM family, this PhD 
aimed to provide a complete transcriptional profile for all LRIMs after various immune challenges 
using NanoString nCounter Gene Expression Analysis (NanoString Technologies, Inc.). As most 
previous experiments focused on expression in the mosquito midgut, this current study used whole 
mosquitoes. Transcriptional regulation often reflects protein function and so profiling will provide 
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candidates for involvement in defence against certain pathogens. Genes that function in the same 
biochemical pathways are frequently transcriptionally co-regulated and therefore profiling can 
identify putative functional relationships between LRIMs. For instance, co-regulation of LRIM1, 
APL1C and TEP1 has previously been demonstrated after P. berghei infection (Blandin et al., 2004; 
Fraiture et al., 2009; Frolet et al., 2006). 
As NanoString allows many genes to be assayed using the same RNA sample in a single reaction, the 
TEP family was also included for analysis. The TEPs are predicted to be interacting partners of the 
LRIMs because TEP1, TEP3, TEP4 and TEP9 have been demonstrated to interact with the 
LRIM1/APL1C complex (Povelones et al., 2011). The TEPs are related to the vertebrate complement 
factors, C3, C4 and C5 (Christophides et al., 2004). They contain highly reactive TE bonds, which 
allow TEPs to covalently bind to and opsonise pathogen surfaces (Blandin and Levashina, 2004). 
However, most mosquito TEPs, including TEP3, lack an active TE bond and could play regulatory roles 
in immunity (Christophides et al., 2002). TEP1 is an essential component of the mosquito 
complement-like pathway and other An. gambiae TEPs have been implicated in Plasmodium and 
bacterial defence (Blandin and Levashina, 2004). Microarrays have reported that TEP4 is upregulated 
by gram-negative and gram-positive bacteria and TEP4 knockdown decreases survival upon bacterial 
challenge (Dong et al., 2006a; Dong et al., 2009). TEP4 also functions in phagocytosis of both 
bacterial gram-types whereas TEP3 is only involved in phagocytosis of gram-negative bacteria (Moita 
et al., 2005).  
The NanoString nCounter System is a novel digital technology for high-throughput mRNA expression 
profiling (Fortina and Surrey, 2008; Geiss et al., 2008). The assay uses unique molecular “barcodes” 
for each gene of interest and hundreds of different transcripts can be multiplexed in a single 
reaction (Figure 4.1). Specific pairs of 50 bp capture and reporter probes are designed to be 
complementary to each transcript of interest. The reporter probe carries a directional fluorescent 
barcode made from combinations of four spectrally distinct dyes at seven regions. The capture 
probe enables immobilisation required for data collection. Both probes are mixed with the total RNA 
sample and allowed to hybridise in solution. Complexes composed of one mRNA transcript, one 
capture probe and one reporter probe form and excess probes are removed by purification. 
Complexes bind to the imaging surface via their capture probes; they are oriented by electrophoresis 
and then immobilised. A digital analyser detects and counts the number of reporter probes for each 
gene, providing quantitation of gene expression. The technique is highly precise and sensitive with 
the equivalent of less than one transcript per cell detectable, which is superior to microarrays and 
comparable to qRT-PCR. Detection of low abundance transcripts is considerably improved compared 
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to microarrays. Unlike qRT-PCR and microarrays, NanoString analysis does not require cDNA 
synthesis or enzymatic reactions, which avoids unnecessary bias.  
A large subset of samples was verified by qRT-PCR, a traditional technique for gene expression 
profiling. Unlike the NanoString, qRT-PCR requires a single reaction per target gene and is 
considerably more laborious.  
 
Figure 4.1  Schematic overview of NanoString technology.  
The total RNA sample is mixed with reporter and capture probes complementary to the different genes 
being assayed (a). Specific mRNA transcripts hybridise with their unique probes in solution (b). 
Purification is utilised to remove unhybridised probes (c). mRNA-probe complexes bind to the imaging 
surfaces and are immobilised in the correct orientation (d). The number of reporter probes per gene 
(corresponding to the number of transcripts) is counted (e). From Fortina and Surrey, 2008. 
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As LRIM1 and APL1C are potent antagonists of P. berghei, the uncharacterised LRIMs were screened 
for a similar phenotype. A functional screen was used to determine whether silencing any novel 
LRIMs influences malaria parasite development, using P. berghei as a laboratory model. 
 
4.2 Results 
Transcriptional profiling of the LRIMs and TEPs 
To investigate transcriptional specificity in the LRIM family, expression was monitored after various 
immune challenges. It was hoped that transcriptional profiling would provide clues about the 
function of novel LRIMs and also the relationships between LRIMs. The TEPs were included in the 
analysis because they are known to be interacting partners of LRIMs: as well as its main functional 
partner TEP1, the LRIM1/APL1C complex has been demonstrated to interact with TEP3, TEP4 and 
TEP9 in vitro (Povelones et al., 2011).  
The Ngousso strain of An. gambiae was used for all transcriptional experiments and RNA was 
extracted from a group of 10 whole mosquitoes per sample. A wide range of immune challenges 
were selected to represent the variety of pathogens that mosquitoes encounter in their blood 
feeding lifestyle. An. gambiae females were infected with three Plasmodium parasites – two murine 
parasites (P. berghei and P. yoelii) and the human malaria parasite, P. falciparum. Interestingly, these 
parasites have different optimal growth temperatures (19 oC for P. berghei, 25 oC for P. yoelii and 27 
oC for P. falciparum). To gain a temporal understanding of transcriptional changes, mosquitoes were 
collected at three time points (24, 48 and 72 h). To ensure parasite-specific responses, Plasmodium 
infections were normalised against naïve blood feeding performed at the same temperature. 
Transcriptional responses to naïve blood feeding at each temperature were also analysed, relative to 
unfed mosquitoes.  
Viral responses were monitored using ONNV, an alphavirus related to CHIKV. ONNV is the only 
arbovirus that is commonly transmitted by An. gambiae (Powers et al., 2000). Most arboviruses are 
transmitted by Culicine mosquitoes (Sim et al., 2005). The virus is ingested with a blood meal, 
replicates in midgut epithelial cells and then disseminates through the hemocoel to the salivary 
glands, fat body, muscles and other tissues (Pierro et al., 2003). In the transcriptional profiling, 
mosquitoes were either infected by injection into the hemocoel or by ingestion in a blood meal of 
virus that had been harvested in the conditioned media of infected VERO cells. This would allow 
comparison of systemic and midgut dissemination responses. Samples were collected at day 1, 3 and 
6 after infection to account for the slower process of viral infection and dissemination. Mosquitoes 
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injected with conditioned media from uninfected VERO cells were used to normalise viral injection. 
The response to conditioned media injection was also monitored, relative to uninjected mosquitoes. 
Results from mosquitoes infected by ONNV blood feeding were normalised using naïve blood 
feeding.  
Mosquitoes were challenged with bacteria and fungi, both organisms that the immune system 
commonly encounters, and samples were collected 24, 48 and 72 h post challenge. Challenges 
included injection of spores of B. bassiana, an entomopathogenic fungus, and live suspensions of E. 
coli (gram-negative) and S. aureus (gram-positive) bacteria. Results were normalised against sterile 
PBS injection. To monitor injury responses, PBS injection alone was also analysed, relative to 
uninjected mosquitoes. In total, four PBS injection time courses were examined by NanoString (two 
from the fungi experiments and two from bacteria). 
Finally, RNA from 10 fourth instar larvae and 10 pupae was extracted and analysed to provide an 
initial insight into the developmental expression profiles of the LRIMs and TEPs. 
Two independent biological experiments were tested by NanoString for each experiment except the 
developmental profiling, for which only one replicate was performed. Raw NanoString data was first 
normalised using positive “spike-in” controls to account for assay based variation. These controls are 
used to monitor and adjust for slight differences in hybridisation, purification and binding efficiency 
due to differences in RNA quality. Next, samples were normalised based on a mosquito reference 
gene to account for differences in total RNA quantity between samples. Probes for three potential 
reference genes, S7, polyubiquitin and actin5C, were included in the analysis. These “housekeeping” 
genes were chosen because they are expressed by virtually all cells. S7 is a ribosomal gene, 
polyubiquitin is involved in protein turnover and actin is a cytoskeletal component. Of the three 
potential reference genes, S7 showed the least variation over all the RNA samples and was chosen to 
normalise all samples. For a large subset of RNA samples and genes, NanoString results were verified 
by qRT-PCR. Four replicates of blood feeding and P. berghei infection, three B. bassiana infection 
and three bacteria experiments were tested by qRT-PCR. Overall, there was very good agreement 
between NanoString and qRT-PCR in terms of fold changes in expression and patterns of expression 
across time courses. 
The LRIMs and TEPs were ranked according to their average number of NanoString reporter counts 
over all experiments to give a guide to expression levels (Table 4.1). Interestingly, LRIM1, APL1C and 
TEP1 were amongst the most highly expressed. LRIM11 and TEP11 were excluded from further 
analysis because their average reporter counts fell within the negative controls. Both were less than 
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the average reporter counts for the negative controls across all experiments plus 2 standard 
deviations. In support of the NanoString data, seven attempts to generate qRT-PCR primers against 
LRIM11 failed and this is likely due to very poor or complete lack of expression. Other poorly 
expressed genes that were not excluded included LRIM18, LRIM19, LRIM20, APL1B, TEP5, TEP9 and 
TEP10. Although very low detection in whole mosquito RNA may indicate low transcription levels in 
immune tissues or limited tissue-specific expression, caution should be taken when interpreting fold 
changes for these poorly expressed genes as a large fold change is not necessarily biologically 
meaningful. It was decided to focus on the transcriptional responses of genes with stronger 
expression but these poorly expressed genes will be discussed further in section 4.3. 
Fold change gene expression data is presented in a heat map to highlight the specific responses of 
each gene to different immune challenges (Figure 4.2). A complete data set is available on the 
Appendix CD. Overall, both the LRIM and TEP families showed a variety of transcriptional profiles, 
with different genes upregulated by distinct immune challenges. 
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Table 4.1  Rank order of all genes based on average number of NanoString gene-specific reporters. 
Rank Gene Average Minimum Maximum 
1 Polyubiquitin 39543 7474 84197 
2 Actin5C 16811 5079 68431 
3 APL1C 4589 1313 19233 
4 TEP1 4255 928 13142 
5 LRIM17 3182 302 11768 
6 TEP15 3017 538 7545 
7 LRIM1 2432 472 7949 
8 LRIM9 2248 2 12142 
9 LRIM8B 2002 5 5618 
10 LRIM8A 870 47 2149 
11 LRIM15 852 31 7856 
12 LRIM4 818 57 3523 
13 TEP4 763 86 2846 
14 TEP14 745 134 2505 
15 LRIM10 506 7 2285 
16 LRIM16B 489 221 1465 
17 LRIM6 482 166 1268 
18 TEP12 456 68 1594 
19 LRIM26 432 122 1092 
20 LRIM3 354 143 907 
21 TEP3 273 54 1184 
22 LRIM16A 258 67 800 
23 LRIM27 249 34 773 
24 TEP2 240 94 521 
25 APL1A 175 26 1467 
26 TEP13 156 38 867 
27 LRIM7 155 16 1380 
28 LRIM12 139 11 623 
29 LRIM5 133 7 396 
30 TEP6 111 3 525 
31 LRIM20 88 15 414 
32 LRIM18 62 20 262 
33 LRIM19 62 0 455 
34 APL1B 36 2 477 
35 TEP5 31 2 509 
36 TEP9 28 3 189 
37 TEP10 27 0 201 
38 NEG_G(0) 20 5 49 
39 LRIM11 15 1 55 
40 TEP11 9 0 140 
41 NEG_C(0) 8 0 61 
42 NEG_A(0) 8 0 22 
43 NEG_F(0) 8 0 18 
44 NEG_D(0) 7 0 52 
45 NEG_H(0) 7 0 30 
46 NEG_E(0) 6 0 18 
47 NEG_B(0) 5 0 18 
 
All genes analysed by NanoString were ranked according to their average number of NanoString 
reporter counts across all experiments, after normalisation to the reference gene, S7. Polyubiquitin and 
Actin5C were analysed as potential reference genes but were not used for normalisation because they 
showed higher variation between RNA samples than S7. Genes are shown in blue and negative controls 
(NEG) in red. The minimum and maximum number of reporter counts in any experiment is shown.  
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Figure 4.2  Transcriptional regulation of the LRIMs and TEPs after various immune challenges.  
Fold differences in gene expression were monitored by NanoString in whole mosquitoes at three time 
points after various immune challenges. Average log2-transformed fold change expression is presented 
as a heat map using Cluster 2.11 and Treeview (Eisen laboratory). The scale bar indicates the colours 
representing different levels of gene expression. Blue indicates downregulation, red is upregulation and 
yellow is unchanged. Poorly expressed genes (average NanoString codes < 100) are indicated with an 
asterix. Time courses shown are murine blood feeding (BF) at 19 oC and 25 oC, human blood feeding at  
27 oC, infection with P. berghei, P. yoelii and P. falciparum, PBS injection, conditioned media (CM) 
injection, ONNV injection, ONNV blood feeding and injection of E. coli, S. aureus and B. bassiana. The 
average of two biological replicates is shown for all challenges except human blood feeding (4 
replicates of 24 h and 72 h, 2 replicates of 48 h) and PBS injection (4 replicates). 
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Hierarchical gene clustering 
Individual transcriptional profiles were utilised to identify potentially co-regulated LRIM and TEP 
genes by employing hierarchical clustering analysis. Co-regulated genes are hypothesised to function 
together, either in the same immune pathway or in defence against the same pathogen(s). It was 
hoped that this analysis would provide clues as to which LRIMs and TEPs interact with each other or 
work together in the mosquito immune system. 
Hierarchical clustering analysis revealed distinct groups of LRIMs and TEPs with similar expression 
profiles (Figure 4.3). Four members of the short LRIM genomic cluster (LRIM8A, LRIM8B, LRIM9 and 
LRIM10) were tightly clustered. As expected, functional partners LRIM1, APL1C and TEP1 were found 
in the same cluster. LRIM1, APL1C and TEP1 were co-regulated with APL1A, TEP3 and TEP4. This 
supports the previous finding that TEP3 and TEP4 interact with the LRIM1/APL1C complex 
(Povelones et al., 2011). Interestingly, APL1A and APL1C were in a different cluster to APL1B despite 
being derived from recent gene duplication (Riehle et al., 2008). LRIM5 and LRIM27 are adjacent to 
each other on chromosome 2R and were also hierarchically clustered together. Another interesting 
cluster was LRIM4, LRIM17, TEP12 and TEP14, which might reflect a novel functional relationship. 
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Figure 4.3  Hierarchical clustering of LRIMs and TEPs based on transcriptional profile.  
Individual biological replicates of NanoString expression data were log2-transformed and clustered 
using Cluster 2.11 and Treeview. Complete linkage clustering analysis was performed using un-centred 
correlation. Branches indicate clusters of co-regulated genes. The data included infections with P. 
berghei, P. yoelii, P. falciparum, injected ONNV, blood fed ONNV, E. coli, S. aureus and B. bassiana (two 
replicates each). Other challenges were naïve blood feeding (8 replicates), PBS injection (4 replicates) 
and conditioned media injection (2 replicates). 
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Transcriptional responses to blood feeding 
Specific LRIMs responded strongly to naïve blood feeding, in the absence of parasite infection. The 
most dramatically induced genes were the Short LRIMs: LRIM8A, LRIM8B, LRIM9 and LRIM10. 
Interestingly, these genes are found clustered together on An. gambiae chromosome 2L and were 
also hierarchically clustered in Figure 4.3. All genes were upregulated by mouse and human blood 
and at all three temperatures (19, 25 and 27 oC). These genes seem to be largely blood feeding 
specific LRIMs. LRIM8A, LRIM8B, LRIM9 and LRIM10 were all induced between 2- and 10-fold within 
24 to 48 h of naïve blood feeding at 19 oC (Figure 4.4 A), with good agreement between NanoString 
and qRT-PCR.  
Differences in the peak and duration of upregulation were observed at different temperatures. For 
example, LRIM9 and LRIM10 peaked at 48 h after feeding on mouse blood at 19 oC, with expression 
rising steadily from 24 h (Figure 4.4 B). After feeding on mouse blood at 25 oC or human blood at  
27 oC, expression of LRIM9 and LRIM10 peaked rapidly at 24 h. As responses to mouse blood at 25 oC 
and human blood at 27 oC were more similar than mouse blood at 25 oC and 19 oC, this suggests that 
the vertebrate species has little influence. It is likely that the higher temperature accelerates gene 
expression. 
Curiously, LRIM7, the fifth member of the genomic cluster, was not co-clustered with the other Short 
LRIMs in Figure 4.3 and was largely uninduced by blood feeding. Although LRIM7 was upregulated  
48 h after human blood feeding in some replicates, it showed a completely distinct pattern of 
induction to the other Short LRIMs. 
Other LRIMs upregulated by blood feeding included Coil-less LRIM26, which was strongly induced at 
all time points, all temperatures and all blood types. LRIM26 was in a neighbouring cluster to 
LRIM8A, LRIM8B, LRIM9 and LRIM10 in Figure 4.3, which might suggest they function in related 
pathways. Transmembrane LRIM15 was also upregulated by naive blood feeding and seemed to be 
very sensitive to changes in temperature. Strikingly, LRIM15 was induced at 72 h at 19 oC, 48 h at 25 
oC and 24 h at 27 oC. As with the Short LRIMs, higher temperatures caused more rapid responses. 
Many genes were downregulated in response to taking a blood meal. This included LRIM12 and 
TEP2, which were hierarchically clustered together in Figure 4.3. 
The TEPs were less responsive to blood feeding compared to the LRIMs. The only TEP with a strong 
and consistent response to blood feeding was TEP13. Interestingly, TEP13 gave a more pronounced 
response to mouse blood feeding, compared to human blood feeding. 
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Figure 4.4  Transcriptional responses of the short LRIMs to blood feeding.  
A) Transcriptional responses of LRIM8A, LRIM8B, LRIM9 and LRIM10 were measured 24, 48 and 72 h 
after feeding on naïve mouse blood at 19 oC. Expression was measured by NanoString (blue line) and 
qRT-PCR (red line), normalising to S7. Average fold change in expression from 2 independent replicates 
is shown with standard error bars. Results are calculated relative to unfed mosquitoes (time “0 h”). B) 
Transcriptional responses of LRIM9 and LRIM10 to naïve blood feeding were monitored at different 
temperatures. Mosquitoes were fed on mouse blood at 19 oC (green line) or 25 oC (orange line) or 
human blood at 27 
o
C (purple line). Average fold change in expression and standard error bars from 2 
replicates are shown (4 replicates for human blood feeding at 24 h and 72 h), measured by NanoString.  
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Transcriptional responses to Plasmodium infection 
Distinct subsets of LRIMs were induced by Plasmodium infection, with differences observed for 
infections with different malaria parasite species. Mosquitoes were infected with two rodent 
parasites, P. berghei and P. yoelii, and one human parasite, P. falciparum. Key players induced by all 
three parasite species included LRIM1, APL1C and TEP1, which are known to function together as 
major antagonists of P. berghei (Fraiture et al., 2009; Povelones et al., 2009) and P. yoelii (Jaramillo-
Gutierrez et al., 2009). LRIM1, APL1C and TEP1 demonstrated tight co-regulation in all Plasmodium 
responses, suggesting they function together against all Plasmodium species. Expression after  
P. berghei infection was also monitored by qRT-PCR, which showed excellent correlation with the 
NanoString. Strong co-regulation of LRIM1, APL1C and TEP1 after P. berghei infection is 
demonstrated in Figure 4.5. APL1A, TEP3 and TEP4, which hierarchically clustered with LRIM1, APL1C 
and TEP1 in Figure 4.3, also shared a similar pattern of regulation after Plasmodium infection, 
suggesting a functional relationship between these 6 genes in Plasmodium defence. However, TEP3 
and APL1A were only weakly induced in response to P. yoelii infection, which implies that these 
genes come into play under specific circumstances. 
The Plasmodium time courses showed intrinsic variability between replicates due to uncontrollable 
biological factors, such as infection levels, minor temperature fluctuations and mosquito rearing 
conditions. For the P. berghei time courses in particular, peak gene expression for particular LRIMs 
occurred at different time points in the two replicates. In replicate 1, most LRIMs peaked at 48 h 
post infectious blood meal whereas they peaked at 72 h in replicate 2. Despite this temporal shift, 
LRIM1, APL1C and TEP1 remained tightly co-regulated in replicate 1 and 2 (Figure 4.5). Importantly, 
peak fold change in replicates 1 and 2 were of the same magnitude – it seems there was a 24 h lag in 
response time in replicate 2. The parasitemia (percentage of infected red blood cells in a blood 
smear) of the mouse used for replicate 1 was higher than in replicate 2, therefore it is likely that the 
level of infection was lower in replicate 2. LRIM15 was an interesting exception, peaking at 48 h in 
both P. berghei experiments. Perhaps LRIM15 was induced by the quality of infected blood rather 
than the parasite per se. LRIMs were considerably less responsive in P. yoelii infection replicate 2 
compared to replicate 1, indicating the infection was much lower in replicate 2. Indeed, surviving 
mosquitoes from the P. yoelii time courses were dissected 7 days after infection and both median 
parasite load and prevalence were lower in replicate 2 (data not shown). 
LRIM4, LRIM17, TEP12 and TEP14 clustered together in Figure 4.3, which implied the possibility of 
cooperative function. Interestingly, LRIM4, LRIM17, TEP12 and TEP14 showed similar transcriptional 
responses to Plasmodium (Figure 4.6), supporting the hypothesis that these genes work together in 
the mosquito immune response. These genes were induced at 48 h after P. berghei infection, 24 h 
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after P. yoelii infection and 48 h after P. falciparum infection. LRIM17 was the only exception as it 
was not induced by P. falciparum. This was surprising as LRIM17 has previously been reported as a 
major antagonist of P. berghei and P. falciparum in the An. gambiae Keele strain (Dong et al., 2006a; 
Garver et al., 2012). 
 
Figure 4.5  Transcriptional co-regulation of LRIM1, APL1C and TEP1 after P. berghei infection. 
Expression of LRIM1, APL1C and TEP1 was measured 24, 48 and 72 h after taking a P. berghei infected 
blood meal. Both NanoString (blue line) and qRT-PCR (red line) were used, normalising to S7. Fold 
change in expression from 2 independent experiments is shown separately (replicate 1 on the left, 
replicate 2 on the right). Expression was normalised to naïve blood feeding at each time point. Fold 
change in expression was calculated relative to unfed mosquitoes (time “0 h”). 
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Figure 4.6 Transcriptional co-regulation of LRIM4, LRIM17, TEP12 and TEP14 after Plasmodium 
infection.  
Mosquitoes were infected with P. berghei at 19 oC (green line), P. yoelii at 25 oC (orange line) or P. 
falciparum at 27 oC (purple line). Expression of LRIM4, LRIM17, TEP12 and TEP14 was measured after 
24, 48 and 72 h by NanoString, normalising to S7. Average relative expression from 2 independent 
experiments is shown, with standard error bars. Expression was normalised to naïve blood feeding (at 
the appropriate temperature) at each time point. Fold change in expression was calculated relative to 
unfed mosquitoes (time “0 h”). 
 
In addition to LRIM17, other LRIMs showed distinct responses to particular parasite species. 
Although parasite infections were performed at different temperatures (19 oC for P. berghei, 25 oC 
for P. yoelii and 27 oC for P. falciparum), responses should be specific to the parasite and 
independent of temperature because each time point was normalised against naïve blood feeding at 
the same temperature. TEP3, APL1A, LRIM5, LRIM7 and TEP15 responded to P. berghei and  
P. falciparum but not P. yoelii. Curiously, LRIM5 and LRIM7 were hierarchically clustered in Figure 
4.3, with TEP15 in a neighbouring cluster. 
The Short LRIMs, LRIM8A, LRIM8B, LRIM9 and LRIM10, were not transcriptionally responsive to any 
of the three Plasmodium species tested. Only very minor responses were observed. To clarify, these 
LRIMs were induced during a Plasmodium infection but the responses were no higher than after 
102 
 
naïve blood feeding, suggesting that these LRIMs do not specifically respond to parasites in a blood 
meal. 
Transcriptional responses to injection of sterile PBS and conditioned media 
PBS injection was performed as a control for bacterial and fungal injection, while injection of 
conditioned media from uninfected VERO cells was performed to normalise ONNV injection. Both 
were also analysed separately to give an indication of injury responses. Overall, most genes did not 
respond to injection of sterile solutions; however, distinct weak responses were observed for some 
genes (Figure 4.7). LRIM6 showed the strongest upregulation after PBS injection, with a 2-4-fold 
induction compared to uninjected mosquitoes. Interestingly, LRIM6 demonstrated no response to 
conditioned media injection. 
LRIMs and TEPs were more responsive to injection of conditioned media compared to PBS. LRIM15 
was non-responsive to PBS but 2.5-fold induced by conditioned media injection (Figure 4.7). LRIM12 
and TEP6 were also induced by conditioned media not PBS injection. VERO cells were grown in MEM 
supplemented with 10% FBS, L-glutamine, non-essential amino acids, penicillin/streptomycin and 
fungizone (amphotericin B). The conditioned media would contain the supplemented MEM and any 
host proteins secreted by the VERO cells. It is likely that this protein-rich content was responsible for 
the increased induction of genes. The Short LRIM cluster, LRIM8A, LRIM8B, LRIM9 and LRIM10, were 
weakly induced by conditioned media injection. As these four LRIMs were highly induced by blood 
feeding, this was probably a response to the serum in the conditioned media. It should be noted that 
the conditioned media injection time course used one different time point to PBS. Samples were 
collected at day 1 (24 h), day 3 (72 h) and day 6 (144 h) to match the slower process of viral 
infection. Despite this discrepancy, it is still reasonable to compare PBS and conditioned media 
injection. 
Many LRIMs and TEPs were not induced by PBS or conditioned media injection. LRIM1 was 
downregulated in response to PBS injection and neutral in response to conditioned media injection 
(Figure 4.7), as were its functional partners, APL1C and TEP1. In fact, most genes were 
downregulated by PBS injection.  
It is not clear whether either of these experiments highlights injury responses rather than responses 
to the introduction of PBS or conditioned media into the hemocoel. Injection of sterile PBS is likely to 
be closest to an injury response because of its basic content, however, mosquitoes could be 
responding to changes in salt balance. For example, LRIM6 could be involved in maintenance of salt 
homeostasis. 
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Figure 4.7  Representative transcriptional responses to injection with PBS or conditioned media.  
A) Transcriptional responses of LRIM6, LRIM15 and LRIM1 were monitored 24, 48 and 72 h after sterile 
PBS injection. Expression was measured by NanoString (blue line) and qRT-PCR (red line), normalising 
to S7. Average fold change in expression from 4 independent experiments is shown (only 3 by qRT-
PCR), with standard error bars. Results were calculated relative to uninjected mosquitoes (time “0 h”). 
B) Expression of LRIM6, LRIM15 and LRIM1 was determined 1, 3 and 6 days after injection of 
conditioned media from uninfected VERO cells. Expression was measured by NanoString only, 
normalising to S7. Average relative expression from 2 biological replicates is shown. 
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Transcriptional responses to viral infection 
Expression of LRIMs and TEPs was analysed after infection by ONNV, both by injection and blood 
feeding. Responses were more conservative than expected, with few genes upregulated above  
2-fold. Genes induced by both injection and blood feeding of ONNV included LRIM1, LRIM4, LRIM7, 
LRIM8A, LRIM12, LRIM15, TEP3 and TEP4. These genes are candidates for roles in viral immunity. Of 
these, LRIM7 and LRIM15 showed the most consistent upregulation across the two independent 
experiments (Figure 4.8). Overall, biological replicate 2 produced a stronger transcriptional response 
and some genes only responded to virus in this replicate, including LRIM4, LRIM12 and LRIM8A 
(Figure 4.8). Plaque assays using individual virally injected mosquitoes showed that the average PFU 
per mosquito was slightly higher in this second replicate (Figure 4.9 A; not significant using Mann 
Whitney U-test). Furthermore, prevalence of viral infection was 67% in replicate 1 and 74% in 
replicate 2. Therefore, virus load had a strong influence over LRIM expression in response to ONNV.  
Differences were observed between systemic infection of virus via injection and oral infection via 
blood feeding. After intrathoracic injection, the virus is dispersed through the hemolymph and 
infects various tissues, such as the head, salivary glands and muscle, with the initial acute phase of 
infection peaking at day 6-8 before declining (Joanna Waldock, PhD thesis, 2011). In contrast, after 
oral infection, the virus first infects the gut about 24 h after ingestion of the blood meal and there is 
a low frequency of dissemination via the hemolymph to secondary tissues in the following days 
(Brault et al., 2004). Mosquitoes were predominantly infected in the cardia (foregut-midgut 
junction) and the anterior gut following ONNV blood feeding (Figure 4.9 B), consistent with previous 
reports (Joanna Waldock, PhD thesis, 2011). Interestingly, LRIM17 was only induced after viral 
infection by blood feeding (Figure 4.8). LRIM7 also showed a stronger response after oral infection. 
Other LRIMs, like LRIM15, showed a delayed response after blood feeding compared to injection, 
with expression peaking at day 3 and day 1, respectively (Figure 4.8). Expression of LRIM7 peaked at 
day 3 after injection and day 6 after blood feeding. This time lag probably represents the delay in 
virus dissemination into the hemolymph after oral infection. 
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Figure 4.8  Responses to injected ONNV and blood fed ONNV.  
A) Transcriptional responses of LRIM7, LRIM8A, LRIM15 and LRIM17 were monitored 1, 3 and 6 days 
after injection with ONNV (collected in conditioned media of infected VERO cells). Expression was 
measured by NanoString, normalising to S7. Average relative expression from 2 independent 
experiments is shown, with standard error bars. Expression was normalised to injection of conditioned 
media from uninfected cells at each time point. Fold change in expression was calculated relative to 
uninjected mosquitoes (time “0 h”). B) As above, but mosquitoes were given an ONNV infected blood 
meal and expression was normalised to naïve blood fed mosquitoes. 
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No particular hierarchical cluster appeared to be strongly viral specific (Figure 4.3). It is interesting 
that LRIM1 responded to ONNV but its usual partners, APL1C and TEP1, did not. Also, LRIM8A was 
the only member of the Short LRIM cluster to be induced by viral infection. LRIM4 and LRIM17, 
which are co-clustered, were both induced by replicate 2 of the viral infection, although LRIM17 was 
only responsive to oral infection. LRIM4 and LRIM17 also clustered with TEP12 and TEP14 (Figure 
4.3). TEP12 was mildly induced by oral infection but TEP14 was non-responsive to all viral challenges. 
 
 
 
Figure 4.9  Viral load and tissue tropism in ONNV infected mosquitoes.  
A) Plaque assays were performed on individual mosquitoes 6 days after ONNV injection. PFU per 
mosquito, which demonstrates viral titre, is shown for 2 independent replicates. Horizontal lines 
indicate the median. B) Entire guts were dissected 6 days after feeding on ONNV infected blood and 
analysed using fluorescent microscopy to determine tissue tropism of infection. Two representative 
guts are shown with GFP-expressing virus in green and gut cells in blue (DAPI staining). Scale bar 
(bottom panel) represents 250 µM. 
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Transcriptional responses to bacteria 
Many LRIMs and TEPs showed strong induction following injection with live E. coli (gram-negative 
bacteria) and S. aureus (gram-positive bacteria). In fact, of all the challenges performed, the TEPs 
responded most highly to bacterial injection. Key genes upregulated by both bacterial species were 
LRIM1, APL1A, APL1C, TEP1, TEP3 and TEP4, which co-cluster as shown in Figure 4.3. Expression of 
these genes peaked rapidly between 4- and 10-fold 24 h after E. coli injection (Figure 4.10), with 
similar responses to S. aureus. Of the 6 co-regulated genes, APL1A showed a slightly delayed 
response to bacterial challenge and peaked at 48 h in some experiments. These 6 genes were also 
co-regulated in response to Plasmodium infection, which might suggest they function together as 
core immune genes that protect mosquitoes from many pathogens. 
NanoString fold changes in expression of the LRIMs and some TEPs were verified by qRT-PCR. 
Unfortunately, the matching qRT-PCR data for biological replicate 1 had to be excluded because of 
technical problems. Nevertheless, the qRT-PCR results for replicate 2 correlated well with the 
NanoString data. Although some differences in fold change were observed, overall trends were 
preserved. 
Another hierarchical cluster, LRIM4, LRIM17, TEP12 and TEP14, was also induced by E. coli and S. 
aureus injection. This strengthens the hypothesis of a functional relationship between these genes. 
TEP2 and LRIM12, another cluster, also shared a similar pattern of induction following bacterial 
challenge. Interestingly, whilst LRIM8A was the only member of the Short LRIM cluster induced by 
viral infection, LRIM8B was the sole member upregulated by E. coli and S. aureus. Other genes 
induced by bacteria included LRIM16A, TEP6, TEP13 and TEP15.  
Overall, very similar responses were observed to E. coli and S. aureus, suggesting that the responsive 
genes are regulated by the same signalling pathway(s) that can be activated by gram-negative and 
gram-positive bacteria. Whether there are functional differences at the protein level remains to be 
determined. One exception was TEP9, which seemed to be specifically induced by E. coli. 
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Figure 4.10  A cluster of core immune genes induced by E. coli injection.  
Mosquitoes were injected with live E. coli and expression of LRIM1, APL1A, APL1C, TEP1, TEP3 and TEP4 
was monitored after 24, 48 and 72 h. Expression was measured by NanoString (blue line) and qRT-PCR 
(red line), normalising to S7. Average fold change in expression by NanoString from 2 independent 
experiments is shown, with standard error bars. Only one replicate was measured by qRT-PCR. 
Expression was normalised to injection of sterile PBS at each time point. Results were calculated 
relative to uninjected mosquitoes (time “0 h”). 
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Transcriptional responses to fungi 
A subset of the genes that responded to bacterial infection also responded to injection of B. 
bassiana spores. Four key genes induced by fungal infection, LRIM1, APL1A, LRIM17 and TEP3, are 
shown in Figure 4.11. NanoString results were verified by qRT-PCR, with good correlation between 
both methods. Some differences in fold changes were observed between the two independent 
replicates. Genes belonging to the core cluster of LRIM1, APL1A, APL1C, TEP1, TEP3 and TEP4 were 
all induced by B. bassiana. These genes were also all induced by Plasmodium and bacteria, 
suggesting they are core immune genes that protect mosquitoes from many pathogens. TEP6, which 
was upregulated by fungi and bacteria, resided in a neighbouring hierarchical cluster to these 6 
genes (Figure 4.3). 
LRIM17 was strongly induced by injection of fungal spores. To a lesser extent, LRIM4, TEP12 and 
TEP14, which co-clustered with LRIM17, were also upregulated. This is another example of co-
regulation between these genes and further evidence to imply a functional relationship. 
Overall, LRIMs and TEPs were less responsive to fungi than bacteria. Gene expression also peaked 
later after fungal infection, with most genes reaching their maximum induction after 48 to 72 h 
compared to 24 h for bacterial infection. This was probably because germination of fungal spores 
and proliferation of fungal hyphae takes considerably longer than bacterial proliferation. 
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Figure 4.11  Key genes responding to fungal infection.  
Expression of LRIM1, APL1A, LRIM17 and TEP3 was monitored 24, 48 and 72 h after injection with B. 
bassiana spores. Both NanoString (blue line) and qRT-PCR (red line) were used, normalising to S7. 
Average fold change in expression from 2 independent replicates is shown, with standard error bars. At 
each time point, expression was normalised to injection of sterile PBS. Results were calculated relative 
to uninjected mosquitoes (time “0 h”). 
 
Expression in larvae and pupae 
In an initial experiment, expression of LRIMs and TEPs was monitored in RNA extracted from fourth 
instar larvae and early pupae of An. gambiae. Rather than fold changes in expression, the number of 
times each gene-specific reporter was detected were compared (Table 4.2). Interestingly, some 
LRIMs and TEPs displayed distinct transcriptional profiles during the developmental cycle of the 
mosquito. 
Some genes were highly expressed throughout all life stages, with high NanoString reporter counts 
in larvae, pupae and adults (Table 4.2). This included LRIM1, APL1C and TEP1, which suggests the 
mosquito complement-like system plays a key role in mosquito immunity at all life stages. LRIM17 
and TEP15 were also highly expressed in larvae, pupae and adults, suggesting they also have an 
important immune function in these life stages. 
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Table 4.2  Developmental profile of LRIMs and TEPs in An. gambiae. 
Gene Larvae Pupae 
Adult 
Sugar fed BF 24 h BF 48 h BF 72 h 
LRIM1 3454 777 3207 1876 2016 1459 
APL1A 211 91 267 106 170 97 
APL1B 367 11 25 83 61 11 
APL1C 6260 1638 6274 3077 4228 2850 
LRIM3 252 584 514 197 256 262 
LRIM4 310 205 1119 395 579 644 
LRIM5 32 172 155 105 122 118 
LRIM6 249 603 606 375 522 337 
LRIM7 62 109 154 39 294 129 
LRIM8A 47 263 893 1611 916 534 
LRIM8B 5 75 2093 4171 2209 923 
LRIM9 2 22 2229 2942 3551 1484 
LRIM10 7 28 472 1261 777 199 
LRIM12 343 58 231 139 53 61 
LRIM15 31 92 880 402 810 1674 
LRIM16A 120 194 256 199 272 228 
LRIM16B 271 575 599 436 494 420 
LRIM17 3068 2361 4490 911 2298 2817 
LRIM18 93 111 62 100 75 57 
LRIM19 0 168 152 21 23 30 
LRIM20 171 217 84 88 140 79 
LRIM26 370 349 278 636 578 607 
LRIM27 34 94 320 115 167 211 
TEP1 6928 2024 5564 3377 4635 2818 
TEP2 338 134 342 185 174 214 
TEP3 243 181 336 262 236 148 
TEP4 509 186 832 700 964 574 
TEP5 20 23 18 90 52 21 
TEP6 192 65 144 33 103 69 
TEP9 52 28 20 50 63 18 
TEP10 15 9 19 57 41 18 
TEP12 690 424 652 186 330 266 
TEP13 451 867 160 252 167 128 
TEP14 395 134 1138 365 529 461 
TEP15 3924 3463 4130 1406 2484 2123 
 
NanoString gene-specific reporter counts, after normalisation to S7, are shown for LRIM and TEP genes 
in RNA samples extracted from larvae, pupae and adult An. gambiae. Per sample, RNA was extracted 
from a pool of 10 whole insects. Larvae and pupae reporter counts are from a single experimental 
replicate. Reporter counts for sugar fed (untreated) adults are averaged from 12 experiments. Reporter 
counts for blood feeding (BF) at 24 h, 48 h and 72 h are averaged from 8, 6 and 8 experiments, 
respectively. Experiments using different temperatures (19, 25 and 27 
o
C) were pooled together. 
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Others genes showed extremely low expression in larvae and pupae but very high expression in 
adult mosquitoes (Table 4.2). These included the Short LRIMs, LRIM8B, LRIM9 and LRIM10, which 
were silent in larvae, slightly higher in pupae and very high in adults. Strikingly, average reporter 
counts for LRIM8B and LRIM9 in adults were three orders of magnitude above those in larvae. 
LRIM8A showed a similar profile except with slightly greater expression in larvae and pupae than the 
others. Reporter counts in larvae were the minimum recorded for each of these genes across all 
experiments (Table 4.1), with LRIM8B, LRIM9 and LRIM10 expressed at the level of the negative 
control probes. Interestingly, these four Short LRIMs were massively induced by blood feeding, a 
behaviour exclusive to adult females. Unfortunately, expression in males was not determined and 
the sex of the larvae and pupae used was unknown. LRIM15 was also relatively low in larvae and 
pupae compared to adults (one order of magnitude lower). 
 
Screening the LRIMs for effects on P. berghei development 
LRIM1 and APL1C are potent antagonists of P. berghei development in the mosquito, shown by 
striking increases in live parasites upon gene silencing (Osta et al., 2004a; Riehle et al., 2006; Riehle 
et al., 2008). To elucidate whether any other LRIM family members play a role in defence against 
P. berghei, the entire family was screened for a similar phenotype upon gene knockdown. Novel 
LRIM genes were silenced by RNA interference (RNAi), mosquitoes were infected with GFP-
expressing P. berghei and parasite load monitored after 7 days. Both fluorescent live oocysts 
(parasites embedded in the mosquito midgut wall) and melanised ookinetes (dead parasites coated 
in black melanin) were analysed (Figure 4.12). Prevalence, the percentage of midguts with at least 
one oocyst or ookinete, was also calculated. LRIM1 was used as a positive control because silencing 
LRIM1 dramatically increases oocyst load (Osta et al., 2004a). Non-specific dsRNA against GFP, a 
gene which does not naturally exist in mosquitoes, was used as a negative control.  
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Figure 4.12  P. berghei oocysts and melanised ookinetes in the An. gambiae midgut.  
A) Live GFP-expressing oocysts in the mosquito midgut observed 7 days after infection using 
fluorescent microscopy. Scale bar represents 500 µM. B) Melanised ookinetes observed 7 days after 
infection using light microscopy. Scale bar represents 100 µM. 
 
20 novel LRIM family members were screened and results are reported in Table 4.3. APL1A and 
APL1B were excluded from the screen as both were previously reported to have no phenotype with 
P. berghei (Riehle et al., 2008). APL1C was not included because its role as a P. berghei antagonist is 
well documented (Riehle et al., 2006; Riehle et al., 2008). Unfortunately, some experiments suffered 
problems with mosquito death after infected blood feeding and low infection levels. Therefore, 
these results give a preliminary indication of antagonistic or agonistic phenotypes and further 
verification is required.  
The only novel LRIM with a significant effect on P. berghei development was LRIM9, a Short LRIM 
that was strongly upregulated by blood feeding in the transcriptional analysis (Figure 4.4). Silencing 
LRIM9 resulted in a significant increase in the median number of live oocysts, compared to dsGFP-
treated control mosquitoes (experiment C of Table 4.3). LRIM9 knockdown also significantly reduced 
the prevalence of melanisation and the number of melanised ookinetes. However, the effect of 
LRIM9 was not as dramatic as upon LRIM1 or APL1C silencing. 
Also in experiment C, LRIM7 and LRIM10 showed a significant decrease in the number of melanised 
ookinetes compared to dsGFP controls. LRIM10 also showed a significant reduction in prevalence of 
melanisation. However, prevalence of melanisation in dsGFP was unusually high in this experiment 
and so the melanisation phenotypes of LRIM7, LRIM9 and LRIM10 require verification. In experiment 
E, low prevalence of parasites and failure of the LRIM1 positive control makes results for LRIM5, 
LRIM15 and LRIM20 particularly unreliable. 
114 
 
Knockdown efficiency varied between genes, although the majority of novel LRIMs were silenced by 
more than 50%. Knockdown efficiency of LRIM1 was consistently high, averaging 90% across all 
experiments. Silencing of LRIM7, LRIM8B, LRIM18, LRIM19 and LRIM26 was particularly poor. For 
LRIM7 and LRIM8B, this might explain the marginal increase in live oocysts observed for these genes. 
At least for LRIM8B, sequencing of the PCR product used for dsRNA synthesis ruled out abundant 
polymorphism for the inefficient knockdown. Knockdown efficiencies for LRIM18 and LRIM19 were  
-18 and -5%, respectively. This unusual result might reflect problems with the qRT-PCR primers or 
the poor expression of these genes. 
In summary, LRIM9 emerged as a novel candidate for a role in Plasmodium defence and will be 
further investigated in Chapter 5. LRIM9 knockdown did not influence P. berghei development to the 
same dramatic extent as LRIM1 and APL1C. None of the other LRIMs screened changed the outcome 
of infection, however, these preliminary experiments must be replicated and knockdown efficiencies 
optimised before firm conclusions are drawn. 
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Table 4.3  The initial RNAi screen of LRIM genes upon P. berghei infection. 
Expt 
(Strain) 
Knock-
down 
N 
Live oocysts Melanised ookinetes 
Knockdown 
efficiency 
(%) 
Prevalence Infection intensity Prevalence Infection intensity 
% P-value 
Median 
(Range) 
P-value % P-value 
Median 
(Range) 
P-value 
A (Y) 
GFP 14 79 N/A 2 (0-73) N/A 43 N/A 0 (0-42) N/A N/A 
LRIM1 6 100 NS 462 (46-552) < 0.001 50 NS 1 (0-3) NS 80 
LRIM8A 17 65 NS 3 (0-29) NS 59 NS 2 (0-77) NS 89 
LRIM8B 16 88 NS 6 (2-160) NS 31 NS 0 (0-34) NS 28 
B (Y) 
GFP 23 91 N/A 9 (0-130) N/A 39 N/A 0 (0-30) N/A N/A 
LRIM1 15 100 NS 367 (64-647) < 0.0001 13 NS 0 (0-2) NS 94 
LRIM4 23 96 NS 20 (0-153) NS 26 NS 0 (0-16) NS 80 
LRIM17 15 80 NS 6 (0-182) NS 20 NS 0 (0-24) NS 92 
C (Y) 
GFP 17 76 N/A 2 (0-89) N/A 88 N/A 4 (0-85) N/A N/A 
LRIM1 10 100 NS 243 (46-805) < 0.0001 0 < 0.0001 0 < 0.001# 79 
LRIM7 11 91 NS 13 (0-167) NS 55 NS 1 (0-10) < 0.05 26 
LRIM9 14 93 NS 44 (0-285) < 0.001 14 < 0.0001 0 (0-2) < 0.0001 65 
LRIM10 18 94 NS 12 (0-92) NS 44 < 0.05 0 (0-22) < 0.01 76 
D (Ng) 
GFP 16 75 N/A 4 (0-22) N/A 13 N/A 0 (0-3) N/A N/A 
LRIM1 13 100 NS 326 (225-748) < 0.0001 0 NS 0 NS# ND 
LRIM6 10 90 NS 11 (0-33) NS 0 NS 0 NS# 69 
LRIM12 13 69 NS 3 (0-104) NS 15 NS 0 (0-2) NS 85 
E (Ng) 
GFP 29 59 N/A 1 (0-42) N/A 0 N/A 0 N/A N/A 
LRIM1 30 37 NS 0 (0-435) NS 0 N/A 0 N/A 95 
LRIM5 36 11 < 0.0001 0 (0-8) < 0.0001 0 N/A 0 N/A 77 
LRIM15 38 45 NS 0 (0-86) NS 0 N/A 0 N/A 78 
LRIM20 37 32 < 0.05 0 (0-61) NS 0 N/A 0 N/A 92 
F (Ng) 
GFP 31 100 N/A 60 (1-225) N/A 26 N/A 0 (0-24) N/A N/A 
LRIM1 21 100 N/A 264 (11-642) < 0.0001 5 NS 0 (0-1) < 0.05 96 
LRIM16A+B 39 95 NS 46 (0-398) NS 28 NS 0 (0-25) NS 62(A) + 39(B) 
LRIM18 41 88 NS 32 (0-238) NS 22 NS 0 (0-32) NS -18 
LRIM19 22 100 N/A 21 (1-235) NS 23 NS 0 (0-5) NS -5 
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Novel LRIM genes were silenced using RNAi, mosquitoes were infected with fluorescent P. berghei and parasite load was monitored after 7 days. Individual experimental 
data sets are shown (one biological replicate). Non-specific dsRNA (GFP) was used as a negative control and LRIM1 as a positive control. Either Yaoundé (Y) or Ngousso 
(Ng) strain mosquitoes were used. N = number of individual mosquito midguts. Prevalence is the percentage of guts that contain at least one oocyst or melanised parasite. 
Mann Whitney U-test was used for infection intensity, comparing to dsGFP. If prevalence for one gene was zero, the Wilcoxon Test was used (#). Fisher’s exact test was 
used for prevalence. Significant P-values (< 0.05) are shown in red. Knockdown efficiency was calculated by qRT-PCR. NS = Not significant; ND = Not determined; N/A = Not 
applicable. 
 
 
 
 
 
 
 
Expt 
(Strain) 
Knock-
down 
N 
Live oocysts Melanised ookinetes 
Knockdown 
efficiency 
(%) 
Prevalence Infection intensity Prevalence Infection intensity 
% P-value 
Median 
(Range) 
P-value % P-value 
Median 
(Range) 
P-value 
G (Ng) 
GFP 31 97 N/A 18 (0-93) N/A 19 N/A 0 (0-27) N/A N/A 
LRIM1 27 96 NS 151 (0-449) < 0.0001 0 < 0.05 0 < 0.05 95 
LRIM26 35 91 NS 12 (0-60) NS 9 NS 0 (0-2) NS 27 
LRIM27 30 87 NS 12 (0-245) NS 20 NS 0 (0-2) NS 58 
H (Ng) 
GFP 38 92 N/A 15 (0-191) N/A 18 N/A 0 (0-11) N/A N/A 
LRIM1 31 94 NS 104 (0-313) < 0.0001 0 < 0.05 0 < 0.05 92 
LRIM3 46 96 NS 18 (0-210) NS 11 NS 0 (0-4) NS 37 
LRIM11 37 76 NS 13 (0-147) NS 8 NS 0 (0-2) NS 45 
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4.3 Discussion 
The LRIMs are a novel, mosquito-specific family of LRR-containing proteins recently discovered in An. 
gambiae. LRR-containing proteins play key defensive roles in many phyla, including TLRs in mammals 
and VLRs in jawless vertebrates (Bent and Mackey, 2007; Guo et al., 2009; Han et al., 2008; Herrin et 
al., 2008; Matsushima et al., 2007). The LRR domain often mediates pathogen recognition and 
protein-protein interactions (Bell et al., 2003; Bella et al., 2008). The founding members of the LRIM 
family, LRIM1 and APL1C, are powerful antagonists of the rodent malaria parasites, P. berghei and P. 
yoelii (Jaramillo-Gutierrez et al., 2009; Osta et al., 2004a; Riehle et al., 2006; Riehle et al., 2008), and 
have an infection intensity-dependent impact on the human parasite, P. falciparum (Garver et al., 
2012). It was hypothesised that the LRIM family has expanded to mediate recognition of the wide 
range of pathogens that mosquitoes encounter. As LRIMs are only found in mosquitoes, their 
function may be associated with blood feeding, perhaps in regulating infections to the various blood-
borne pathogens and parasites. 
Transcriptional profiling was used to determine whether there is specificity in the responses of 
different LRIMs to distinct immune challenges. It was hoped the profiling would identify candidates 
for involvement in defence against particular pathogens. Activation of immune effectors and 
mechanisms is largely regulated at the transcriptional level in An. gambiae (Aguilar et al., 2005b). 
Previous studies have demonstrated that gene expression and putative function show good 
correlation (Dimopoulos et al., 2002). The TEP family was included in the analysis as potential 
interacting partners of the LRIMs. Hierarchical clustering of the transcriptional data was used to 
provide clues about the functional relationships between LRIMs and TEPs.  
Overall, LRIM family members showed distinct transcriptional responses to different immune 
challenges, such as blood feeding, Plasmodium parasites, bacteria, fungi and virus. This correlates 
well with the hypothesis that the LRIMs are PRRs responding to different pathogens faced by 
mosquitoes. To a lesser extent, the TEPs also demonstrated transcriptional specificity. Several LRIMs 
and TEPs seem to be generalists that responded to many challenges and are probably core immune 
genes. The versatile LRR domain is capable of detecting various structurally unrelated ligands (Bell et 
al., 2003) and so these LRIMs might recognise several PAMPs or “danger signals”. Alternatively, they 
might be activated by a range of other immune effectors under different circumstances. The 
generalist TEPs could be capable of opsonising a variety of pathogen surfaces, signalling their 
destruction. Upon proteolytic activation, TEPs covalently bind to pathogens via their TE bond 
(Levashina et al., 2001). TEPs lacking an active TE, like TEP3, are likely to play a regulatory role 
(Christophides et al., 2002). Core immune LRIMs and TEPs responded most strongly to Plasmodium 
118 
 
and bacterial infections. This correlates well with previous studies reporting a significant overlap in 
mosquito immune responses against malaria parasites and bacteria (Christophides et al., 2002; 
Dimopoulos et al., 2002; Dong et al., 2006a). Furthermore, midgut bacteria have been demonstrated 
to prime the mosquito’s basal immune response, which can limit Plasmodium development (Dong et 
al., 2009; Meister et al., 2009). 
LRIM1, APL1C and TEP1 were upregulated by many challenges, which correlates well with their 
important role in the mosquito complement-like system. These three genes transcriptionally co-
clustered with TEP3, TEP4 and APL1A. This strongly supports the previous finding that the 
LRIM1/APL1C complex interacts with processed forms of TEP3 and TEP4 in vitro (Povelones et al., 
2011). The transcriptional co-regulation demonstrated in this Chapter suggests these interactions 
are likely to be functionally important in vivo. In addition, APL1A has been reported to protect 
against infection by P. falciparum (Mitri et al., 2009). TEP3, TEP4 and APL1A should be further 
investigated for roles in the mosquito complement-like system. In Chapter 5, the roles of TEP3 and 
TEP4 in P. berghei infections and melanisation will be explored. 
Another potential functional group are LRIM4, LRIM17, TEP12 and TEP14, which showed broad 
upregulation in response to various challenges. These four genes were hierarchically clustered 
together, suggesting the proteins might function in the same or related biochemical pathway(s). 
LRIM4 and LRIM17 have previously been implicated in P. falciparum defence (Dong et al., 2006a), 
which implies TEP12 and TEP14 could be important candidates for activity against this important 
human pathogen. 
Other LRIMs and TEPs responded to specific challenges indicating they might play a more targeted 
immunity role. Specialists included the Short LRIMs, LRIM8A, LRIM8B, LRIM9 and LRIM10, which 
were dramatically upregulated by naïve blood feeding yet unresponsive to most other challenges. 
These blood feeding specific LRIMs might be adapted to defend against vertebrate proteins, 
antibodies, viruses or parasites present in the blood meal, tissue damage caused by midgut 
distension during blood feeding or specific bacteria found in the mosquito gut that proliferate after a 
blood meal. The response of the Short LRIMs varied with temperature, which is known to impact on 
mosquito physiology, such as blood metabolism, but also bacterial proliferation. LRIM6 was the only 
LRIM specifically upregulated by PBS injection, which might indicate a role in injury responses or 
maintenance of salt homeostasis. 
Some genes, such as LRIM3, LRIM27, LRIM16A and LRIM16B, were barely responsive to any of the 
challenges. This was not due to poor complementarity between the NanoString probes and these 
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transcripts as NanoString results were verified by qRT-PCR. It is possible that these genes have 
important functions but are not transcriptionally responsive. They are unlikely to be pseudogenes 
because they have not accumulated stop codons and it is evolutionarily costly and potentially 
dangerous to transcribe and translate non-functional genes. Alternatively, these unresponsive genes 
might be involved in defence against pathogens untested to date, such as filarial worms. 
Several LRIMs, such as LRIM18, APL1B, LRIM19, and many TEPs were very poorly expressed with low 
NanoString reporter counts in all experiments. It is uncertain whether changes in relative expression 
of these genes are biologically significant or biased by the low expression levels. These genes might 
be highly specific responders, redundant or pseudogenes, although there is no evidence of 
accumulation of stop codons in their sequences. TEPs are highly polymorphic (Obbard et al., 2008), 
which might reduce the efficiency of NanoString probe hybridisation. However, NanoString probes 
are quite long and so they are expected to tolerate SNPs well. It was difficult to silence the 
transcripts of APL1B (data not shown), LRIM18 and LRIM19 by RNAi. In the RNAi screen with P. 
berghei, the knockdown efficiencies for LRIM18 and LRIM19 were very low, which supports the 
hypothesis that these genes are not expressed. Alternatively, they might be expressed at low levels 
in a tissue refractory to RNAi-mediated gene knockdown. 
NanoString results were verified by qRT-PCR and, overall, the comparison was very good. Even when 
fold changes differed between methods, trends in expression were the same or very similar. Any 
minor differences could be accounted for by the different templates used: the NanoString utilises 
unamplified total RNA whereas the template for qRT-PCR is cDNA synthesised from this RNA. cDNA 
synthesis can introduce gene-specific or 3' biases, particularly affecting low abundance transcripts 
(Geiss et al., 2008). As qRT-PCR involves multiple steps where tiny volumes are pipetted by hand, 
there is more opportunity for the introduction of error than with the NanoString assay.  
Overall, the NanoString transcriptional profiling correlated well with previous reports. For 
Plasmodium, a previous microarray showed LRIM7 is induced by P. berghei infection (Dong et al., 
2006a), which agrees with the NanoString data. The same microarray found LRIM4, LRIM8B, LRIM10 
and LRIM17 to be upregulated in the midgut after P. falciparum invasion (Dong et al., 2006a). The 
NanoString also showed minor induction of LRIM4 and LRIM8B in whole mosquitoes after P. 
falciparum infection but not LRIM10 and LRIM17. Perhaps expression in the whole mosquito masks 
the effect of individual tissues, such as the midgut. Gene silencing of APL1A was reported to increase 
the prevalence of P. falciparum infection (Mitri et al., 2009). Indeed, APL1A was induced by P. 
falciparum in the current study at the time of ookinete invasion. It was also upregulated by P. 
berghei and weakly by P. yoelii. This may indicate that the mechanisms controlling transcriptional 
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regulation of APL1A cannot distinguish between Plasmodium species but APL1A can only bind to 
epitopes on the surface of P. falciparum. Furthermore, APL1A expression is at least partly regulated 
by Imd and REL2-S (Mitri et al., 2009). 
Differences and similarities were evident between the responses of LRIMs to the rodent parasites, P. 
berghei and P. yoelii, and the human parasite, P. falciparum. LRIM1, APL1C and LRIM4 were 
transcriptionally induced by all Plasmodium parasites at approximately the time of ookinete 
invasion. For LRIM1 and APL1C, this correlates well with their known roles as antagonists of P. 
berghei and P. yoelii (Jaramillo-Gutierrez et al., 2009; Osta et al., 2004a; Riehle et al., 2006) and, 
dependent on infection intensity, P. falciparum (Garver et al., 2012). LRIM4 knockdown did not 
affect P. berghei development but this LRIM is a candidate for involvement in P. falciparum defence. 
Other LRIMs were specifically induced by P. berghei (e.g. LRIM17) and P. falciparum (e.g. LRIM20). 
Previous studies have shown that mosquito responses against P. berghei and P. falciparum involve 
both common and species-specific components (Dong et al., 2006a; Tahar et al., 2002). Importantly, 
the time points used only covered ookinete invasion and early oocyst formation but did not show 
mosquito responses to sporozoites in the hemolymph, which occurs approximately 2 weeks after P. 
berghei infection (Sinden, 2002). Immune responses against sporozoites are poorly characterised to 
date. It would be interesting to see if the same LRIMs are induced in response to sporozoite release 
into the hemolymph and invasion of the mosquito salivary glands. As the parasite displays distinct 
surface antigens at each developmental stage, it is plausible that different LRIMs could recognise the 
sporozoite. 
Although P. berghei is not a natural parasite of An. gambiae, it has become a powerful laboratory 
model to dissect the mosquito immune response to Plasmodium. It is often assumed that virulence 
is artificially high in host-pathogen associations that have not co-evolved (Hogg and Hurd, 1997). This 
was supported by meta-analysis showing that unnatural Plasmodium-Anopheles combinations are 
more likely to reduce mosquito survival than natural associations (Ferguson and Read, 2002). 
Unnatural associations often have higher infection levels (Boete, 2005; Hogg and Hurd, 1997). For 
example, P. berghei infections of An. gambiae result in higher oocyst levels than P. falciparum 
infections (Tahar et al., 2002), which might contribute to differences in gene expression. Low 
numbers of oocysts in natural P. falciparum infections has been associated with increased mosquito 
survival (Boete, 2005). P. falciparum and An. gambiae have a complex relationship that has been 
finely tuned by co-evolutionary adaptation. The mosquito has adapted to tolerate a certain level of 
parasitism because excessive immune responses would be detrimental to mosquito fitness (Boete, 
2005). Reducing parasite load is beneficial to both the host and parasite by increasing host survival 
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and reducing competition between individual parasites. In turn, the parasite has evolved to exploit, 
suppress and evade the mosquito immune system to complete its sexual developmental cycle and 
be transmitted to a new vertebrate host. Gene silencing often has a stronger effect in unnatural 
host-pathogen associations. For example, LRIM1 and APL1C display strong RNAi phenotypes with P. 
berghei (Osta et al., 2004a; Riehle et al., 2006; Riehle et al., 2008), but are only antagonists of P. 
falciparum at medium and low infection intensities, respectively (Garver et al., 2012). It seems likely 
that P. falciparum has evolved to avoid particular immune pathways to aid its transmission. In fact, a 
recent report provided evidence that certain strains of P. falciparum evade the mosquito 
complement-like system in the L3-5 strain of An. gambiae (Molina-Cruz et al., 2012). Comparing 
LRIM function in P. berghei and P. falciparum infections has provided insights into the mechanisms 
of immune evasion used by P. falciparum. 
Transcriptional responses to Plasmodium parasite infections showed considerable intrinsic variability 
between replicates. Known partners, LRIM1, APL1C and TEP1, were co-regulated in all replicates, 
demonstrating that this variation was biological rather than experimental. It could represent the 
complex interplay between at least four different taxa: vertebrate, parasite, mosquito and 
endogenous midgut bacteria. Minor uncontrollable changes in any of these systems and additional 
environmental factors can affect gene expression. Higher infection intensities could result in 
increased speed and magnitude of gene induction, which is likely to explain the differences between 
P. yoelii replicates 1 and 2. Parasite developmental stages, such as gametocytes, present in the 
mouse blood can differ considerably depending on time of feed. Blood meal nutrients also vary, 
which could affect proliferation of midgut bacteria and therefore transcriptional responses. Levels of 
mosquito midgut bacteria vary between individual mosquitoes and can affect oocyst formation 
(Dong et al., 2009; Meister et al., 2009). Slight changes in mosquito age and temperature could also 
play a role. 
Several genes, including LRIM1, LRIM7, LRIM8A, LRIM15, TEP3 and TEP4, emerged as candidates for 
involvement in viral defence. These were induced by ONNV infection via blood feeding and injection. 
The LRIMs could be involved in recognition of viral particles in the hemolymph whereas the TEPs 
might be involved in viral opsonisation. Many LRIMs responded most strongly after ingestion of 
virally infected blood, which is the natural infection route. Perhaps it is viral penetration of the 
mosquito gut wall that induces expression of immune genes as well as the presence of virus particles 
in the hemolymph. More genes were induced at higher viral load, which could reflect a threshold for 
gene induction or the increased tissue damage caused by more virus particles. Viral responses were 
consistent with a previous microarray in which whole mosquitoes were analysed 1, 4 and 9 days 
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after inoculation with ONNV (Waldock et al., 2012). In this previous study, LRIM1, LRIM4, LRIM7, 
LRIM10, LRIM17, TEP4, TEP12, TEP10, TEP9 and TEP14 were all induced by ONNV injection. With the 
exception of TEP14, all these genes responded to ONNV infection in this NanoString analysis, 
although some genes only responded after a viral blood meal rather than injection. Interestingly, 
LRIM4, LRIM17, TEP12 and TEP14 hierarchically clustered in the present study, suggesting they might 
function in a viral defence pathway. 
Anopheles mosquitoes are poor viral vectors and, to date, are only able to transmit ONNV (Waldock 
et al., 2012). In contrast, Aedes and Culex mosquitoes transmit many arboviruses, including dengue, 
CHIKV and WNV (Tolle, 2009). This leads to the intriguing hypothesis that LRIMs and TEPs in 
Anopheles are more efficient at recognising and killing viral particles than their Aedes and Culex 
counterparts. It would therefore be interesting to elucidate the responses of LRIMs and TEPs to viral 
infection in Aedes and Culex mosquitoes. If the hypothesis is confirmed, expressing Anopheles LRIMs 
or TEPs in other mosquitoes could reduce their ability to transmit arboviruses, which would be an 
exciting prospect for arboviral control. 
Many LRIMs and TEPs were induced by bacterial challenge, including components of the mosquito 
complement-like pathway. This was largely concurrent with previous reports. In agreement with the 
NanoString analysis presented here, a previous microarray reported that TEP4 is upregulated by 
gram-negative and gram-positive bacteria and TEP4 knockdown decreases survival upon bacterial 
challenge (Dong et al., 2006a; Dong et al., 2009). LRIM8B, LRIM10, LRIM17 and TEP1 were induced 
by E. coli infection in an earlier microarray (Dong et al., 2006a), which agrees with the current data, 
except all but LRIM10 were also induced by S. aureus. This might reflect differences in the S. aureus 
strains used in the two studies. APL1 (prior to re-annotation as APL1A, APL1B and APL1C) was 
induced by both gram-types in the same microarray (Dong et al., 2006a) and all three APL1 genes 
were also upregulated in the NanoString analysis. Several LRIMs and TEPs have also been previously 
implicated in bacterial phagocytosis, which correlates well with the NanoString expression data. 
LRIM1 and TEP3 were shown to be involved in phagocytosis of gram-negative bacteria whereas TEP1 
and TEP4 are important for phagocytosis of both gram-types (Moita et al., 2005). 
There was significant overlap in the transcriptional responses of LRIMs and TEPs to gram-negative 
and gram-positive bacteria (E. coli and S. aureus, respectively). This was in agreement with a 
previous microarray that found similarities in the responses of other immune genes to both gram-
types (Dimopoulos et al., 2002). The authors speculated that overstimulation of the immune system 
or responses to the effects of phagocytosis could be responsible. Induction by both gram-types does 
not necessarily indicate a defensive role against both gram-types. For example, CTL4 and CTLMA2 
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are only involved in defence against gram-negative bacteria but are upregulated by both gram-types 
(Schnitger et al., 2009). It should be noted that the laboratory models, E. coli and S. aureus, are 
unlikely to be natural pathogens encountered by An. gambiae in the wild. E. coli is weakly virulent in 
An. gambiae and injection of high numbers are required to cause lethality (Gupta et al., 2009). 
Furthermore, E. coli is commonly found as part of the endogenous midgut flora of laboratory-reared 
An. gambiae (Dong et al., 2009) and presumably wild mosquitoes too. Therefore, E. coli has the 
potential to invade the hemolymph during malaria parasite invasion. It would be beneficial to 
compare the responses of LRIMs and TEPs to natural bacterial pathogens, such as Enterococcus 
faecalis and Enterobacter cloacae.  
Candidates for involvement in defence against fungi include LRIM1, APL1A, LRIM4, LRIM17 and TEP3. 
Results correlated well with a previous microarray, which found that LRIM1, APL1C, LRIM4 and 
LRIM17 were induced 48 h after injection of B. bassiana spores (Fanny Turlure, personal 
communication). Interestingly, no genes were uniquely fungal specific. There was a strong 
association between transcriptional responses to bacteria and fungi whereby all genes induced by 
fungi were also upregulated by bacteria. This is probably due to the broad spectrum of the mosquito 
Toll pathway, which largely responds to both fungi and gram-positive bacteria (Hillyer, 2010). There 
is also considerable crosstalk with the Imd pathway, which is primarily activated by gram-negative 
bacteria (Lemaitre and Hoffmann, 2007). 
Given their strong virulence, responses to injection of B. bassiana spores were weaker than 
anticipated. It is not known whether fungal spores are recognised directly or only after proliferation 
into hyphae, as suggested by the observation that most genes responded the strongest at 72 h after 
spore injection. Therefore, time points after 72 h might be more informative in highlighting LRIMs 
and TEPs defending against fungal infections. It should be noted that injection of spores is an 
unnatural means of infection as most entomopathogenic fungal spores adhere to the outer cuticle, 
germinate and invade the hemocoel (Thomas and Read, 2007). The insect immune system is 
activated upon penetration of the cuticle (Thomas and Read, 2007), presumably by detection of 
cuticle degradation products in the hemolymph. It would be interesting to see how transcriptional 
responses vary if fungal spores are added directly to the mosquito cuticle. After application to the 
surface of An. stephensi, B. bassiana has been demonstrated to kill 90% of mosquitoes within 14 
days (Thomas and Read, 2007).  
Hierarchical clustering of the transcriptional data highlighted putative functional relationships 
between LRIMs and TEPs. Differential responses to the various immune challenges and intrinsic 
variability between biological replicates were exploited to find co-regulated genes. Genes in the 
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same cluster might function in the same biochemical pathway or be under the same regulation. They 
might physically interact with each other, like LRIM1, APL1C and TEP1 (Fraiture et al., 2009; 
Povelones et al., 2011; Povelones et al., 2009). It was predicted that clustered genes might be 
involved in defence against the same pathogen(s). As proof of principle, the known functional 
partners, LRIM1, APL1C and TEP1, clustered tightly together. Although their regulation remains 
unclear, it has been reported that these genes are basally expressed under the regulation of REL1 
and REL2 and regulated by REL1 after an infection (Blandin et al., 2008; Frolet et al., 2006; Mitri et 
al., 2009). APL1A, TEP3 and TEP4 were clustered alongside LRIM1/APL1C/TEP1, suggesting they 
might also function in the complement-like pathway. TEP3 and TEP4 are known to be involved in 
bacterial defence like LRIM1, APL1C and TEP1 (Dong et al., 2006a; Dong and Dimopoulos, 2009). 
APL1A has been reported to reduce the prevalence of P. falciparum infections (Mitri et al., 2009), 
which suggests the rest of the cluster should be thoroughly investigated for roles in P. falciparum 
defence. A promising cluster, comprised of LRIM4, LRIM17, TEP12 and TEP14, was induced by 
Plasmodium, bacterial and viral infections. The relationship between these genes should be 
investigated further as it might represent a novel defence module. Expression clusters formed by 
meta-analysis of all extant microarray data (Maccallum et al., 2011) are consistent with hierarchical 
clustering of the NanoString data in this study. LRIM8B, LRIM9 and LRIM10 clustered in both 
analyses, as did LRIM4 and LRIM17 and also LRIM1 and APL1C. 
Preliminary results have provided fascinating insights into the expression profile of An. gambiae 
LRIMs and TEPs during the mosquito developmental stages. Mosquito eggs are deposited on water 
and larvae and pupae are completely aquatic (Clements, 2000; Reiter, 2001). Larval and pupal 
habitats are usually small or shallow bodies of water with little current, such as rice fields, marshes, 
water-filled tree holes and man-made containers (Clements, 2000). Larvae typically filter feed on 
particulate matter at the water surface, including plant-derived detritus, bacteria, diatoms and 
algae. Adult mosquitoes have an aerial lifestyle and feed on plant sugar, such as nectar. Females 
take blood meals from vertebrates to enable egg development. In their extremely contrasting 
lifestyles, mosquito larvae and adults are subjected to widely different pathogens and parasites. 
Interestingly, LRIM1, APL1C, TEP1, LRIM17 and TEP15 were highly expressed in fourth instar larvae, 
pupae and adults, suggesting they play an essential immunity role throughout the life of the insect. 
These five genes were induced by several immune challenges including bacteria, which are likely to 
be the predominant pathogens encountered by larvae. We would expect the complement-like 
pathway to be critical for immunity in all life stages. Furthermore, it has been proposed that 
selection pressure imposed by larval pathogens is more powerful than the pressure exerted by adult 
pathogens (White et al., 2011). Adaptive divergence in TEP1 alleles has been attributed to 
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evolutionary pressure in larval habitats. Other genes were poorly expressed in larvae and pupae but 
very high in adults, such as the Short LRIMs, LRIM8B, LRIM9 and LRIM10. This is in agreement with 
the hypothesis that these LRIMs are specific to blood feeding, a behaviour exclusive to adult 
females. As these Short LRIMs were not well expressed in larvae, this suggests they are unlikely to be 
important for bacterial defence. It is important to verify these results with further replicates, 
although they correlate well with a previous microarray (Koutsos et al., 2007). It would also be 
enlightening to investigate other developmental stages, such as eggs, early larvae, young adults and 
older adults.  
Expression in male adult mosquitoes was not investigated in the current study and the sex of larvae 
and pupae used was undetermined. Expression of LRIMs and TEPs in males and females should be 
compared in the future. It would be predicted that the core LRIMs, such as LRIM1 and APL1C, would 
be strongly expressed in both sexes whereas blood feeding specific LRIMs, such as LRIM9, would 
only be expressed in females. Existing microarray data support this hypothesis (Baker et al., 2011; 
Koutsos et al., 2007; Marinotti et al., 2005). 
Several LRIMs were previously shown to be enriched in An. gambiae circulating hemocytes (Pinto et 
al., 2009). As well as mediating phagocytosis and encapsulation, hemocytes are known to secrete a 
variety of immune factors, including melanisation factors, opsonins and AMPs (Pinto et al., 2009) 
(Hillyer, 2009). LRIM1, APL1C, LRIM4, LRIM6, LRIM15, LRIM16A, LRIM16B, LRIM17, TEP3, TEP4, 
TEP12, TEP14 and TEP15 are all hemocyte expressed genes (Pinto et al., 2009). Hemocytes are 
believed to play an important role in immune responses against Plasmodium parasites. TEP1 was 
previously revealed to be present in hemocytes attached to the midgut and Malpighian tubules 
(Blandin et al., 2004). As LRIM15, LRIM16A and LRIM16B are Transmembrane LRIMs, they are likely 
to be inserted into the membrane of circulating hemocytes. The presence of a functional 
transmembrane domain in these LRIMs has recently been confirmed by immunolocalisation studies 
in cultured cells (Michael Povelones, personal communication). An attractive hypothesis is that these 
Transmembrane LRIMs sense pathogens that hemocytes encounter and trigger cellular responses, 
such as phagocytosis. It is interesting that the complement-like pathway components, LRIM1, APL1C 
and TEP1, and their interacting partners, TEP3 and TEP4, are all hemocyte-enriched. The hierarchical 
cluster of LRIM4, LRIM17, TEP12 and TEP14 are also hemocyte expressed, suggesting they might 
have a hemocyte-related function. The increase in their transcripts detected after some infections 
might result from an overproliferation of hemocytes. 
To expand the transcriptional profiling of LRIMs and TEPs in An. gambiae, it would be interesting to 
try other immune challenges, such as filarial worms and more pathogenic bacterial species. An. 
126 
 
gambiae frequently suffer co-infections with Plasmodium parasites and filarial worms (Muturi et al., 
2008). Monitoring gene expression might highlight the tripartite interaction between the mosquito 
immune system, filarial worms and malaria parasites, which is currently poorly understood. It would 
also be interesting to monitor expression in specific tissues upon the various immune challenges, 
such as the midgut, fat body and hemocytes. This is because subtle gene regulation in specific tissues 
could be masked when whole mosquitoes are analysed. Transcriptional responses of LRIMs and TEPs 
in other disease vector mosquitoes, such as Aedes and Culex, should also be undertaken to 
investigate whether the transcriptional programmes and putative functions of orthologues are 
conserved. Preliminary evidence suggests that the LRIM1/APL1C/TEP1 module is conserved in Ae. 
aegypti as their orthologues are all upregulated by Wolbachia infection (Kambris et al., 2009).  
Despite the upregulation of several LRIMs by Plasmodium infection, the RNAi screen only identified 
one novel P. berghei antagonist: LRIM9. A single experimental replicate was sufficient to rule out 
other LRIMs having a dramatic phenotype like LRIM1 and APL1C. This provides further evidence that 
all LRIMs do not behave similarly and supports the theory that different LRIMs defend against 
specific pathogens. Nevertheless, this preliminary screen warrants repetition as knockdown 
efficiencies of some LRIMs were very poor. Silencing efficiency is gene-specific depending on their 
tissue expression characteristics, the efficiency of dsRNA uptake by particular tissues, transcription 
and protein turnover rates, polymorphisms and the efficiency of the dsRNA probe. It is more 
informative to monitor gene knockdowns at the protein level (Moita et al., 2005), which was 
unachievable in this screen. It is also important to consider that a gene knockdown showing no 
effect on P. berghei infection might highlight functional redundancies in the mosquito immune 
system. In other words, another immune effector might substitute for the role of the absent protein. 
In particular, LRIM7, LRIM8B, LRIM12, LRIM15 and LRIM16 (A and B silenced concurrently) 
demonstrated marginal phenotypes with P. berghei that warrant further verification.  
For LRIM1, APL1C and TEP1, there was a strong functional link between their transcriptional 
upregulation by P. berghei and their RNAi phenotype as P. berghei antagonists. Despite acting as a P. 
berghei antagonist, the LRIM9 transcript was not induced by P. berghei, P. falciparum or P. yoelii. 
Transcriptional activity of a gene does not necessarily reflect functional specificity to a particular 
challenge. Nevertheless, LRIM9 was strongly upregulated by naïve blood feeding, which might 
function to boost LRIM9 levels in the hemolymph in anticipation of a parasite infection. LRIM9 will 
be investigated further in Chapter 5. 
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To continue the functional analysis, candidate LRIMs should be screened for an RNAi phenotype with 
the human parasite, P. falciparum. Survival assays with fungi, bacteria and ONNV should also be 
performed on candidate LRIMs chosen from the transcriptional profiling presented in this Chapter. 
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5 LRIM9 – a novel antagonist of Plasmodium berghei 
 
5.1 Background 
Increasing our understanding of the mosquito immune system and how it targets and kills malaria 
parasites could lead to the development of novel malaria control strategies. Two key mosquito 
immune proteins, LRIM1 and APL1C, mediate killing of Plasmodium parasites through their 
interaction with the complement-like effector, TEP1 (Fraiture et al., 2009; Povelones et al., 2009). 
We recently discovered a mosquito-specific family of immune proteins related to LRIM1 and APLIC - 
the LRIMs. This PhD involved examining the roles of uncharacterised LRIMs in mosquito immunity. 
As presented in Chapter 4, transcriptional profiling and RNAi screens following immune challenge 
and Plasmodium infection identified LRIM9 as a highly promising candidate. This present Chapter 
describes the thorough characterisation of LRIM9 to learn more about its involvement in parasite 
killing and mosquito immunity.  
LRIM9 is a Short LRIM, with protein domain architecture typical for this LRIM subfamily (Figure 5.1). 
It has a predicted signal peptide sequence, which suggests it is secreted into the mosquito 
hemolymph. LRIM9 has seven LRRs predicted to form a shallow horseshoe shape (Waterhouse et al., 
2010). The LRRs are preceded by a leucine-rich leader sequence, which is similar to an LRR motif but 
with higher leucine substitutions and it rarely has the characteristic asparagine (Waterhouse et al., 
2010). These leucine-rich leader sequences are common in vertebrate TLRs (Matsushima et al., 
2007). LRIM9 has a single coiled-coil domain whereas LRIM1, APL1C and some Short LRIMs have two 
tightly-linked coiled-coils (Waterhouse et al., 2010). The LRIM1/APL1C coiled-coils interact with TEP 
proteins (Povelones et al., 2011). LRIMs have well conserved patterns of cysteine residues between 
the LRRs and coiled-coil and LRIM9 is quite typical. LRIM9 has a leading N-terminal cysteine motif (C-
C) and a C-terminal cysteine pattern (C-C-CC) (Waterhouse et al., 2010). In LRIM1 and APL1C, the C-
terminal cysteines form two intramolecular disulphide bonds that likely play a role in protein folding 
(Baxter et al., 2010; Povelones et al., 2011). However, LRIM9 lacks a final C-terminal single cysteine 
immediately prior to the coiled-coil, which is only found in LRIM1 and the APL1 cluster. The final 
cysteine of LRIM1 and APL1C is crucial for covalently linking the proteins by a disulphide bond, 
although this linkage is not essential for the LRIM1/APL1C interaction and their interaction with TEP1 
(Povelones et al., 2011). 
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Figure 5.1  Schematic representation of LRIM9 protein structure. 
To-scale diagram of LRIM9 protein structure, with LRIM1 shown for comparison. Predicted size of 
mature proteins is shown in grey. Structures shown are black box: signal peptide, blue box: LRR, green 
box: coiled-coil domain, red line: cysteine residue. The leading N-terminal (C-C) and C-terminal (C-C-CC) 
cysteine motifs of LRIM9 are highlighted. The LRIM1 diagram has been adapted from Povelones et al., 
2011. 
 
LRIM9 forms a genomic cluster with four other LRIMs in An. gambiae: LRIM7, LRIM8A, LRIM8B and 
LRIM10 (Waterhouse et al., 2010). Comparative sequence analyses have revealed orthologous 
clusters in the genomes of Ae. aegypti and C. quinquefasciatus mosquitoes with evidence of gene 
duplication and shuffling (Figure 5.2). However, in all three mosquito species, LRIM9 has been 
conserved as a single-copy orthologue and has retained its relative location and orientation. In 
comparison, LRIM8 has been duplicated in An. gambiae and LRIM10 in Ae. aegypti. The orthologous 
region is approximately four times larger in Ae. aegypti due to accumulation of repetitive sequences, 
which is a common phenomenon in the Ae. aegypti genome. 
In Chapter 4, the LRIM9 transcript was found to be unresponsive to Plasmodium, bacteria, fungi, 
ONNV and PBS injection but was induced 24 to 48 h after mouse and human blood feeding, 
responding more rapidly at higher temperatures. A 1.6-fold induction in LRIM9 transcript was also 
observed 24 h after injection of conditioned media from uninfected VERO cells, probably in response 
to the serum-containing media. Previous transcriptional profiling data have also demonstrated 
significant differential expression of LRIM9 after blood feeding, with highest expression at 24 h and 
lowest at 3 h (Marinotti et al., 2005). Like several other LRIMs, including LRIM1 and APL1C, LRIM9 
showed significantly higher expression in the fat body compared to the midgut or ovaries (Marinotti 
et al., 2005). Preliminary evidence suggests LRIM9 is poorly expressed in larvae and pupae. 
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Figure 5.2  Orthologous genomic clusters of Short LRIMs in different mosquito species. 
 In An. gambiae, LRIM9 is a member of a five gene cluster of Short LRIMs. This cluster is conserved in 
the other sequenced mosquito species, Culex and Aedes, with evidence of gene duplication and 
shuffling of gene order and orientation. The Anopheles chromosome (Chr) 2L is shown in red and the 
orthologous Culex and Aedes supercontigs (Scont) in purple and yellow, respectively. The LRIM genes 
(in green) are within the intron of a guanine nuclear exchange factor (GNEF) containing gene (in blue) in 
all three mosquito species. Orthologues are linked with solid grey lines whereas duplicated genes are 
linked with dashed lines. Repetitive sequences are lightly shaded. From Waterhouse et al., 2010. 
 
 
5.2 Results 
LRIM9 and P. berghei infections 
Initially, a dsRNA injection time course was performed to enable optimisation of LRIM9 silencing, if 
necessary. Mosquitoes were injected with dsGFP (non-specific dsRNA) or dsLRIM9 and 10 
mosquitoes from each group were collected on day 1, 2, 3, 4 and 7. RNA was extracted and cDNA 
was analysed by qRT-PCR for LRIM9 expression. LRIM9 expression was first normalised for total 
amount of RNA material using expression of S7, a gene encoding a ribosomal housekeeping protein. 
For each time point, levels of LRIM9 after dsLRIM9 treatment were calculated relative to the 
corresponding dsGFP treatment. The LRIM9 transcript was very efficiently silenced at the RNA level, 
even 7 days after dsRNA injection (Figure 5.3). Knockdown ranged from a minimum of 88% on day 7 
to a maximum of 99% on day 2. Therefore, LRIM9 silencing did not require optimisation and dsRNA 
was injected 3 or 4 days prior to blood feeding or further treatments in all subsequent experiments. 
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Figure 5.3  Knockdown efficiency time course for LRIM9 transcript.   
RNA was extracted from mosquitoes 1, 2, 3, 4 and 7 days after dsGFP or dsLRIM9 injection. Per time 
point and group, 10 mosquitoes were pooled for RNA extraction and cDNA synthesis. cDNA was 
analysed by qRT-PCR to determine LRIM9 expression, normalising to S7, a constitutively expressed 
housekeeping gene. For each day, LRIM9 expression in the LRIM9 knockdown (red) was calculated 
relative to expression in the dsGFP-treated control (blue).  
 
As presented in Chapter 4, LRIM9 knockdown caused a significant effect on P. berghei infection. This 
initial finding was followed up with further biological replicates to verify the result. Mosquitoes were 
injected with dsLRIM9, dsLRIM1 (as a positive control) and dsGFP (as a negative control). After 3 to 4 
days, mosquitoes were allowed to feed on a P. berghei infected mouse. Midguts were dissected 7 
days later and live GFP-labelled oocysts and dead melanised ookinetes were counted. Silencing 
LRIM9 resulted in a highly significant 5-fold increase in live oocysts compared to dsGFP-treated 
controls (Figure 5.4 A and Table 5.1). This result was reproducible in two An. gambiae strains 
(Yaoundé and Ngousso) known to be susceptible to Plasmodium infection, suggesting that LRIM9 is 
somehow involved in limiting parasite development or killing parasites. The increase in oocysts 
observed after LRIM9 silencing was less dramatic than LRIM1 or APL1C silencing, the latter resulting 
in increases between 3.6-fold and 50-fold (Osta et al., 2004a; Povelones et al., 2009). Knockdown of 
LRIM9 also significantly reduced spontaneous ookinete melanisation in susceptible mosquitoes 
(Figure 5.4 B and Table 5.1), which is also observed upon silencing LRIM1, APL1C or TEP1. The effect 
on spontaneous melanisation was largely from one biological replicate, although this was sufficient 
to have a significant effect on the pooled results. As shown in Figure 5.3, the LRIM9 knockdown 
phenotype with P. berghei is not affected by poor or transient knockdown. 
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Prevalence of live oocyst infection, the percentage of midguts containing at least one oocyst, was 
comparable between dsLRIM9 and dsGFP in the pooled experiments (not significant using Fisher’s 
exact test). In contrast, prevalence of live oocyst infection in dsLRIM1 was significantly higher than in 
dsGFP (P-value < 0.01 using Fisher’s exact test). Both dsLRIM9 and dsLRIM1 significantly reduced the 
prevalence of spontaneous melanisation (P-value < 0.05 and < 0.0001, respectively, using Fisher’s 
exact test). 
 
 
 
 
Figure 5.4  LRIM9 knockdown in susceptible mosquitoes.  
LRIM9 was silenced using RNAi, mosquitoes were infected with fluorescent P. berghei and parasite load 
was monitored after 7 days. Non-specific dsRNA (GFP) was used as a control. The graphs show pooled 
data from five independent biological experiments in Plasmodium susceptible mosquitoes (two from 
Yaoundé strain and three from Ngousso strain, see Table 5.1). Horizontal lines represent the median 
parasite number. Two LRIM9 knockdown mosquitoes with 403 and 608 oocysts, respectively, were 
excluded from the graph for presentation purposes. A) Live fluorescent oocyst counts (P-value  
< 0.0001, Mann Whitney U-test). B) Melanised (killed) ookinete counts (P-value < 0.01, Mann Whitney 
U-test). 
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Table 5.1  The effect of LRIM9 silencing on P. berghei development in susceptible mosquitoes. 
Expt 
(Strain) 
Knock-
down 
N 
Live oocysts Melanised ookinetes 
Knockdown 
efficiency 
(%) 
Prevalence Infection intensity Prevalence Infection intensity 
% P-value 
Median 
(Range) 
P-value % P-value 
Median 
(Range) 
P-value 
1 (Y) 
GFP 17 76 N/A 2 (0-89) N/A 88 N/A 4 (0-85) N/A N/A 
LRIM1 10 100 NS 243 (46-805) < 0.0001 0 < 0.0001 0 < 0.001
#
 79 
LRIM9 14 93 NS 44 (0-285) < 0.001 14 < 0.0001 0 (0-2) < 0.0001 65 
2 (Y) 
GFP 5 100 N/A 4 (3-63) N/A 0 N/A 0 N/A N/A 
LRIM1 7 100 N/A 349 (5-744) < 0.05 0 N/A 0 N/A 79 
LRIM9 5 80 NS 29 (0-50) NS 20 NS 0 (0-15) NS
#
 78 
3 (Ng) 
GFP 7 86 N/A 6 (0-19) N/A 14 N/A 0 (0-1) N/A N/A 
LRIM1 4 100 NS 519 (307-751) < 0.01 0 NS 0 NS# 72 
LRIM9 10 100 NS 26 (4-608) < 0.05 30 NS 0 (0-8) NS 81 
4 (Ng) 
GFP 16 75 N/A 3.5 (0-22) N/A 13 N/A 0 (0-3) N/A N/A 
LRIM1 13 100 NS 326 (225-748) < 0.0001 0 NS 0 NS# 95 
LRIM9 17 59 NS 1 (0-183) NS 18 NS 0 (0-2) NS 86 
5 (Ng) 
GFP 33 88 N/A 13 (0-298) N/A 39 N/A 0 (0-10) N/A N/A 
TEP1 20 95 NS 240 (0-700) < 0.0001 15 NS 0 (0-1) < 0.05 ND 
LRIM9 42 95 NS 43 (0-293) < 0.01 26 NS 0 (0-11) NS ND 
Pooled 1-5 
GFP 78 83 N/A 6 (0-298) N/A 40 N/A 0 (0-85) N/A N/A 
LRIM1 34 100 < 0.01 317 (5-805) < 0.0001 0 < 0.0001 0 < 0.0001# 81 
LRIM9 88 88 NS 27 (0-608) < 0.0001 23 < 0.05 0 (0-15) < 0.01 78 
 
LRIM9 was silenced using RNAi, mosquitoes were infected with fluorescent P. berghei and parasite load was monitored after 7 days. Five biological replicates and pooled 
data are shown. Non-specific dsRNA (GFP) was used as a negative control and LRIM1 or TEP1 as a positive control. Either Yaoundé (Y) or Ngousso (Ng) mosquito strains 
were used. N = number of individual mosquito midguts. Prevalence is the percentage of guts that contain at least one oocyst or melanised parasite. Mann Whitney U-test 
was used for infection intensity, comparing to dsGFP. If prevalence for one gene was zero, the Wilcoxon Test was used (#). Fisher’s exact test was used for prevalence. 
Significant P-values (< 0.05) are shown in red. Knockdown efficiency was calculated by qRT-PCR. NS = Not significant; ND = Not determined; N/A = Not applicable. 
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To further investigate the role of LRIM9 in melanisation, the gene was silenced in L3-5 mosquitoes, a 
laboratory-selected refractory strain of An. gambiae that melanises virtually all invading P. berghei 
ookinetes (Collins et al., 1986). LRIM9 knockdown in the L3-5 strain caused a significant decrease in 
melanisation but no parallel increase in live oocysts (Figure 5.5). In contrast, when LRIM1 or APL1C is 
silenced in L3-5, melanisation is blocked and there is an 80-fold increase in live parasites (Povelones 
et al., 2009). The LRIM9 phenotype was verified using two different lines of genetically modified P. 
berghei parasite (EF1 and 507), shown separately in Figure 5.5. These parasites share the same 
genetic background (ANKA) and EF1 eGFP promoter but have different insertion loci – SSU for EF1 
and 230P for 507. Knockdown efficiency of LRIM9 in L3-5 mosquitoes was 89%. 
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Figure 5.5  LRIM9 knockdown in L3-5 mosquitoes using two lines of P. berghei.  
LRIM9 silencing in refractory L3-5 mosquitoes which melanise virtually all invading P. berghei parasites. 
Mosquitoes were infected with two fluorescent P. berghei lines and parasite load was monitored after 
7 days. Non-specific dsRNA (GFP) was used as a control. Horizontal lines represent the median parasite 
number. A and B) Infection with EF1 parasites. C and D) Infection with 507 parasites. A and C) 
Melanised (killed) ookinete counts (P-value < 0.01 for A and < 0.0001 for C using Mann Whitney U-test). 
B and D) Live oocyst counts (no significant differences using Mann Whitney U-test).  
 
To determine the effect of LRIM9 on parasite melanisation in a different genetic background, LRIM9 
was silenced alongside CTL4, a C-type lectin that usually inhibits parasite melanisation in susceptible 
mosquitoes (Volz et al., 2006). Silencing CTL4 alone induces dramatic melanisation of invading 
137 
 
ookinetes, inhibiting their development to oocysts, while double knockdown of LRIM1/CTL4 or 
TEP1/CTL4 reverses the CTL4 phenotype, resulting in negligible melanisation and many live oocysts, 
which indicates that LRIM1 and TEP1 are epistatic to CTL4 (Osta et al., 2004a). Therefore, silencing 
CTL4 and LRIM9 together can also provide information about epistatic relationships between these 
two genes in the melanisation cascade. In this experiment, GFP/GFP and GFP/CTL4 double 
knockdowns served as controls. As expected, GFP/CTL4 silencing showed increased melanisation and 
fewer developing oocysts compared to the GFP/GFP control (Figure 5.6). However, LRIM9/CTL4 
knockdown showed no significant change in live oocysts or melanised parasites compared to 
GFP/CTL4 knockdown. In contrast, as expected, TEP1/CTL4 knockdown reversed the CTL4 
phenotype. Therefore, the LRIM9 knockdown phenotype of increased live parasites is suppressed 
when LRIM9 is silenced alongside CTL4.  
 
 
Figure 5.6  LRIM9 and CTL4 double knockdown in susceptible mosquitoes.  
LRIM9 was silenced with CTL4, a known inhibitor of parasite melanisation. Mosquitoes were infected 
with fluorescent P. berghei and parasite load was monitored after 7 days. Double knockdowns of 
GFP/GFP, GFP/CTL4 and TEP1/CTL4 were used as controls. All significant results by the Mann Whitney 
U-test (P < 0.05) are highlighted on the graphs. Results shown are representative of two independent 
biological replicates and the horizontal lines represent the median parasite number. A) Live oocyst 
counts. B) Melanised (killed) ookinete counts. 
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Recombinant LRIM9 in insect cell culture 
To analyse the biochemical characteristics of LRIM9 in vitro, the gene was cloned into the pIEx-10 
insect expression vector. This vector adds an N-terminal Strep-tag and a C-terminal His-tag for 
tandem purification and detection. In an initial experiment, pIEx-10-LRIM9 was transfected into two 
insect cell lines, Lepidopteran Sf9 and An. gambiae hemocyte-like Sua4.0, to monitor expression 
levels, protein mobility and complex formation. Conditioned media were analysed by western blot 
using the His probe to detect LRIM9. Sf9 cells are excellent secretory cells, contain no endogenous 
LRIM proteins and can be grown under serum-free conditions, facilitating purification of proteins 
from the conditioned medium. Sua4.0 cells naturally secrete a subset of mosquito hemolymph 
proteins and show inducible immune gene expression (Muller et al., 1999). Therefore, LRIM9 
expression in Sf9 cells would uncover intrinsic properties of the LRIM9 protein, such as the ability to 
form homomeric complexes, whereas expression in Sua4.0 cells would allow screening for LRIM9 
partners. 
Recombinant LRIM9 was highly expressed and secreted as a monomer in both cell lines after 
transfection (Figure 5.7). The predominant band was at 54 kDa in non-reduced samples, consistent 
with the predicted size of mature His/Strep-tagged LRIM9. A slight mobility shift (to 60 kDa) was 
observed in reduced samples, which is common upon reduction of intramolecular disulphide bonds 
because proteins become less compact with slower electrophoretic mobility. Lower molecular 
weight bands (25-40 kDa) were visible in conditioned media from Sf9 cells, which were likely to be N-
terminally cleaved forms of LRIM9 due to limited protease activity in the samples. Higher molecular 
weight bands in the conditioned media of Sua4.0 cells were probably non-specific as they were also 
observed in control transfection using a GFP-expressing plasmid. A band at approximately 120 kDa in 
the non-reduced LRIM9 sample was perhaps an artefact of overexpression. Overall, LRIM9 does not 
appear to form a covalent homo- or heteromeric complex when expressed in cultured insect cells. 
However, it is possible that recombinant LRIM9 behaves differently to the native protein, while the 
presence and abundance of mosquito proteins is likely to differ between conditioned media and 
mosquito hemolymph. Therefore, an antibody against LRIM9 was required to investigate complex 
formation in vivo. 
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Figure 5.7  Expression of recombinant LRIM9 in insect cell lines.  
Recombinant pIEx-10-LRIM9 plasmids were transfected into Lepidopteran-derived Sf9 cells (A) and 
mosquito hemocyte-like Sua4.0 cells (B). Cells transfected with a GFP-expressing plasmid were used as 
a negative control. Cell conditioned media were collected 3 days after transfection and analysed by 
western blot using an anti-His antibody under reducing (R) and non-reducing (NR) conditions. 
 
Developing an antibody against LRIM9 
To investigate the function of the LRIM9 protein, rabbit antibodies were initially raised against two 
LRIM9 peptides, one at the C-terminus and another located in an internal region between the LRRs 
and coiled-coil. However, after an initial characterisation, these peptide antibodies were not optimal 
and showed prominent non-specific bands (Appendix Figure 9.1). As an alternative, polyclonal 
guinea pig antibodies were raised against the entire LRIM9 protein that was produced in stably 
transfected Sf9 cells that continually secrete LRIM9 protein into their conditioned media. This cell 
line was kindly generated by Dr Lavanya Bhagavatula using antibiotic selection after co-transfection 
of the previously mentioned pIE1-neo and pIEx-10-LRIM9 plasmid vectors. Conditioned medium 
containing tagged LRIM9 was purified by affinity chromatography using the C-terminal 10x His-tag. 
The purified LRIM9 protein was analysed by Coomassie staining, concentrated and sent to 
Eurogentec for immunisation of two guinea pigs.  
The immune sera were evaluated using conditioned media from pIEx-10-LRIM9 transfected Sua4.0 
cells. A MiniBlotter was used to optimise the concentration and blocking buffer for western blot 
(Figure 5.8). Pre-immune serum (collected from the same animal before immunisation) was used to 
confirm specificity of immunodetection. The antibodies detected LRIM9 as an abundant monomer at 
54 kDa, in agreement with the His probe, whereas the pre-immune serum did not. There was no 
evidence to suggest that LRIM9 is endogenously expressed by Sua4.0 cells under naïve conditions. 
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Faint bands at approximately 120 and 180 kDa detected in the antisera from both guinea pigs may 
be an artefact of LRIM9 overexpression. 
 
 
Figure 5.8  Testing LRIM9 whole protein antibody using conditioned media from mosquito cells.  
Sera from two guinea pigs (named 59 and 60) were screened for LRIM9 antibodies by western blot of 
conditioned media collected from LRIM9-expressing Sua4.0 cells. Pre-immune serum (PPI), a large 
bleed (GP) and final bleed (SAB) were used at 1/500 and 1/1000 dilutions. Molecular weight markers 
are indicated on the left (kDa). 
 
LRIM9 in the hemolymph 
To gain insights into the role of LRIM9 in vivo, the next step was to analyse hemolymph using the 
LRIM9 whole protein antibody. To verify the results from cell culture, the pre-immune serum and 
final bleed serum from guinea pig 59 (hereafter LRIM9 antibody or α-LRIM9) were used to probe 
hemolymph collected 4 days after dsGFP, dsLRIM9 or dsLRIM1 injection (Figure 5.9 A). SRPN3, a 
protein constitutively present in the hemolymph, was also analysed to confirm equal loading. With 
the LRIM9 antibody, a unique band just below 50kDa was detected in dsGFP and dsLRIM1 
hemolymph but was absent in dsLRIM9. This band (shown by red arrow in Figure 5.9) matches the 
predicted size for an LRIM9 monomer and corresponds well with the observations in vitro. A band at 
approximately 70 kDa and another faint cluster of bands between 180 and 250 kDa were unaffected 
by LRIM9 silencing and therefore considered non-specific. None of these bands were detected in the 
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pre-immune serum, which confirms the LRIM9 antibodies were induced by immunisation and not an 
artefact of the guinea pig blood. The band detected by the LRIM9 antibody was weaker than 
anticipated given that LRIM9 was highly transcribed in unchallenged mosquitoes, as described in 
Chapter 4. 
 
Figure 5.9  Testing LRIM9 antibody with hemolymph after LRIM9 knockdown.  
A) Female Ngousso mosquitoes were injected with dsGFP, dsLRIM9 or dsLRIM1 and hemolymph was 
collected after 4 days. Non-reduced hemolymph was analysed by western blot and probed with the 
pre-immune serum (PPI) or α-LRIM9 antibody. Blots were re-probed with an antibody against 
constitutively expressed SRPN3 as a loading control. B) 3 days after dsGFP or dsLRIM9 injection, 
mosquitoes were fed either sugar or blood. Hemolymph was collected 24 h later and analysed by 
western blot using α-LRIM9 and α-SRPN3 antibodies. Molecular weight markers are indicated (kDa). 
Red arrowheads indicate the position of LRIM9. 
 
As the LRIM9 transcript was upregulated after naïve blood feeding, it was investigated whether the 
LRIM9 protein would be more abundant in the hemolymph following a blood meal. Hemolymph 
collected 24 h after sugar or blood feeding was analysed by western blot using the LRIM9 antibody 
(Figure 5.9 B). The 50 kDa LRIM9 band was massively enriched in hemolymph collected from blood 
fed compared to sugar fed mosquitoes, whereas the abundance of SRPN3 was relatively unaffected. 
The LRIM9 protein was completely absent after LRIM9 knockdown in the sugar fed mosquitoes but a 
faint band remained after blood feeding, suggesting RNAi silencing was unable to completely 
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knockdown the large increase in protein production. Despite this, the remaining band was still much 
less intense than in the naïve mosquito. Non-specific bands were unaffected by blood feeding. 
Next, the temporal dynamics of LRIM9 transcript and protein levels were monitored following a 
naïve blood meal. Female mosquitoes were allowed to feed on an anaesthetised naïve mouse and 
hemolymph was collected after 3, 8, 24, 48, 72 and 96 h. Hemolymph was also collected from a 
group of mosquitoes prior to blood feeding to determine the basal expression (“0 h”). In this 
experiment, mosquitoes were incubated at 19 oC after blood feeding, which was consistent with the 
temperature required for P. berghei infection. LRIM9 and other hemolymph proteins were analysed 
by western blot (Figure 5.10 A). Strikingly, the upregulation of LRIM9 after blood feeding was very 
specific and transient, peaking dramatically at 24 to 48h and rapidly decreasing again by 72h. LRIM9 
band intensities were determined and normalised using the SRPN3 loading control to account for 
total protein in each hemolymph sample (Figure 5.10 B). Levels of LRIM9 protein in naïve 
hemolymph were relatively low but, by 48 h, this had increased dramatically by over 12-fold. 
However, it should be noted that enhanced chemiluminescence western blot analysis performed 
here is only a semi-quantitative technique so this number is provided as an estimate. Analysis of the 
LRIM1/APL1C complex and LRIM4 demonstrated that not all LRIMs are induced by blood feeding as 
these proteins remained relatively stable during the time course. The LRIM1/APL1C complex was 
constitutively present at high levels in naïve hemolymph and further upregulated in response to a 
challenge. In contrast to LRIM9, levels of TEP1-F and TEP1cut were depleted during a blood meal. 
Interestingly, the concentration of LRIM9 in the hemolymph at 96 h was still higher than before the 
blood meal. 
LRIM9 transcript abundance was analysed by qRT-PCR over the time course and it correlated very 
closely with the protein abundance (Figure 5.10 C). This suggests that LRIM9 is transcribed and 
secreted when required rather than the protein being stored in large quantities inside the cell. By 72 
and 96 h, LRIM9 transcription returned back to basal levels indicating that the elevated protein 
levels observed at these time points likely reflect the time required for protein turnover. 
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Figure 5.10  LRIM9 transcript and protein expression after feeding on rodent naïve blood.  
Mosquitoes were allowed to blood feed on an uninfected mouse and hemolymph and RNA samples 
were collected after 3, 8, 24, 48, 72 and 96 h. A group of mosquitoes before blood feeding were used to 
show basal expression levels (“0 h”). A) Hemolymph was analysed by western blot under non-reducing 
conditions and probed with α-LRIM9. The blot was re-probed with α-SRPN3 as a loading control and α-
LRIM2-300 to analyse the LRIM1/APL1C complex. Another blot of the same samples was probed with α-
LRIM4 and α-TEP1 antibodies. Molecular weight markers are shown (kDa). B) LRIM9 protein bands 
were measured semi-quantitatively and normalised to SRPN3. C) LRIM9 transcript was analysed in total 
RNA isolated from whole mosquitoes by qRT-PCR using LRIM9 primers and normalising to ribosomal S7 
gene. 
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To determine whether feeding on human blood also causes upregulation of LRIM9, mosquitoes were 
fed through a membrane feeder on human blood warmed to 37 oC. Fed mosquitoes were then kept 
at their optimal rearing temperature of 27 oC, which is also consistent with infection with the human 
malaria parasite, P. falciparum. Hemolymph was collected after 8, 24, 48 and 72 h, with sugar fed 
mosquitoes used as “0 h”, and analysed by western blot using the LRIM9 antibody (Figure 5.11 A). 
Like with mouse blood, the LRIM9 protein showed a dramatic and very transient induction. 
Upregulation was faster with human blood, peaking at 24 h rather than 48 h for mouse blood, which 
is probably due to the different temperatures used to rear mosquitoes although it may also reflect 
batch-to-batch variation in mosquito fitness. In Chapter 4, variation in temporal LRIM9 induction was 
observed between mosquito batches, either 24 or 48 h. When LRIM9 band intensity was assessed 
semi-quantitatively and normalised to the SRPN3 control, LRIM9 was found to be upregulated over 
20-fold compared to sugar fed mosquitoes (Figure 5.11 B). In summary, mosquitoes responded 
similarly to murine and human blood, indicating that common mammalian blood components, 
formation of the blood bolus, distension of the gut or signalling occurring after blood feeding are 
likely to cause the upregulation of LRIM9. 
 
Figure 5.11  LRIM9 protein expression after feeding on human naïve blood.  
Mosquitoes were allowed to feed on human blood and hemolymph was collected after 8, 24, 48 and 72 
h. A) Hemolymph was analysed by western blot under non-reducing conditions and probed with α-
LRIM9. The blot was re-probed with α-SRPN3 as a loading control and α-LRIM2-300 to analyse the 
LRIM1/APL1C complex. Molecular weight markers are indicated (kDa). B) LRIM9 protein bands were 
measured semi-quantitatively and normalised to SRPN3. 
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LRIM9 expression in the midgut 
It was investigated whether LRIM9 is expressed in the mosquito midgut and exerts its role on 
malaria parasites from the midgut cells. Other parasite-killing immune proteins show midgut 
expression. For example, SRPN6 is specifically expressed by midgut cells after P. berghei invasion 
(Abraham et al., 2005). The LRIM9 transcript was monitored in dsGFP- or dsLRIM9-treated 
mosquitoes by qRT-PCR 24 h after a P. berghei infected blood meal in midguts and carcasses (with 
midgut removed) (Figure 5.12). LRIM9 was not or poorly expressed in midgut tissues before or 24 h 
after an infected blood meal, respectively, compared to corresponding carcass samples that showed 
strong LRIM9 expression. This correlates well with previous microarray findings that LRIM9 is most 
highly expressed in the fat body (Marinotti et al., 2005). Silencing efficiency of the LRIM9 transcript 
in the carcass was very high: 95% after sugar feeding and 91% after blood feeding. 
 
 
Figure 5.12  LRIM9 transcript levels in the midgut.  
Mosquitoes were injected with dsGFP (blue) or dsLRIM9 (pink) and, 3 days later, some were given a P. 
berghei infected blood meal whereas others were only sugar fed. After 24 h, midguts were dissected 
and RNA was extracted from 20 guts per group. qRT-PCR was used to analyse LRIM9 expression, using 
S7 for normalisation. 
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LRIM9 and TEP1-mediated parasite killing 
Members of the TEP family of complement C3-like proteins have been shown to interact with LRIMs 
(Povelones et al., 2011; Povelones et al., 2009). The LRIM1/APL1C complex is involved in parasite 
killing through its interaction with complement-like effector protein, TEP1. The complex binds to the 
cleaved form of TEP1, promoting its stabilisation, preventing it from reacting with self-tissues and 
enabling it to opsonise P. berghei parasites (Fraiture et al., 2009; Povelones et al., 2009). 
To investigate whether LRIM9 plays a role in TEP1-mediated parasite killing, it was first examined 
whether LRIM9 interacts with TEP1 or LRIM1/APL1C. Binding assays were performed using 
recombinant His-tagged LRIM9 expressed in Sua4.0 cells, a hemocyte-like cell line that naturally 
secretes endogenous TEP1, LRIM1 and APL1C (Povelones et al., 2009) (Figure 5.13). A recombinant 
secreted His-tagged GFP was used as a negative control whereas His-tagged LRIM1 and APL1C were 
used as positive controls. Expression of the recombinant proteins in the starting conditioned media 
was determined by western blot detection of the His-tag to ensure equivalent amounts of protein 
were used for the binding assay since expression varied between the different proteins, despite 
being driven by the same viral promoter. His-tagged proteins and their interacting partners were 
affinity-captured from the conditioned media using cobalt-charged beads. Protein interactions were 
analysed in the captured material by probing western blots with TEP1, LRIM1 and APL1C antibodies.  
As observed previously (Povelones et al., 2009), His-tagged LRIM1 and APL1C were able to interact 
with their endogenously expressed partner either as a monomer or homodimers. In addition, both 
recombinant LRIM1 and APL1C captured endogenous TEP1cut. In contrast, no interaction was 
observed between His-tagged LRIM9 and endogenous TEP1, LRIM1 or APL1C. However, it cannot be 
ruled out that LRIM9 requires a partner to interact with TEP1, LRIM1 or APL1C and this partner is not 
produced by Sua4.0 cells. 
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Figure 5.13  Binding assay to test interactions between LRIM9 and TEP1, LRIM1 and APL1C.  
Conditioned media (CM) was collected 3.5 days after transfection of Sua4.0 cells with secreted GFP 
(sGFP), LRIM9, APL1C and LRIM1 constructs. His-tagged proteins and any interacting partners were 
captured from the conditioned media using metal affinity beads. Starting conditioned media (left 
panels) and bound material (right panels) were analysed by non-reducing western blot. One blot was 
incubated with the His probe (top panels). A second blot was probed with an antibody against TEP1 
(middle panels) and re-probed with antibodies against LRIM1 and APL1C (bottom panels). Molecular 
weight markers are indicated (kDa). 
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Even though LRIM9 did not physically interact with known members of the mosquito complement-
like cascade, western blotting of hemolymph was performed to determine whether LRIM9 
functionally interacts with these proteins. In the absence of LRIM1 or APL1C, TEP1cut is depleted 
from the hemolymph (Povelones et al., 2009). Using a C-terminal TEP1 antibody, TEP1-F and TEP1cut 
were both detected in GFP and LRIM9 knockdown hemolymph whereas TEP1cut was specifically 
depleted after LRIM1 knockdown (Figure 5.14 A). This suggests LRIM9 is not involved in the 
transcription, processing, stabilisation or activity of TEP1 in naïve mosquitoes. Antibodies against 
LRIM1 and APL1C, which both detect the LRIM1/APL1C complex under non-reducing conditions, 
demonstrated good silencing efficiency of the complex in the LRIM1 knockdown. 
Given the strong increase in LRIM9 protein upon blood feeding, it was hypothesised that LRIM9 may 
not be functional in the hemolymph until after the mosquito has blood fed. To examine this 
possibility, hemolymph was collected 24 h after a blood meal to ensure that sufficient LRIM9 was 
present and active (Figure 5.14 B). Blood fed mosquitoes were incubated at 27 oC to ensure 
optimum mosquito physiology. LRIM1/APL1C and LRIM9 were silenced efficiently in their respective 
knockdowns at the protein level, using the appropriate antibodies. However, like in the naïve 
hemolymph, LRIM9 knockdown had no effect on levels of TEP1-F and TEP1cut. Furthermore, there 
was no difference in the abundance of LRIM9 protein in the dsGFP- and dsLRIM1-treated 
mosquitoes, revealing that knockdown of the LRIM1/APL1C complex and concomitant loss of TEP1cut 
does not affect LRIM9 protein induction following blood feeding (Figure 5.14 B). 
In support of these data, an initial experiment found that LRIM9 knockdown did not affect TEP1 
localisation to the surface of P. berghei parasites during an infection (Figure 5.15). Although only a 
single experimental replicate, this result is consistent with the other findings and suggests that 
LRIM9 does not interact with TEP1 or affect its stability or activity. 
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Figure 5.14  Investigating the involvement of LRIM9 in TEP1 activity in the hemolymph.  
Hemolymph was collected from naïve (A) and blood fed (B) mosquitoes after injection with dsGFP, 
dsLRIM1 and dsLRIM9. Samples were analysed by non-reducing western blot using α-TEP1, α-SRPN3, α-
LRIM1, α-APL1C and α-LRIM9 antibodies. 
 
 
 
Figure 5.15  TEP1 localisation to P. berghei ookinetes after LRIM9 silencing.  
Midguts were dissected from dsGFP-, dsTEP1- and dsLRIM9-treated mosquitoes 27-30 h after infection 
with GFP-expressing P. berghei. The blood meal was carefully removed and midgut epithelia were 
stained with TEP1 antibody and an Alexa Fluor 546 conjugated secondary antibody. A representative 
photograph was taken per gut and the number of GFP-labelled (live) and TEP1-labelled (dead) parasites 
were counted. In a single experiment, 7, 5 and 4 guts were analysed for dsGFP, dsTEP1 and dsLRIM9, 
respectively. The graph shows the mean percentage of GFP-labelled (green) and TEP1-labelled (red) 
parasites with standard error bars. 
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It was previously established that TEP1-F is lost in the hemolymph after challenge with bacterial 
bioparticles (see Appendix Figure 9.2). Bioparticles are heat-killed bacteria which are very 
convenient for assaying rapid responses of complement proteins without the complication of 
bacterial proliferation. It was examined whether LRIM9 silencing affects the depletion of TEP1-F 
after E. coli bioparticles challenge (Figure 5.16). Western blot analysis was performed on hemolymph 
collected 2 h after challenge with bioparticles, the time point with the strongest effect on TEP1. 
LRIM9 silencing had no effect on TEP1-F or TEP1cut. As observed previously, there was cross-
reactivity with E. coli proteins in the SRPN3 control, resulting in a fuzzy band, because this antibody 
was raised against a SRPN3 protein fragment produced in E. coli. 
 
 
Figure 5.16  TEP1 protein levels after E. coli bioparticle challenge after LRIM9 silencing.  
Mosquitoes were injected with dsGFP, dsLRIM9 and dsLRIM1. After 4 days, hemolymph was collected 
from half these mosquitoes (naïve) and half were injected with E. coli bioparticles and hemolymph was 
collected 2 h post challenge (Ec BP). Samples were analysed by non-reducing western blot, probing 
with α-TEP1 and α-SRPN3 antibodies. Molecular weight markers are indicated (kDa). 
 
LRIM9 and other TEP family members 
It was next examined whether LRIM9 might function together with other TEP family members in 
eliminating invading P. berghei parasites. Apart from TEP1, the LRIM1/APL1C complex has been 
shown to interact with TEP3, TEP4 and TEP9 in the conditioned media of An. gambiae cultured cells 
(Povelones et al., 2011). Of these proteins, TEP3 and TEP4 also emerged as interesting candidates 
from the transcriptional profiling presented in Chapter 4. They were induced by a broad spectrum of 
pathogens, including P. berghei, P. yoelii, P. falciparum, ONNV (especially by oral infection), bacteria 
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and fungi. This suggests that TEP3 and TEP4 are important core immune genes with a generalised 
role in mosquito defence.  
To investigate potential interactions between LRIM9 and TEP3 and/or TEP4, it was attempted to 
create C-terminal antibodies against TEP3 and TEP4, using the same approach that produced the C-
terminal TEP1 antibody. Fusion proteins of TEP3 and TEP4 C-terminal fragments with GST were 
generated and sequence verified. Plasmids containing the GST-fusion proteins were transformed 
into BL21-pLysS cells, which are IPTG inducible and excellent for protein expression. Unfortunately, 
small and large scale IPTG inductions and His purifications were unsuccessful. The C-terminal 
fragments were poorly induced and not very soluble under both native and denaturing conditions 
(data not shown). Due to time constraints, this problem was unable to be resolved. Peptide 
antibodies previously generated in the laboratory were not successful. 
In the absence of antibodies against TEP3 and TEP4, phenotypic analyses were carried out to 
investigate whether knockdown phenotypes of TEP3 and TEP4 are similar to that of LRIM9, i.e. 
significant increase of P. berghei oocysts and inhibition of parasite melanisation in susceptible 
mosquitoes, but no effect on parasite melanisation in CTL4 knockdown mosquitoes. This could 
suggest a functional relationship between LRIM9 and TEP3 and/or TEP4. The following findings were 
recently published (Povelones et al., 2011). 
TEP3 and TEP4 were silenced alongside known antagonist TEP1 in susceptible mosquitoes to 
investigate the effect on P. berghei development (Figure 5.17). The results showed that TEP3 is a 
Plasmodium antagonist, like LRIM9. TEP3 silencing resulted in a highly significant increase in 
developing oocysts. The increase of median infection intensity after dsTEP3-treatment was higher 
than dsLRIM9 but much lower than dsTEP1, which was more comparable to dsLRIM1. There was a 
modest trend towards more oocysts after TEP4 silencing but the increase was not statistically 
significant. 
To further investigate the phenotypic relationship between LRIM9, TEP3 and TEP4, they were 
silenced in double knockdowns with CTL4, a known inhibitor of P. berghei melanisation (Figure 5.18). 
In this experiment, the GFP/CTL4 knockdown showed increased melanisation and fewer developing 
oocysts compared to the GFP/GFP control. TEP1/CTL4 knockdown fully reversed the CTL4 
phenotype, greatly increasing the number of live oocysts and completely abolishing ookinete 
melanisation. TEP3/CTL4 knockdown gave an intermediate phenotype whereby numbers of live 
oocysts increased whilst maintaining high levels of melanisation. Silencing TEP4/CTL4 caused no 
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significant change in either live oocysts or melanised ookinetes compared to GFP/CTL4, although 
there was a marginal non-significant increase in ookinete melanisation.  
 
 
 
Figure 5.17  The effect of TEP3 and TEP4 knockdown on P. berghei development.  
TEP3 and TEP4 were silenced, mosquitoes were infected with GFP-expressing P. berghei and parasite 
load was monitored after 7 days. GFP and antagonist TEP1 were used as controls. Horizontal lines 
indicate the median parasite number and all significant results (P < 0.05, Mann Whitney U-test) are 
highlighted. A representative experiment of three independent biological replicates is shown. A) Live 
oocyst counts. B) Melanised (killed) ookinete counts. 
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Figure 5.18  Double knockdowns of CTL4 with TEP3 and TEP4.  
TEP3 and TEP4 were silenced using RNAi in double knockdowns with CTL4, a known inhibitor of parasite 
melanisation. Mosquitoes were infected with fluorescent P. berghei and parasite load was monitored 
after 7 days. Double knockdowns of GFP/GFP, GFP/CTL4 and TEP1/CTL4 were used as controls. All 
significant results (P < 0.05, Mann Whitney U-test) are highlighted. Results shown are representative of 
two independent biological replicates. A) Live oocyst counts. B) Melanised (killed) ookinete counts. 
 
Involvement of LRIM9 in antibacterial defence 
As LRIM9 responds strongly to blood feeding, it was examined whether it functions in antibacterial 
defence. Although the blood meal itself is sterile, the influx of nutrients upon blood feeding causes 
dramatic proliferation of endogenous bacteria within the mosquito midgut (Kumar et al., 2010; 
Meister et al., 2009). The midgut undergoes extreme distension, which could damage the gut 
epithelia and allow midgut bacteria to invade the hemolymph, leading to systemic infection. The 
mosquito innate immune system constitutively and actively controls midgut bacterial load (Dong et 
al., 2009). Thus, LRIM9 induction after blood feeding might be a response to signalling triggered by 
the increase in midgut bacteria or detection of bacteria in the hemolymph. Parasite melanisation is 
also dependent on levels of commensal bacteria (Fanny Turlure, personal communication), which 
strengthens the hypothesis given the previously described role for LRIM9 in parasite melanisation. 
To test this hypothesis, it was investigated whether LRIM9 knockdown affects mosquito survival 
after E. coli injection. Although E. coli is not a natural pathogen of An. gambiae, it is a typical gram-
negative bacterium and conveniently ampicillin-resistant. LRIM9 was silenced by RNAi, mosquitoes 
were injected with live E. coli 4 days later and survival monitored for 10 days. In naïve (non-blood 
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fed) mosquitoes, LRIM9 knockdown had no significant effect on mosquito survival compared to the 
dsGFP control (Figure 5.19 A), using the Log-rank (Mantel-Cox) test. Silencing the positive control, 
LRIM1, which has a known role in defence against E. coli infection (Moita et al., 2005), resulted in 
significantly higher mosquito mortality compared to dsGFP. As LRIM9 was present at low levels in 
the hemolymph before blood feeding, the survival assay was repeated using mosquitoes that were 
blood fed 24 h before E. coli injection (Figure 5.19 B). Again, LRIM9 knockdown did not affect 
mosquito survival indicating that LRIM9 does not protect mosquitoes from dying during an E. coli 
infection in both naïve and blood fed mosquitoes. 
 
Figure 5.19  Survival after E. coli injection in naïve and blood fed mosquitoes.  
A) Mosquitoes were injected with dsGFP, dsLRIM9 and dsLRIM1 and inoculated with live E. coli 4 days 
later. Mosquito survival was monitored daily for 10 days. Survival was compared to dsGFP using the 
Log-rank (Mantel-Cox) test (*** = P-value < 0.0001). B) As above, but mosquitoes were blood fed 24 h 
prior to E. coli injection. 
155 
 
Since survival is not always connected with bacterial proliferation (Ayres et al., 2008), it was 
investigated whether LRIM9 affects bacterial proliferation when E. coli is injected into the hemocoel 
(Figure 5.20). GFP, LRIM9 and LRIM1 were silenced and mosquitoes were inoculated with live 
ampicillin-resistant E. coli. After 24 h, batches of 10 mosquitoes were surface-sterilised, washed and 
homogenised. The resulting suspension was plated onto ampicillin agar, incubated overnight at 37 oC 
and colonies were counted the next day to measure bacterial proliferation. Uninjected mosquitoes 
were homogenised as additional controls and showed no colony formation on ampicillin plates. The 
results showed that LRIM9 knockdown had no significant impact on proliferation of injected E. coli 
compared to control dsGFP-treated mosquitoes (P-value = 0.804, Meta-Analysis). A sample of the 
injected bacteria was plated to ensure comparable viability between experiments. In contrast, LRIM1 
knockdown resulted in a consistently higher number of CFU per mosquito.  
 
 
 
Figure 5.20  The effect of LRIM9 knockdown on bacterial proliferation.  
Mosquitoes were injected with dsGFP, dsLRIM9 and dsLRIM1 and after 4 days inoculated with live 
ampicillin-resistant E. coli. After 24 h, batches of 10 mosquitoes were collected per group, surface-
sterilised, homogenised and plated onto ampicillin agar. After incubation at 37 
o
C overnight, CFU were 
counted. Mean CFU per mosquito from three independent experiments is shown, with standard error 
bars. dsLRIM9 and dsLRIM1 were compared to dsGFP using Meta-Analysis (*** = P-value < 0.0001). 
 
Antibiotics were used to investigate whether LRIM9 upregulation after blood feeding is dependent 
on the massive proliferation of midgut bacteria. It was hypothesised that antibiotics would prevent 
the induction of LRIM9. Mosquitoes were fed on a spectrum of antibiotics dissolved in sterile sugar 
to significantly reduce their midgut flora. To confirm antibiotic efficacy, surface-sterilised 
mosquitoes were homogenised and plated on agar. The antibiotics were very effective at 
significantly reducing the midgut flora. Four days into the treatment, some mosquitoes were allowed 
to blood feed whereas others were only given antibiotic sugar. Hemolymph was collected 24 h later 
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and analysed by non-reducing western blot (Figure 5.21 A) for LRIM9 and SRPN3. Untreated 
mosquitoes, which were fed sterile sugar with or without blood feeding, acted as controls. LRIM9 
was low in sugar fed hemolymph irrespective of antibiotic treatment. Interestingly, LRIM9 was still 
dramatically induced at the protein level after blood feeding, even with a significantly reduced 
midgut flora. This suggests that the upregulation of LRIM9 after blood feeding is independent of the 
endogenous bacteria. 
In Chapter 4, E. coli or S. aureus injection did not affect LRIM9 transcript levels. It was decided to 
verify this result at the protein level by collecting hemolymph 24 h after injection of live E. coli or S. 
aureus. Hemolymph was analysed by western blot under non-reducing conditions and probed with 
antibodies against LRIM9 and SRPN3 (Figure 5.21 B). LRIM9 protein was not upregulated after E. coli 
or S. aureus injection, consistent with the transcriptional results. Levels of LRIM9 in the hemolymph 
were comparable to naïve mosquitoes. Even the injury at the site of injection did not affect LRIM9. 
Therefore, LRIM9 did not respond to bacteria at both the transcript and protein level. Overall, it can 
be concluded that LRIM9 is unlikely to be involved in antibacterial immunity. 
 
Figure 5.21  The effect of antibiotics and bacterial injection on LRIM9 expression.  
A) Newly emerged mosquitoes were fed either sterile sugar solution (No Ab) or a cocktail of antibiotics 
dissolved in sugar (+ Ab) for the entire experiment. After 4 days of treatment, mosquitoes were either 
fed on naïve blood or kept on sugar. 24 h later, hemolymph was collected and analysed by non-
reducing western blot, probing with α-LRIM9 and α-SRPN3 antibodies. B) Hemolymph was collected 
from naïve mosquitoes 24 h after injection with live E. coli or S. aureus. Samples were analysed by 
western blot and probed with α-LRIM9 and α-SRPN3 antibodies. Molecular weight markers are shown 
(kDa) and LRIM9 is indicated with a red arrowhead. 
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LRIM9 and the melanisation pathway 
After showing an interesting parasite melanisation phenotype, it was decided to investigate the 
functional role played by LRIM9 in melanisation, a powerful innate immune response of arthropods 
(Cerenius and Soderhall, 2004; Christensen et al., 2005; Jiravanichpaisal et al., 2006). Melanisation is 
triggered by a clip-domain serine protease cascade that culminates in proteolytic activation of the 
inactive PPO into the active PO. Active PO then catalyses the rate-limiting step in the production of 
melanin that is deposited on the surfaces of invading parasites and pathogens and at tissue wound 
sites, crosslinking surrounding proteins. CLIPA8, a noncatalytic clip-domain SPH, is a vital regulator of 
PO activation in An. gambiae. It is essential for ookinete and bacterial melanisation (Schnitger et al., 
2007; Volz et al., 2006). CLIPA8 circulates in the hemolymph and is rapidly activated by cleavage 
after wounding and bacterial challenge (Schnitger et al., 2007). It has been shown to bind to the 
surface of bacteria (Hassan Yassine, personal communication). 
Firstly, it was examined whether CLIPA8 activation requires LRIM9 (Figure 5.22). To this end, 
mosquitoes were injected with dsGFP, dsLRIM9, dsTEP1 or dsLRIM1. TEP1 and LRIM1 used as 
positive controls because both have striking effects on CLIPA8 activation cleavage. TEP1 silencing 
blocks CLIPA8 cleavage whereas LRIM1 silencing leads to spontaneous CLIPA8 cleavage, even in 
unchallenged mosquitoes (Michael Povelones, personal communication). Four days after injection of 
dsRNA, hemolymph was collected from naïve mosquitoes (dsRNA injected only) and 2 h after 
injection with S. aureus bioparticles (heat-killed bacteria). S. aureus was chosen because it is a 
potent inducer of CLIPA8 cleavage (Schnitger et al., 2007). Western blot analysis of hemolymph 
under reducing conditions was performed using a CLIPA8 monoclonal antibody. In dsGFP-treated 
mosquitoes, only a 47 kDa band was observed in naïve hemolymph, which corresponds to full-length 
CLIPA8. After S. aureus challenge, a cleaved form of CLIPA8 at 38 kDa was also detected. 
Interestingly, the full-length CLIPA8 was less abundant after S. aureus challenge, probably due to 
CLIPA8 cleavage and binding of CLIPA8 to bacterial surfaces and mosquito tissues. CLIPA8 appeared 
unchanged by LRIM9 silencing compared to GFP silencing. As expected, TEP1 silencing blocked 
CLIPA8 cleavage after S. aureus challenge and full-length CLIPA8 was very strong in both lanes. There 
was mild spontaneous cleavage observed after LRIM1 knockdown, in both naïve and challenged 
hemolymph, which was not further enhanced by S. aureus. Interestingly, compared to the dsGFP-
treated control group, full-length CLIPA8 was considerably less abundant in hemolymph isolated 
from both naïve and S. aureus challenged dsLRIM1-treated mosquitoes. Therefore, these data 
suggest LRIM9 is not involved in CLIPA8 activation. The blot was re-probed with antibodies against 
TEP1 and LRIM9, which both revealed good knockdown efficiencies. As seen in Figure 5.16, LRIM9 
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was also not involved in the loss of TEP1-F after bioparticle challenge. LRIM9 was unchanged in the 
hemolymph after bioparticle challenge. 
 
Figure 5.22  Investigating the involvement of LRIM9 in CLIPA8 activation cleavage.  
Mosquitoes were injected with dsGFP, dsLRIM9, dsTEP1 and dsLRIM1. After 4 days, hemolymph was 
collected from half these mosquitoes (naïve) and half were injected with S. aureus bioparticles and 
hemolymph was collected 2 h post challenge (Sa BP). Hemolymph was normalised to 1.5 
mosquitoes/µL (to boost CLIPA8 signal) and analysed by reducing western blot. The blot was probed 
with α-CLIPA8, α-SRPN3, α-LRIM9 and α-TEP1 antibodies. This blot is representative of two 
independent experiments. 
 
It was next investigated whether LRIM9 functions downstream of CLIPA8 in the melanisation 
pathway and affects PO activation. To test this, live bacteria were injected into the hemocoel of 
dsGFP, dsLRIM9 and dsLRIM1 mosquitoes and hemolymph was collected 5 h after injection (Figure 
5.23). Equivalent amounts of hemolymph proteins were incubated with L-DOPA, a key PO substrate, 
and absorbance at 490 nm was measured at kinetic intervals. Absorbance at 490 nm detects 
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dopachrome production by PO and gives an indication of systemic melanisation after bacterial 
challenge.  
Despite variation between replicates, there was significant indication that LRIM9 knockdown 
reduces PO activity. Hemolymph from dsGFP controls showed consistently high PO activity after 
bacterial challenge, with dopachrome production continuing to increase throughout the 90 minute 
assay. In the first replicate using naïve non-blood fed mosquitoes, LRIM9 knockdown blocked PO 
activity to the same extent as LRIM1, a known regulator of melanisation (Figure 5.23 A). In the 
second replicate, LRIM9 silencing inhibited PO activity but did not completely block activity to basal 
levels like LRIM1 silencing (Figure 5.23 B). Next, the assay was repeated using blood fed mosquitoes 
to determine whether boosting LRIM9 concentration would make the effect of LRIM9 more 
pronounced. Although basal PO activity was higher after blood feeding and the resolution poorer, a 
similar trend was observed (Figure 5.23 C). LRIM9 silencing reduced PO activity without blocking it. It 
was concluded that LRIM9 knockdown partially inhibits PO activity, even after blood feeding. 
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Figure 5.23  LRIM9 and phenoloxidase activity.  
PO enzymatic activity was measured in hemolymph from dsGFP, dsLRIM9 and dsLRIM1 injected 
mosquitoes 5 h after injection of E. coli and S. aureus. To measure PO activity, hemolymph was 
normalised for protein content and incubated with L-DOPA, the substrate of PO. Absorbance at 490 nm 
(OD 490) was measured at kinetic intervals of 10 minutes. A) Replicate 1 in naïve mosquitoes. B) 
Replicate 2 in naïve mosquitoes, including untreated mosquitoes (not challenged with bacteria) to 
show basal activity. C) Replicate 3 in mosquitoes challenged 24 h after blood feeding. 
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Tissue melanisation at the site of wounding is another distinct insect defence response. It plays a 
physiological role in wound healing and cuticle sclerotisation (Asano and Ashida, 2001a, b). In Ae. 
aegypti, it has been reported that immune melanisation and tissue melanisation have distinct 
mechanisms of PPO activation (Zou et al., 2010). In fact, CLIPA8 is dispensable for wound 
melanisation (Schnitger et al., 2007), which suggests a similar system in An. gambiae. To determine 
whether LRIM9 influences tissue melanisation, dsRNA-treated mosquitoes were pricked with a 
sterile needle 24 h after blood feeding. Melanisation of the epidermis at the site of injury was 
visualised in immobilised mosquitoes 24 h later. Wound melanisation was equally efficient in dsGFP 
and dsLRIM9 mosquitoes, suggesting that LRIM9 is not involved in this process (Figure 5.24). 
 
Figure 5.24  The effect of LRIM9 knockdown on tissue melanisation.  
Mosquitoes were blood fed 3 days after dsGFP or dsLRIM9 injection. 24 h later, mosquito thoraxes 
were pricked several times with a sterile needle. The thoraxes of live immobilised mosquitoes were 
imaged 24 h after wounding. White arrowheads indicate sites of tissue melanisation. The scale bar in 
the top left panel represents 100 µM. 
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LRIM9 and mosquito fecundity 
Female mosquitoes take a blood meal to obtain nutrients that activate egg development (oogenesis) 
in their ovaries. In anautogenous mosquitoes, like An. gambiae, the reproductive system remains 
dormant until after blood feeding (Attardo et al., 2005; Hansen et al., 2004). A key physiological 
event in egg maturation is vitellogenesis, the production and secretion of yolk protein precursors 
(YPPs) by the fat body (Raikhel et al., 2002). Amino acids and lipids from a blood meal are 
transported through the midgut cells into the hemolymph where they stimulate the nutrient-
sensitive target of rampamycin (TOR) pathway (Hansen et al., 2004). This initiates YPP production, 
which are transported to the ovaries for oogenesis. Vitellogenesis is also regulated by the 
ecdysteroid hormone, 20-hydroxyecdysone. It has been previously shown that apolipophorin II/I 
(ApoII/I; also known as lipophorin) and vitellogenin, two key YPPs that transport nutrients to the 
developing mosquito oocytes, reduce the efficiency of TEP1-mediated parasite killing (Rono et al., 
2010). This demonstrates that there is a trade-off between mosquito immunity and reproduction. 
Modulating the immune response to block mosquito reproduction has exciting prospects for malaria 
control. 
As LRIM9 was so strongly induced by blood feeding, it was hypothesised that LRIM9 might play a role 
in mosquito fecundity. To examine this possibility, mosquitoes were allowed to mate in a large cage 
for 3 days before being injected with dsGFP or dsLRIM9 and blood fed 3 days later. After 72 h, 
individual blood fed females were placed in dishes with wet filter paper and encouraged to lay eggs 
in darkness for 24 h. The number of eggs laid and larvae hatched were counted (Table 5.2). A few 
mosquitoes from both treatment groups were dissected 72 h after blood feeding and, in both 
groups, the ovaries were well developed and the blood meal was well digested (data not shown).  
LRIM9 silencing had no impact on mosquito fecundity (Table 5.2). There was no significant difference 
between the number of eggs laid (P-value = 0.6842) and the number of larvae hatched (P-value = 
0.6596) between dsGFP and dsLRIM9, using the Mann Whitney U-test. Total eggs laid, mean eggs 
laid per female, proportion of eggs that hatched into larvae and percentage of fertile females (laying 
at least one egg and hatching at least one larva) were equivalent between dsGFP and dsLRIM9.  
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Table 5.2  The effect of LRIM9 knockdown on egg laying and larval hatching. 
Gene 
knockdown 
Females 
at start 
Females 
laid eggs 
Total 
eggs laid 
Mean 
eggs per 
female 
% 
Females 
laid eggs 
% 
Hatchability 
% Fertile 
females 
GFP 46 27 1809 67 59 62 50 
LRIM9 46 29 1958 68 63 64 52 
 
Mosquitoes were allowed to mate, treated with dsGFP and dsLRIM9 and then blood fed. After 72 h, 
individual females were placed in dishes with wet filter paper and encouraged to lay eggs in the dark. 
Eggs laid and larvae hatched were counted. % Hatchability is the percentage of eggs that hatched into 
larvae. Fertile females were defined as those that laid at least one egg and produced at least one larva.  
 
 
5.3 Discussion 
LRIM9 is a member of the LRIM family, a novel group of LRR-containing proteins exclusively found in 
mosquitoes. The family are predicted to be pathogen recognition proteins but most LRIMs are 
largely uncharacterised. The founding members of the family, LRIM1 and APL1C, are components of 
the An. gambiae complement-like system alongside the complement-like effector, TEP1 (Blandin et 
al., 2008; Fraiture et al., 2009; Povelones et al., 2009). These three proteins are powerful antagonists 
of Plasmodium infections of An. gambiae. In Chapter 4, LRIM9 was identified as a new P. berghei 
antagonist that was massively upregulated by naïve blood feeding. The role of LRIM9 in mosquito 
innate immunity and parasite killing was investigated in this Chapter. 
LRIM9 was discovered to be a novel antagonist of P. berghei infections of An. gambiae. Silencing 
LRIM9 in susceptible mosquitoes resulted in a 5-fold increase in live oocysts. The LRIM9 knockdown 
phenotype was less dramatic than LRIM1, APL1C or TEP1. This moderate phenotype cannot be 
explained by poor knockdown of the LRIM9 transcript as expression was demonstrated to be 
significantly reduced for at least 7 days after dsRNA injection. Alternatively, there could be 
independent pathways involved in parasite recognition and killing and impairing one pathway would 
have a moderate impact on parasite survival (Blandin et al., 2008). Furthermore, different parasite 
recognition pathways might take precedence depending on the basal immune status of individual 
mosquitoes. 
Evidence suggests that LRIM9 is not directly involved in the mosquito complement-like pathway. 
Recombinant LRIM9 did not interact with TEP1, LRIM1 or APL1C in binding assays in vitro. However, 
it cannot be excluded that LRIM9 requires another mosquito partner to enable interaction with 
TEP1/LRIM1/APL1C, which was not secreted by the mosquito cell line used. Also, recombinant LRIM9 
164 
 
may not have the same functional properties as the native protein. Unlike the LRIM1/APL1C 
complex, LRIM9 showed no involvement in TEP1 stability, processing or activity in naïve mosquitoes, 
after blood feeding and after injection of E. coli bioparticles. An initial experiment suggested that 
LRIM9 was not required for TEP1 localisation to the surface of P. berghei parasites. Together, this 
evidence implies that LRIM family members can exhibit different behaviours and can function in 
distinct immune pathways. 
TEP3 and TEP4 showed interesting transcriptional profiles and therefore were investigated as 
putative interacting partners of LRIM9. Phenotypic characterisation revealed that TEP3 is another 
novel antagonist of P. berghei infections of An. gambiae (Povelones et al., 2011), demonstrating a 
moderate phenotype similar to LRIM9. However, in double knockdowns with CTL4, TEP3 silencing 
results in a significant increase in live parasites without blocking melanisation. In contrast, LRIM9 
had no effect in CTL4 double knockdowns. By comparison, TEP4 silencing does not impact P. berghei 
infections in susceptible mosquitoes or when silenced alongside CTL4. TEP3 and TEP4 antibodies and 
in vitro binding assays are required to conclusively determine whether these TEPs function alongside 
LRIM9. Nonetheless, evidence so far suggests an interaction is unlikely. Both TEP3 and TEP4 are 
highly upregulated by bacteria, as shown in Chapter 4 and previous microarrays (Dimopoulos et al., 
2002; Dong et al., 2006a). Furthermore, TEP4 is required for survival of bacterial infections (Dong et 
al., 2006a) and is known to function in bacterial phagocytosis (Moita et al., 2005). In comparison, 
LRIM9 does not seem to be involved in antibacterial defence. Additionally, TEP3 and TEP4 interact 
with the LRIM1/APL1C complex in vitro and there is no evidence linking LRIM9 to the mosquito 
complement-like pathway.  
LRIM9 demonstrated an atypical role in melanisation. Its silencing reduced the intensity and 
prevalence of spontaneous parasite melanisation in susceptible mosquitoes. In refractory L3-5 
mosquitoes, which usually melanise virtually all invading ookinetes, LRIM9 knockdown resulted in a 
significant reduction in melanisation but no corresponding increase in live oocysts. In other words, 
parasites were not melanised but were still killed successfully. This was in contrast to the 
phenotypes of LRIM1, APL1C and TEP1, which fully reverse the refractory L3-5 phenotype: 
melanisation is blocked and there is a massive increase in live parasites (Blandin et al., 2004; 
Povelones et al., 2009). This suggests that parasite lysis and/or TEP1-mediated killing are blocked 
when LRIM1, APL1C or TEP1 are silenced but not when LRIM9 is silenced. Therefore, LRIM9 might be 
independent of these lysis/killing mechanisms, which correlates with the lack of evidence linking 
LRIM9 to the complement-like pathway. The unusual phenotype of LRIM9 knockdown in L3-5 
mosquitoes is shared by some other mosquito proteins: CLIPA8, ApoII/I, Frizzled2 (Fz2) and Cell 
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division cycle 42 (Cdc42) (Mendes et al., 2008; Shiao et al., 2006; Volz et al., 2006). CLIPA8, a non-
catalytic SPH, is an essential regulator of melanisation (Volz et al., 2006) and recent data place 
CLIPA8 downstream of the complement-like pathway (Hassan Yassine, personal communication). 
ApoII/I is a key nutrient transport protein that delivers lipids and fatty acids to various target tissues, 
including developing mosquito oocytes (Atella et al., 2006; Rono et al., 2010). Silencing ApoII/I in 
susceptible mosquitoes decreases oocyst levels by enhancing the efficiency of TEP1-mediated killing 
and aborts egg development (Mendes et al., 2008; Rono et al., 2010; Vlachou et al., 2005). Unlike 
LRIM9, silencing CLIPA8, Fz2 or Cdc42 does not affect oocyst levels in susceptible mosquitoes (Shiao 
et al., 2006; Volz et al., 2006).  
In susceptible mosquitoes, LRIM9 had no effect on parasite melanisation when silenced alongside 
CTL4, a known repressor of melanisation. This suggested there is no genetic interaction between 
LRIM9 and the CTL4 module. Even so, the increase in live oocysts usually seen upon LRIM9 silencing 
in susceptible mosquitoes was suppressed, which suggests CTL4 might be upstream of LRIM9 in the 
melanisation cascade. CTL4 is known to be downstream of TEP1 (Michael Povelones, personal 
communication). The function of melanisation is thought to vary depending on the mosquito genetic 
background. Interestingly, melanisation has been proposed as a killing mechanism after CTL4 
knockdown and a clearance mechanism of dead parasites in L3-5 mosquitoes (Volz et al., 2006). This 
suggests that LRIM9 might be involved in the disposal of parasites rather than killing per se. With its 
LRR domain, LRIM9 could recognise dead or dying parasites and promote their melanisation. For 
instance, LRIM9 might recognise parasites damaged by ROS or NO. In contrast to LRIM9, CLIPA8 is 
essential for melanisation in both L3-5 and CTL4 knockdown genetic backgrounds (Volz et al., 2006). 
CLIPA8 is activated by cleavage in response to injury and bacterial infection (Schnitger et al., 2007). 
Curiously, LRIM9 knockdown did not affect CLIPA8 cleavage after injection of S. aureus bioparticles, 
unlike TEP1 and LRIM1. This could mean that LRIM9 functions downstream of CLIPA8 in the 
melanisation cascade or LRIM9 might be involved in an unidentified tributary pathway, independent 
of CLIPA8 activation. Alternatively, LRIM9 could have a minor, regulatory role in melanisation that 
does not affect CLIPA8 cleavage. It would be informative to test whether LRIM9 knockdown inhibits 
CLIPA8 cleavage in L3-5 mosquitoes. 
LRIM9 was shown to influence the activity of PO, a fundamental enzyme required for melanin 
synthesis. LRIM9 knockdown partially inhibited PO activity, even after blood feeding. The extent of 
this inhibition varied between biological replicates from complete blockage to a reduction in PO 
activity. Apart from one biological replicate, the inhibitory effect of LRIM1 knockdown was more 
robust than LRIM9. LRIM1 and the complement-like pathway are master regulators of melanisation 
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(Warr et al., 2006) and so LRIM9 is likely to play a less central or partially redundant role in 
promoting melanisation. For instance, LRIM9 might improve the efficiency of melanisation without 
being essential. Furthermore, the An. gambiae genome encodes nine PPO genes (Christophides et 
al., 2002), which have distinct transcriptional profiles during mosquito development (Muller et al., 
1999). For example, PPO2, PPO3 and PPO9 are strongly induced after blood feeding (Christophides 
et al., 2004; Christophides et al., 2002; Muller et al., 1999). Perhaps LRIM9 only affects the activity of 
particular PPOs, such as those induced by blood feeding, which could explain the partial inhibition of 
PO activity. It should be noted that the PO assay is an artificial system that measures systemic 
melanisation in collected hemolymph after bacterial challenge. Melanisation is usually tightly 
controlled and only deployed in discrete locations to minimise self-damage from highly toxic 
intermediates (Christensen et al., 2005). Therefore, this assay does not conclusively prove that 
LRIM9 regulates PO activity on the parasite surface in vivo. 
LRIM9 knockdown had no effect on melanisation of cuticular wound sites or egg sclerotisation. 
Therefore, LRIM9 is probably only involved in immune melanisation. This is in agreement with recent 
studies suggesting immune and tissue melanisation have distinct pathways of PPO activation in Ae. 
aegypti (Zou et al., 2010). The same is thought to apply in An. gambiae as CLIPA8 is not required for 
wound melanisation but is critical for parasite and bacterial melanisation (Schnitger et al., 2007).  
LRIM9 was dramatically induced at the transcript and protein level 24 to 48 h after an uninfected 
blood meal. This correlated well with whole-genome transcriptomics analysis (Marinotti et al., 2005). 
Upregulation of LRIM9 proceeded faster at higher temperatures, which is probably due to increased 
metabolic rate. Analysis of hemolymph revealed that normally there were low levels of LRIM9 
circulating in naïve hemolymph and that its levels were massively boosted upon blood feeding. This 
is unusual for most mosquito immune proteins, which are typically constitutively expressed and 
secreted at high levels. For example, LRIM1 and APL1C are basally expressed at high levels and 
further upregulated during infection, perhaps to replenish utilised protein (Fraiture et al., 2009). It 
was hypothesised that LRIM9 is a blood feeding specific LRIM, which was reinforced by preliminary 
data suggesting it is very poorly expressed in larvae and pupae. The blood feeding hypothesis 
correlates well with previous microarrays showing significantly higher expression of LRIM9 in 
females than adult male mosquitoes (Baker et al., 2011; Koutsos et al., 2007; Marinotti et al., 2005). 
It is unknown whether LRIM9 is expressed at low levels in males or not expressed at all. Ongoing 
work is aimed at investigating further the developmental and sex specific expression patterns of 
LRIM9. 
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Blood feeding has a profound effect on mosquito physiology and several hypotheses were tested to 
explain the massive increase in LRIM9 after a blood meal. Firstly, the purpose of blood feeding is to 
provide amino acids and nutrients to enable egg development (Attardo et al., 2005). The mosquito’s 
vitellogenic period lasts until 30 h post blood feeding (Kokoza et al., 2001), which corresponds well 
with the LRIM9 induction. Secondly, a major consequence of blood feeding is a dramatic rise in 
levels of endogenous midgut bacteria, which subsequently must be controlled by the mosquito 
immune system (Cirimotich et al., 2010; Kumar et al., 2010; Meister et al., 2009). Therefore, it was 
predicted that LRIM9 could play a role in mosquito fecundity or antibacterial defence. However, 
LRIM9 silencing had no impact on the mosquito’s ability to produce eggs or viable larvae. LRIM9 
knockdown also had no effect on survival during E. coli infections (in both naïve and blood fed 
mosquitoes) or E. coli proliferation in the hemocoel. Furthermore, antibiotic treatment did not affect 
LRIM9 levels in the hemolymph after blood feeding. These results suggest that LRIM9 is probably not 
involved in mosquito reproduction or antibacterial responses. As bacteria are the predominant larval 
pathogens, the results correlate well with poor expression of LRIM9 in larvae. Although LRIM9 was 
not shown to be involved in tissue melanisation, a further hypothesis is that LRIM9 could be involved 
in injury responses caused by gut distension during blood feeding. This could be investigated by 
feeding mosquitoes low melting point agarose to mimic gut distension in the absence of blood 
feeding (Oliveira et al., 2011) and monitoring LRIM9 in the hemolymph. 
There was an intriguing discrepancy in LRIM9 expression at the transcript and protein level in naïve 
mosquitoes. Based on NanoString reporter counts, LRIM9 transcripts were very abundant in naïve 
mosquitoes and further upregulated upon blood feeding. In fact, the average reporter count for 
LRIM9 was ranked 8th highest of all genes tested. However, western blot analysis of hemolymph 
showed that LRIM9 was low in naïve hemolymph and dramatically boosted upon a blood meal. This 
is unlikely to be a technical issue with the NanoString probes because qRT-PCR analysis confirmed 
high levels of LRIM9 in naïve mosquitoes. The discrepancy between the transcript and protein might 
suggest that LRIM9 is subject to translational repression. There might also be a high turnover of 
LRIM9 protein in the hemolymph of naïve mosquitoes. Perhaps LRIM9 protein is constitutively 
produced at high levels but retained in fat body or hemocyte cell vesicles and secreted when 
required, such as upon blood feeding. The Anopheles PPOs are an interesting example of immune 
proteins that are constitutively expressed and sequestered in cytoplasmic granules of circulating 
oenocytoid hemocytes (Castillo et al., 2006). The majority of PPOs lack a signal peptide and are 
degranulated upon hemocyte activation (Castillo et al., 2006; Christophides et al., 2002). This allows 
melanisation activity to be tightly controlled, both spatially and temporally. To investigate whether 
LRIM9 is also sequestered, fat body and hemocytes collected before and after blood feeding should 
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be stained with the LRIM9 antibody to determine whether LRIM9 is sequestered in these cells and 
released upon blood feeding. It would be informative to undergo a more fine-tuned analysis of how 
LRIM9 transcript and protein levels change after blood feeding. For example, if hemolymph protein 
levels are regulated at the level of secretion, then LRIM9 protein should accumulate in the 
hemolymph at time points preceding transcriptional upregulation. 
Unlike LRIM1 and APL1C, LRIM9 was detected as a monomer in cell culture and in the hemolymph by 
non-reducing western blot. Therefore, LRIM9 does not seem to form stable, covalent homo- or 
heterocomplexes in vitro or in vivo. The LRIM family has a conserved pattern of cysteine residues 
between the LRR domains and the coiled-coil (Waterhouse et al., 2010). Mutational analyses 
revealed that the LRIM1/APL1C complex is held together by a covalent linkage between orthologous 
cysteine residues in LRIM1 (C352) and APL1C (C562) (Baxter et al., 2010; Povelones et al., 2011). 
These cysteines are directly opposite each other in the LRIM1/APL1C crystal structure (Baxter et al., 
2010) and are the last conserved cysteines in the characteristic LRIM pattern, immediately upstream 
of the coiled-coil domain (see Figure 5.1). Interestingly, LRIM9 is missing this cysteine, which is 
consistent with monomer formation although, as discussed in detail in Chapter 6, the position of the 
dimerising cysteine residue is very flexible (Povelones et al., 2011). Nevertheless, LRIM9 might 
interact non-covalently with other proteins or other LRIM9 molecules. These interactions are 
disrupted by denaturing SDS-PAGE analysis. To investigate LRIM9 protein interactions further, 
hemolymph should be analysed by gel filtration or native PAGE, which electrophoretically separates 
proteins under gentle non-denaturing conditions. His-tagged LRIM9 could be captured from the 
conditioned media of transfected mosquito cells. Proteins captured alongside LRIM9 could be 
separated by non-reducing SDS-PAGE, visualised by Coomassie staining and any interesting protein 
bands identified using mass spectrometry. This approach successfully revealed that the 
LRIM1/APL1C complex interacts with TEP3, TEP4 and TEP9 (Povelones et al., 2011). 
Immunoprecipitation is also an important tool for identifying interacting partners. In this approach, 
the LRIM9 antibody would be immobilised on beads and used to capture LRIM9 and any interacting 
partners from the hemolymph of blood fed mosquitoes. Protein bands specific to the LRIM9 
immunoprecipitation and not present in a control immunoprecipitation performed with pre-immune 
serum would be identified by mass spectrometry. Any candidate partners could be tested in direct 
binding assays performed in cell culture and for a knockdown phenotype similar to LRIM9 with P. 
berghei. 
The tissue localisation of LRIM9 expression is still an open question that warrants further 
investigation. Analysis of the LRIM9 transcript in An. gambiae midguts showed LRIM9 was poorly 
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expressed in the midgut, even after blood feeding. Although this needs to be confirmed at the 
protein level by western blot, this result was consistent with a previous microarray analysis that 
reported significantly higher expression of LRIM9 in the fat body compared to the midgut and 
ovaries (Marinotti et al., 2005). The fat body and hemocytes should be investigated as the probable 
source of LRIM9 expression and secretion. LRIM9 was not found to be enriched in circulating 
hemocytes (Pinto et al., 2009) but the majority of hemocytes are largely sedentary and attached to 
visceral surfaces, such as the trachea and Malpighian tubules (Blandin and Levashina, 2007). Most 
immune effectors, such as TEP1, LRIM1 and APL1C, are secreted by hemocytes and the fat body and 
encounter malaria parasites in hemolymph bathing the basal labyrinth (Blandin et al., 2004; Blandin 
et al., 2008; Frolet et al., 2006). The LRIM9 antibody could be used to analyse fat body samples by 
western blot and to stain hemocytes. 
The precise function of LRIM9 in mosquito immunity, particularly Plasmodium defence, remains 
unclear and requires further investigation. The characteristic LRR and coiled-coil domains of LRIM9 
are good indicators for involvement in pathogen recognition and interactions with other immune 
proteins (Waterhouse et al., 2010). The effect of LRIM9 on P. berghei development might be indirect 
and related to its putative role in melanisation. In Drosophila, melanisation has been shown to 
increase the efficiency of other immune reactions (Tang et al., 2006) and the same has been 
proposed in An. gambiae (Schnitger et al., 2007). Therefore, reduced efficiency of P. berghei parasite 
detection, killing or clearance could explain the moderate increase in infection intensity observed 
upon LRIM9 knockdown. To further investigate the role of LRIM9 in parasite defence, P. berghei 
infected midguts should be stained with the LRIM9 antibody to see if LRIM9 localises to parasite 
surfaces. In vitro ookinete binding assays could also be used to determine whether LRIM9 interacts 
directly with P. berghei parasites. To examine whether LRIM9 is involved in ookinete killing or 
clearance of dead ookinetes, numbers of live and dead ookinetes should be compared in GFP and 
LRIM9 knockdown mosquitoes 30 h after an infectious blood meal. To this end, midguts infected 
with the P. berghei CONGFP strain (Franke-Fayard et al., 2004) should be stained with an antibody 
against the P. berghei surface antigen, Pbs28. In this experiment, live parasites would show GFP 
fluorescence and Pbs28 staining whereas dead parasites would show only Pbs28 staining. The LRIM9 
antibody could also be used to determine if LRIM9 localises to the surface of live or dead parasites. 
Furthermore, many oocysts are known to die between 3 and 12 days post infection and then be 
cleared by the mosquito (Gupta et al., 2009; Dina Vlachou, personal communication). To elucidate 
whether LRIM9 plays a role in their disposal, the ratio of live to dead oocysts should be compared at 
days 4 and 10 post infection in GFP and LRIM9 knockdown midguts. If LRIM9 is involved, an 
accumulation of dead oocysts would be expected after LRIM9 is silenced. As P. berghei-An. gambiae 
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is an unnatural combination, the role of LRIM9 in P. falciparum infections should be investigated 
using RNAi to determine whether LRIM9 is also an antagonist of this important human pathogen. 
A favourable hypothesis is that LRIM9 is an immune factor induced in anticipation of blood-borne 
infections. The ability to anticipate infection is a novel concept in mosquito immunity. Some immune 
genes, like the complement-like pathway components, are constitutively expressed and 
permanently circulate in the hemolymph poised to defend against invaders (Frolet et al., 2006). This 
basal immunity provides a front-line of attack that is critical in antiparasitic responses. LRIM1, APL1C 
and TEP1 are subsequently induced by the Imd pathway, possibly to replenish utilised protein. Other 
immune genes are transiently induced upon detection of a pathogen, such as the induction of AMPs 
in response to a microbial infection (Lemaitre and Hoffmann, 2007). In contrast, LRIM9 is induced 
after blood feeding to defend against potential blood-borne invaders or dangers. Although vital for 
egg production, feeding on vertebrate blood potentially exposes mosquitoes to ingestion of 
parasites, viruses and other “foreign” substances. Plasmodium parasites and filarial worms both 
penetrate the mosquito midgut, resulting in considerable tissue damage (Aliota et al., 2011; Vlachou 
et al., 2006). Immunoglobulins and other host proteins could be detrimental to the mosquito and 
have even been found to permeate the gut into the hemolymph (Vaughan and Azad, 1988). 
Although blood is typically sterile, diseased vertebrates can be bacteremic and mosquitoes could 
become exposed to these bacteria upon blood feeding. As LRIM9 is induced after both uninfected 
and infected blood meals, this suggests it is upregulated in anticipation of infection rather than in 
response to infection. It is unknown whether LRIM9 is fully functional prior to blood feeding, 
although silencing LRIM9 inhibited PO activity in naïve hemolymph. It would be interesting to 
elucidate whether the same induction of LRIM9 occurs after multiple blood meals. It should also be 
determined whether LRIM9 orthologues are blood feeding specific in other mosquitoes, such as Ae. 
aegypti and C. quinquefasciatus. 
Using the genome-wide expression map available for An. gambiae (Maccallum et al., 2011), LRIM9 is 
found to cluster to the same node as vitellogenin, the major YPP that delivers nutrients to 
developing oocytes. Therefore, based on the extant microarray data, LRIM9 and vitellogenin are co-
regulated. Expression of both genes is significantly higher in females and induced 24 h after an 
uninfected blood meal (Baker et al., 2011; Koutsos et al., 2007; Marinotti et al., 2005). It is tempting 
to speculate that transcription of these two genes is under the same regulatory mechanism and the 
proteins function in the same pathway. However, LRIM9 and vitellogenin are located on different 
chromosomes (2L and 2R, respectively), so they are unlikely to share the same regulatory sequences. 
Vitellogenin is produced specifically by fat body and secreted into the hemolymph where it travels to 
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oocytes, is internalised and transformed into vitellin crystals (Clements, 2000). Vitellogenin is 
regulated by the steroid hormone, 20-hydroxyecdysone (20E), which is produced 10-36 h post blood 
feeding (Clements, 2000). The prohormone, ecdysone, is secreted by the ovaries and hydroxylated 
into 20E by the fat body (Clements, 2000). Interestingly, vitellogenin interferes with TEP1-mediated 
killing of Plasmodium parasites by reducing the efficiency of TEP1 binding to parasite surfaces (Rono 
et al., 2010). This is a clear example of a trade-off between immunity and reproduction. ApoII/I, a 
lipid transporter and YPP, is required for full induction of vitellogenin after blood feeding and 
indirectly impacts TEP1-killing (Rono et al., 2010). Like vitellogenin, ApoII/I is regulated by 20E and 
produced by the fat body (Sun et al., 2000). Exciting preliminary evidence indicates that LRIM9 is also 
under 20E regulation (Michael Povelones, personal communication). 20E regulation of immune 
genes has been observed previously and there seems to be a link between melanisation, 20E and 
vitellogenesis. Melanisation pathway components, such as PPO, are also under 20E regulation in 
Anopheles (Ahmed et al., 1999; Muller et al., 1999) and other blood feeding insects (Genta et al., 
2010). Furthermore, ApoII/I was shown to immunoprecipitate PPO2 in vitro (Rono et al., 2010). As 
mentioned earlier, LRIM9 and ApoII/I share the same knockdown phenotype in L3-5 mosquitoes 
(Mendes et al., 2008). However, unlike vitellogenin and ApoII/I, LRIM9 was not shown to be required 
for mosquito fecundity.  
An interesting hypothesis is that LRIM9 might inhibit vitellogenin or ApoII/I to readdress the balance 
between immunity and reproduction. After blood feeding, LRIM9 could reduce the activity of 
vitellogenin or ApoII/I, which increases the efficiency of TEP1 binding to ookinetes and parasite 
killing. In the absence of LRIM9, the activity of vitellogenin or ApoII/I could increase, which reduces 
the efficiency of TEP1 binding and results in more surviving oocysts (i.e. the LRIM9 knockdown 
phenotype). If the efficiency of TEP1 binding was reduced but not blocked, this could explain the 
moderate increase in oocysts upon LRIM9 knockdown. The only caveat to this hypothesis is an initial 
experiment showed LRIM9 did not affect TEP1 accumulation on P. berghei parasites. Therefore, this 
theory requires further investigation. To examine this hypothesis, epistasis experiments could be 
performed to explore any putative interactions between LRIM9, vitellogenin and ApoII/I. For 
example, the effect of vitellogenin or ApoII/I silencing on LRIM9 levels in the hemolymph could be 
investigated, and vice versa. Proteins captured from blood fed hemolymph using the LRIM9 antibody 
could be analysed by western blot, probing for vitellogenin or ApoII/I. It is unknown whether LRIM9 
is directly activated by the ecdysone receptor or indirectly via an ecdysone-regulated transcription 
factor. This could be resolved using an electrophoretic mobility-shift assay (EMSA). The 5' regulatory 
region of vitellogenin possesses a functional ecdysteroid-responsive element (EcRE) and the gene is 
both directly and indirectly regulated by 20E (Martin et al., 2001; Raikhel et al., 2002). It seems 
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parsimonious that LRIM9 is transcriptionally regulated by 20E, like vitellogenin (Kokoza et al., 2001). 
Alternatively, if LRIM9 is sequestered inside cells, 20E could trigger its release. LRIM9 is likely to be 
under additional forms of regulation because it is expressed at lower levels prior to blood feeding 
and 20E induction.  
Exploiting LRIM9 and its promoter could have exciting prospects for vector control. Blood meal 
inducible promoters are highly desirable for driving expression of anti-pathogen factors in GM 
mosquitoes, increasing refractoriness to blood-borne pathogens (Raikhel et al., 2002). With the help 
of a gene drive system, it is hoped these GM mosquitoes could replace natural populations and 
reduce disease transmission (Christophides, 2005). Overexpression of effectors can be deleterious to 
mosquito fitness (Marrelli et al., 2006) and the local ecology (Christophides, 2005) so it is 
advantageous to only express the desired gene after blood feeding. The LRIM9 promoter could be 
used to drive expression of an anti-Plasmodium effector in response to blood feeding in GM An. 
gambiae. This would be effective if LRIM9 is expressed at very low levels in naïve hemolymph and 
massively induced upon blood feeding (as shown by the antibody) rather than constitutively 
expressed and sequestered. The vitellogenin promoter has already been exploited to produce An. 
stephensi overexpressing REL2 after blood feeding, which enhanced resistance to P. falciparum 
infection (Dong et al., 2011). Ae. aegypti co-expressing the AMPs defensin and cecropin under the 
control of the vitellogenin promoter also blocked P. gallinaceum infection (Kokoza et al., 2010). If the 
LRIM9 promoter behaves similarly in Aedes and Culex, the same approach could be applied to 
arboviral control. Ae. aegypti expressing an anti-dengue effector transgene, Mnp, was recently 
shown to suppress dengue infection (Mathur et al., 2010). 
Alternatively, if LRIM9 is expressed at high levels in naïve females (as shown by the NanoString) but 
not in males, the LRIM9 promoter could be utilised for RIDL mosquito control strategies (Alphey et 
al., 2008; Labbe et al., 2012; Thomas et al., 2000). Preliminary NanoString data suggested that LRIM9 
transcription commences in late pupae. The LRIM9 promoter could be linked to a dominant lethal 
gene, resulting in death of female mosquitoes upon emergence as adults. Male mosquitoes would 
survive and could be released into the field to mate with wild females and pass on the lethal gene. 
As all female offspring would die and male offspring would continue to spread the lethal gene, this 
would suppress the natural vector population and reduce disease transmission. The lethal gene 
should be under tetracycline-dependent repression so mosquitoes can be reared to adulthood in the 
laboratory and females are killed in the absence of tetracycline (i.e. immediately prior to mosquito 
release and subsequently in the wild) (Thomas et al., 2000). The Ae. aegypti OX513A transgenic line 
173 
 
is the most successful example of a female-specific tetracycline-repressible dominant lethal and field 
trials are underway (Bargielowski et al., 2011; Harris et al., 2011; Phuc et al., 2007). 
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6 Functional analysis of other LRIMs 
6.1 Background 
The LRIMs are a novel mosquito-specific family recently discovered in the malaria vector, An. 
gambiae (Povelones et al., 2009; Waterhouse et al., 2010). The founding members, LRIM1 and 
APL1C, play a key role in killing malaria parasites via a TEP1-mediated pathway (Fraiture et al., 2009; 
Povelones et al., 2009). LRIM1 and APL1C circulate in the mosquito hemolymph as an obligate 
heterodimer and stabilise the mature form of TEP1 (Baxter et al., 2010; Povelones et al., 2011). The 
LRIM1/APL1C complex delivers TEP1 to the surface of P. berghei parasites, which labels the invaders 
for destruction by lysis and melanisation. 
The other 22 LRIMs were largely uncharacterised at the start of this PhD project. LRIM family 
members share similar protein domain architecture that comprises a signal peptide, a region of LRR 
domains, a conserved pattern of cysteines and an optional coiled-coil domain. There are four 
subfamilies of LRIMs based on variations to this core structure (Povelones et al., 2009; Waterhouse 
et al., 2010). Long LRIMs, including LRIM1 and APL1C, have 10 or more LRRs whereas Short LRIMs 
possess 6 or 7 LRRs. Transmembrane LRIMs have a predicted C-terminal transmembrane region. 
Coil-less LRIMs are missing the C-terminal coiled-coil domain but exhibit all other characteristics of 
the LRIM family. 
In this Chapter, a representative from each LRIM subfamily was further characterised to investigate 
its biochemical, functional and structural properties. It was hoped this would provide insights into 
the evolution and function of the LRIM family in mosquito immunity. LRIM4 (Long), LRIM17 (Coil-
less) and LRIM15 (Transmembrane) were chosen because of their interesting transcriptional profiles, 
as described in Chapter 4. LRIM4 and LRIM17 were also previously implicated in malaria parasite 
defence (Dong et al., 2006a). The representative Short subfamily member, LRIM9, was covered in 
detail in Chapter 5. Representatives of the Long subfamily, LRIM1 and APL1C, were previously 
characterised (Baxter et al., 2010; Fraiture et al., 2009; Povelones et al., 2011; Povelones et al., 
2009). 
LRIM4 is a typical Long LRIM, with 11 LRRs and two closely spaced coiled-coil domains (Waterhouse 
et al., 2010). As described in Chapter 4, LRIM4 showed strong basal expression and was upregulated 
by various challenges, including P. berghei, P. yoelii, P. falciparum, ONNV, bacteria and fungi; 
however, knockdown of LRIM4 had no effect on P. berghei development. In agreement, a previous 
study found LRIM4 (referred to as LRRD5) was significantly induced in the mosquito midgut upon P. 
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falciparum ookinete invasion (Dong et al., 2006a). However, the same report showed LRIM4 was not 
induced by P. berghei invasion, which conflicts with the data presented in Chapter 4. 
LRIM17 is the longest Coil-less LRIM and has previously been implicated in immune defence against 
P. falciparum, P. berghei and bacteria (Dong et al., 2006a; Dong et al., 2009; Garver et al., 2012). It 
has 13 LRRs and is without a coiled-coil domain (Waterhouse et al., 2010). LRIM17 has also been 
referred to in the literature as LRRD7 (Dong et al., 2006a; Dong et al., 2011; Dong et al., 2009) and 
APL2 (Riehle et al., 2006). It was originally identified together with APL1 in an Anopheles population 
survey as both mapped to a genetic locus that controls mosquito infections with P. falciparum 
(Riehle et al., 2006). With a similar transcriptional profile to LRIM4, LRIM17 was upregulated by a 
range of challenges in Chapter 4. The LRIM17 transcript was induced by P. berghei, P. yoelii, ONNV 
after blood feeding, bacteria and fungi but not P. falciparum. Interestingly, a previous microarray 
reported the opposite effect: LRIM17 was upregulated 8-fold in the midgut during P. falciparum 
invasion but not after P. berghei infection (Dong et al., 2006a). Previous RNAi experiments reported 
that LRIM17 is a major antagonist of P. berghei and P. falciparum in the An. gambiae Keele strain 
(Dong et al., 2006a). However, knockdown of LRIM17 in An. gambiae G3 strain did not result in any 
change in P. berghei infection (Riehle et al., 2006). Similarly, as shown in Chapter 4, LRIM17 silencing 
did not affect P. berghei development in the An. gambiae Yaoundé strain. Also in G3 mosquitoes, 
LRIM17 knockdown did not affect oocyst development after P. falciparum infection (Michael 
Povelones, personal communication). LRIM17 was also implicated in defence against opportunistic 
bacterial infection and gene silencing significantly increased bacterial load in the midgut (Dong et al., 
2009) and reduced survival to E. coli and S. aureus infections (Dong et al., 2006a). A previous 
microarray found it was only responsive to gram-negative and not gram-positive bacterial infection 
(Dong et al., 2006a). 
As LRIM4 and LRIM17 share a similar transcriptional profile in Chapter 4 (see Figure 4.3), it was 
hypothesised that these LRIMs may function together. Previous microarrays have shown that LRIM4 
and LRIM17 were induced after injection of ONNV virus (Waldock et al., 2012) and B. bassiana 
spores (Fanny Turlure, personal communication). The hypothesis that LRIM4 and LRIM17 work in the 
same biochemical pathway and interact, directly or indirectly, was investigated in this Chapter. 
Prior to this PhD project, relatively little was known about LRIM15. LRIM15 is the smallest of the 
Transmembrane LRIMs and possesses 13 LRRs (Waterhouse et al., 2010). Instead of the 
characteristic double cysteine motif, LRIM15 and the other Transmembrane LRIMs have a tyrosine-
cysteine motif. In Chapter 4, preliminary results indicated that LRIM15 was not a P. berghei 
antagonist. The LRIM15 transcript was induced by naïve blood feeding, Plasmodium (especially P. 
177 
 
berghei), conditioned media injection and ONNV. It was not responsive to E. coli, S. aureus or B. 
bassiana infection at the time points used. 
 
6.2 Results 
Recombinant LRIM4, LRIM15 and LRIM17 in insect cell culture 
Expression constructs for LRIM4, LRIM15 and LRIM17 were generated to facilitate their biochemical 
characterisation in order to elucidate whether any of these LRIMs formed complexes in vitro. LRIM4, 
LRIM15 and LRIM17 genes were cloned into the pIEx-10 insect expression vector, which adds an N-
terminal Strep-tag and a C-terminal His-tag. pIEx-10-LRIM4, -LRIM15 and -LRIM17 were transfected 
into Sf9 cells, which lack endogenous LRIM expression, to test for secretion and complex formation. 
pIEx-10-GFP (secreted GFP) and pIEx-10-LRIM9 were used as controls. Proteins in the conditioned 
media were analysed by western blot under non-reducing and reducing conditions, probing for His 
or Strep (Figure 6.1 A and B). Interestingly, LRIM4 migrated at approximately 124 kDa under non-
reducing conditions, which is the predicted size of a homodimer. Upon reduction, LRIM4 was 
detected as a monomer at approximately 62 kDa, which demonstrates that LRIM4 forms a 
disulphide-bonded homodimer in vitro. Lower molecular weight LRIM4 bands in the reducing blot 
were probably N-terminal cleavage products. Under both non-reducing and reducing conditions, 
LRIM17 migrated at approximately 51 kDa, consistent with the expected size of a monomer and 
comparable to LRIM9. LRIM15 was not detected in the conditioned media, which is consistent with 
the prediction that it is a transmembrane protein and not secreted. Subsequently, LRIM15 was 
detected as a monomer in cell lysate (Michael Povelones, personal communication).  
LRIM4 and LRIM17 constructs were next transfected into mosquito Sua4.0 cells, which secrete an 
array of hemolymph proteins, to determine whether they interact with other mosquito proteins. As 
LRIM4 and LRIM17 have a similar transcriptional profile and showed expression-based clustering in 
Chapter 4, it was predicted that they might function together. LRIM4 and LRIM17 were co-
transfected to elucidate whether they form a heterocomplex. Functional partners LRIM1 and APL1C 
were co-transfected as a positive control of heterocomplex formation. Conditioned media were 
analysed by non-reducing western blot using the His probe (Figure 6.1 C). Again, LRIM4 was 
expressed as a homodimer, although expression levels were much lower than in Sf9 cells. LRIM17 
migrated predominantly as a monomer but a fainter band was visible at approximately 150 kDa after 
His purification, which could be a LRIM17 trimer or indicate interaction with another protein (data 
not shown). However, this could also be an artefact of overexpression in vitro. No disulphide-bonded 
complex between LRIM4 and LRIM17 was observed in the co-transfection as only the LRIM17 
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monomer and LRIM4 homodimer were detected. However, this does not rule out a non-covalent 
interaction between the two proteins. 
Using a strategy similar to that described for LRIM9, a whole protein polyclonal antibody was 
generated against recombinant LRIM4. Using this antibody, LRIM4 was also shown to circulate as a 
disulphide-bonded homodimer in hemolymph (Figure 6.1 D). A fainter higher molecular weight band 
was also visible in both hemolymph and after His purification from Sf9 conditioned media, which 
could represent a tetrameric complex (a dimer of homodimers). 
 
Figure 6.1  LRIM4 and LRIM17 expression in cell culture and hemolymph.  
LRIM4, LRIM15 and LRIM17 were cloned into pIEx-10, transfected into Sf9 or Sua4.0 cells and 
conditioned media were collected after 3 days. pIEx-10-GFP and -LRIM9 were used as controls. A) 
Conditioned media from Sf9 cells were analysed by western blot under non-reducing (NR) conditions 
with the His probe. B) The same samples were analysed under reducing (R) conditions with a Strep 
antibody. C) pIEx-10-LRIM4 and -LRIM17 were transfected into Sua4.0 cells, both separately and co-
transfected to test for an interaction. LRIM1 and APL1C were co-transfected as an additional control for 
heterocomplex formation. Conditioned media were analysed by NR western blot using the His probe. 
D) Hemolymph and His purified recombinant LRIM4 (from Sf9 cells) were analysed by NR western blot 
using an LRIM4 antibody (this blot was kindly provided by Michael Povelones). 
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Analysing the role of cysteine residues in LRIM4 homodimerisation 
The role of the cysteine residues in LRIM4 homodimer formation was investigated. The LRIM1/APL1C 
heterodimer is held together by a disulphide bond between LRIM1 C352 and APL1C C562 (Baxter et 
al., 2010; Povelones et al., 2011). These homologous cysteines are found just N-terminal to the 
coiled-coil domain, as highlighted by yellow stars in Figure 6.2 A. Mutating either cysteine prevents 
LRIM1/APL1C complex formation and only LRIM1 and APL1C monomers are secreted in cell culture. 
LRIM4 lacks a homologous cysteine to either LRIM1 C352 or APL1C C562 but it does have an 
additional cysteine residue (C535) at its extreme C-terminus (Figure 6.2 A). It was hypothesised that 
C535 is responsible for covalently linking two LRIM4 molecules in the homodimer. To test this 
theory, a cysteine to serine missense mutation of C535 was generated (C535S) by site-directed 
mutagenesis and verified by sequencing. Wild-type LRIM4 and the C535S mutant were expressed in 
Sf9 cells and conditioned media were analysed by western blot using the His probe (Figure 6.2 B). 
When analysed under reducing conditions, both wild-type LRIM4 and the C535S mutant migrated at 
approximately 62 kDa, the predicted monomeric size for LRIM4. Under non-reducing conditions, 
wild-type LRIM4 migrated as a homodimer at 124 kDa, whereas the C535S mutant remained a 
monomer. These results showed that C535 is crucial for LRIM4 homodimer formation. Furthermore, 
LRIM4 C535 is functionally equivalent to LRIM1 C352 and APL1C C562, which demonstrates that 
there is inherent flexibility in the position of the cysteine responsible for dimerising two LRIM 
molecules. This work and the subsequent experiments for LRIM4 were published in Povelones et al., 
2011. 
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Figure 6.2  Investigating the cysteine residue responsible for LRIM4 homodimer formation.  
A) Schematic representation of wild-type (wt) and cysteine mutant alleles for LRIM1, APL1C and LRIM4. 
Predicted size of mature His/Strep-tagged proteins in kDa is shown in grey. Structures shown are black 
box: signal peptide, blue box: LRR, green box: coiled-coil domain, red line: cysteine residue, yellow star: 
cysteine to serine missense mutation. Mutations indicated are C352S in LRIM1, C562S in APL1C and 
C535S in LRIM4. B) LRIM4 wt and C535S mutant were transfected into Sf9 cells and conditioned media 
were collected after 3.5 days. Conditioned media were analysed by western blot under non-reducing 
(NR) and reducing (R) using the His probe. LRIM4 monomer and homodimer are shown by a small black 
arrow and white arrowhead, respectively. Adapted from Povelones et al., 2011. 
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LRIM4 and parasite killing 
The interaction between the LRIM1/APL1C heterodimer and TEP1 plays an important role in the 
mosquito complement-like pathway. It was investigated whether the LRIM4 homodimer can also 
interact with TEP1. Binding assays were performed using recombinant LRIM4 expressed in Sua4.0 
cells, which secrete endogenous TEP1, LRIM1 and APL1C. Secreted GFP, LRIM1 and APL1C were 
chosen as controls. Expression of the tagged proteins in the conditioned media was determined by 
western blot using the His probe to ensure equivalent amounts of protein were used for the binding 
assay. His-tagged proteins were captured from the conditioned media using cobalt-charged beads. 
The captured material was analysed by western blot for interactions with TEP1, LRIM1 and APL1C 
using antibodies.  
No interaction was observed between LRIM4 and endogenous TEP1, LRIM1 or APL1C (Figure 6.3). 
Nevertheless, it is possible that LRIM4 requires an additional protein partner to interact with these 
proteins and that this partner is not expressed by Sua4.0 cells. As expected, LRIM1 and APL1C were 
able to interact with their endogenously expressed partner, form the LRIM1/APL1C heterodimer and 
capture TEP1cut from the conditioned media. These data demonstrated the specificity of the 
LRIM1/APL1C interaction with TEP1 and showed that it is not common to all LRIM dimers. 
The initial RNAi screen in Chapter 4 revealed that LRIM4 knockdown had no effect on P. berghei 
development. LRIM4 silencing and P. berghei infection was repeated since a modest phenotype 
might have been overlooked in the first replicate. However, upon repetition, LRIM4 knockdown did 
not affect infection intensity or prevalence (Figure 6.4). Both live oocysts and melanised ookinetes 
were unaffected. It can therefore be concluded that, although the LRIM4 transcript was induced by 
P. berghei infection, LRIM4 is not involved in P. berghei defence. 
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Figure 6.3  Binding assay to investigate whether LRIM4 interacts with TEP1 and LRIM1/APL1C. 
Conditioned media (CM) were collected 3.5 days after transfection of Sua4.0 cells with secreted GFP 
(sGFP), LRIM4, APL1C and LRIM1 constructs. His-tagged proteins were captured from the conditioned 
media using metal affinity beads. Starting conditioned media (left panels) and bound material (right 
panels) were analysed by non-reducing western blot. One blot was incubated with the His probe (top 
panels). A second blot was probed with an antibody against TEP1 (middle panels) and re-probed with 
antibodies against LRIM1 and APL1C (bottom panels). Adapted from Povelones et al., 2011. 
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Figure 6.4  LRIM4 silencing and P. berghei infection. 
LRIM4 was silenced, mosquitoes were infected with fluorescent P. berghei and parasite load was 
monitored after 7 days. dsGFP and dsLRIM1 were injected as controls. The graphs display pooled data 
from two independent biological experiments in Plasmodium susceptible mosquitoes (one from 
Yaoundé strain and one from Ngousso strain). Horizontal lines represent the median parasite number. 
Significant differences in infection intensity by Mann Whitney U-test are shown. A) Live fluorescent 
oocyst counts. Prevalence of live oocysts for dsGFP, dsLRIM1 and dsLRIM4 was 92, 98 and 83%, 
respectively (all comparisons non-significant, Fisher’s exact test). B) Melanised (killed) ookinete counts. 
Prevalence of melanisation for dsGFP, dsLRIM1 and dsLRIM4 was 26, 4 and 17%, respectively. Only 
prevalence for LRIM1 was significant (< 0.01, Fisher’s exact test). Adapted from Povelones et al., 2011. 
 
LRIM17 and parasite killing 
The role of LRIM17 in P. berghei defence was questionable due to conflicting results from different 
laboratories. In the RNAi screen presented in Chapter 4, LRIM17 silencing had no effect on infection 
intensity or prevalence in the Yaoundé strain of An. gambiae. This supports other reports using G3 
strain mosquitoes (Riehle et al., 2006). However, LRIM17 was reported as a major Plasmodium 
antagonist in the Keele strain of An. gambiae (Dong et al., 2006a; Dong et al., 2011; Dong et al., 
2009; Garver et al., 2012). It was decided to silence LRIM17 in Keele mosquitoes to try to replicate 
the findings of Dong et al. in another laboratory using the same dsRNA fragment. Interestingly, it 
was found that LRIM17 knockdown did not affect P. berghei development in Keele mosquitoes in 
two independent experiments (Figure 6.5). Infection intensity and prevalence of live oocysts and 
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melanised ookinetes were unaffected by LRIM17 knockdown. The efficiency of LRIM17 silencing in 
Keele mosquitoes was determined to be 83%. 
 
 
 
Figure 6.5  LRIM17 silencing and P. berghei development in Keele mosquitoes.  
LRIM17 was silenced in Keele strain An. gambiae, using GFP and TEP1 as controls. Mosquitoes were 
infected with fluorescent P. berghei and infection intensity and prevalence were monitored 7 days 
later. The graphs display pooled data from two independent biological experiments, with horizontal 
lines representing the median parasite number. Significant differences in infection intensity by Mann 
Whitney U-test are shown. A) Live fluorescent oocyst counts. Prevalence of live oocysts for dsGFP, 
dsTEP1 and dsLRIM17 was 82, 95 and 81%, respectively (all comparisons non-significant, Fisher’s exact 
test). B) Melanised (killed) ookinete counts. Prevalence of melanisation for dsGFP, dsTEP1 and 
dsLRIM17 was 29, 0 and 11%, respectively. Only prevalence for TEP1 was significant (< 0.05, Fisher’s 
exact test).  
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6.3 Discussion 
Members of the mosquito-specific LRIM family in An. gambiae share similar protein domain 
architecture and are divided into four subfamilies. This Chapter aimed to characterise a 
representative member of the Long, Transmembrane and Coil-less subfamilies: LRIM4, LRIM15 and 
LRIM17, respectively. These three LRIMs demonstrated interesting transcriptional profiles in Chapter 
4. Furthermore, LRIM4 and LRIM17 have previously been implicated in Plasmodium defence (Dong 
et al., 2006a; Dong et al., 2011; Garver et al., 2012). 
The Long subfamily member LRIM4 seems likely to play a core role in An. gambiae immunity based 
on its diverse transcriptional profile. The LRIM4 transcript was induced by a wide range of 
challenges, including Plasmodium, ONNV, bacteria and fungi. Despite being upregulated by all three 
Plasmodium species tested, LRIM4 knockdown has no impact on P. berghei infections (Povelones et 
al., 2011), which demonstrates that transcriptional induction does not always correlate with 
function. Interestingly, the lack of RNAi phenotype with P. berghei matches a lack of transcriptional 
response to this rodent parasite reported in a previous microarray (Dong et al., 2006a). The same 
microarray showed that LRIM4 was induced by P. falciparum, in agreement with Chapter 4. An 
exciting possibility is that LRIM4 might function exclusively in defence against P. falciparum. 
Furthermore, the effect of LRIM4 silencing might only be detectable under certain Plasmodium 
infection intensities, which have been shown to modulate antiparasitic responses (Garver et al., 
2012; Mendes et al., 2011). Another indicator that LRIM4 is an important immune effector is that it 
is enriched in circulating An. gambiae hemocytes, like LRIM1 and APL1C (Pinto et al., 2009). This 
might suggest LRIM4 is part of the mosquito’s basal immune response, poised ready to attack 
invaders. However, there is no evidence linking LRIM4 to the mosquito complement-like pathway 
and it does not interact with LRIM1, APL1C or TEP1 in vitro (Povelones et al., 2011). Preliminary 
evidence suggests that LRIM4 is fairly well expressed in larvae and pupae, which is consistent with a 
generalist immunity role. 
Further investigation is required to determine the precise function of LRIM4 in mosquito immunity. 
As the LRIM4 transcript responds to bacterial and fungal infection, it would be enlightening to 
perform bacterial and fungal survival assays after LRIM4 silencing. As described for LRIM9, the LRIM4 
polyclonal antibody could be used to immunoprecipitate interacting proteins from hemolymph. This 
approach would highlight covalent and non-covalent interactions, providing new insights into the 
function of LRIM4. 
Evidence suggests that the Coil-less LRIM17 is also a core immune protein involved in defence 
against a range of pathogens, although its exact role is unknown. LRIM17 was induced by many 
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challenges in Chapter 4, including P. berghei, P. yoelii, ONNV after blood feeding, bacteria and fungi 
but not P. falciparum. This correlates well with previous reports that LRIM17 silencing reduces 
mosquito survival during E. coli and S. aureus infections (Dong et al., 2006a) and significantly 
increases bacterial load in the midgut (Dong et al., 2009). Curiously, a previous microarray reported 
LRIM17 upregulation after P. falciparum but not P. berghei infection (Dong et al., 2006a). Like LRIM4, 
LRIM17 is also highly expressed by circulating hemocytes (Pinto et al., 2009), suggesting it could play 
a role in the mosquito’s basal immune response. Furthermore, preliminary data suggests it is highly 
expressed in larvae and pupae, which implies it is important for immunity in all life stages. 
The role of LRIM17 in Plasmodium defence remains uncertain due to conflicting results between 
different laboratories and mosquito strains. LRIM17 was reported to be a major antagonist of P. 
berghei and P. falciparum in the An. gambiae Keele strain (Dong et al., 2006a; Garver et al., 2012) 
and An. stephensi (Dong et al., 2011). Like APL1A-C, LRIM17 maps to a genetic locus in An. gambiae 
controlling P. falciparum infections (Riehle et al., 2006). However, LRIM17 knockdown was shown to 
have no effect on P. berghei development in An. gambiae G3 (Riehle et al., 2006) and Yaoundé 
(Chapter 4). Furthermore, knockdown experiments using G3 showed no effect on P. falciparum 
infections (Michael Povelones, personal communication). In an attempt to resolve this discrepancy, 
LRIM17 was silenced in Keele mosquitoes in this Chapter but no impact on P. berghei development 
was observed. Crucially, the same RNAi primers as Dong et al. were utilised and the knockdown was 
highly efficient. This could suggest the effect of LRIM17 silencing is dependent upon laboratory 
conditions rather than mosquito strain. The discrepancy between laboratories could be explained by 
differences in mosquito midgut microbiota. Microbiota have been shown to modulate parasite 
infections by stimulating the mosquito’s basal immune response or directly inhibiting parasite 
development (Cirimotich et al., 2011a; Dong et al., 2009; Meister et al., 2009). Furthermore, it is 
unknown whether laboratory colonies of Keele mosquitoes have been inadvertently “contaminated” 
by interbreeding with other mosquito strains. It would be interesting to sequence LRIM17 from 
different laboratory colonies of Keele mosquitoes to rule out significant polymorphism. In addition, 
LRIM17 in hemolymph collected from various Keele colonies could be analysed by western blot to 
determine whether the protein migrates at different molecular weights or forms different 
complexes. The intensity of parasite infections could also influence results as LRIM17 silencing has 
been shown to significantly affect P. falciparum development at low and medium but not high 
intensities in Keele mosquitoes (Garver et al., 2012). Importantly, lower intensities are more 
consistent with infections in the field. 
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If LRIM17 is involved in Plasmodium killing under certain circumstances, the mechanism remains 
unknown. LRIM17 is known to be regulated by the Imd pathway, like TEP1 (Garver et al., 2009). 
However, preliminary evidence suggests LRIM17 does not interact with TEP1, LRIM1 or APL1C so it 
might not be directly involved in the complement-like system. As the LRIM1/APL1C complex binds 
TEP1 via its intertwined coiled-coil domains (Povelones et al., 2011), it is perhaps unsurprising that 
the Coil-less LRIM17 is unable to interact with TEP1. It would be useful to determine whether 
LRIM17 silencing affects the processing of TEP1-F into mature TEP1cut. Also, it should be investigated 
whether LRIM17 knockdown affects TEP1 localisation to ookinete surfaces. LRIM17 might function in 
a TEP1-independent parasite killing mechanism that is only active under particular circumstances. 
Identification of LRIM17 interacting partners would provide important clues to its function. A 
polyclonal antibody against LRIM17 is being developed to facilitate this investigation.  
As LRIM4 and LRIM17 were transcriptionally co-regulated, it was hypothesised that they function 
together. However, no disulphide-bonded complex between LRIM4 and LRIM17 was observed upon 
co-transfection of cultured cells. Nevertheless, LRIM4 and LRIM17 might still interact non-covalently, 
which could be investigated by western blot analysis of hemolymph proteins immunoprecipitated by 
His-tagged LRIM17, probing with the LRIM4 antibody. Alternatively, LRIM4 and LRIM17 could 
function in the same or related biochemical pathway(s) without physically interacting. Interestingly, 
both LRIM4 and LRIM17 hierarchically clustered with TEP12 and TEP14 in Chapter 4, based on their 
transcriptional regulation. This could be a novel functional relationship in the mosquito immune 
system. It would be interesting to determine whether LRIM4 or LRIM17 can pull-down TEP12 or 
TEP14 from hemolymph. Preliminary evidence suggests that LRIM4, LRIM17, TEP12 and TEP14 are 
not endogenously expressed by mosquito Sua4.0 cells (data not shown). If the presence of all four 
proteins is required for normal functionality, this could explain why LRIM4 and LRIM17 did not 
interact with each other, TEP1, LRIM1 or APL1C in experiments using these cells. Curiously, TEP12 
and TEP14 are phylogenetically clustered in the An. gambiae TEP family, based on protein sequence, 
but do not seem to originate by a recent gene duplication (Christophides et al., 2002). Both lack an 
active thioester motif, like most An. gambiae TEPs. 
Unfortunately, time constraints prevented a thorough analysis of LRIM15 and this Transmembrane 
LRIM requires further investigation. It was recently shown that LRIM15 is a true transmembrane 
protein (Michael Povelones, personal communication). After transfection of recombinant LRIM15, 
the protein was immunolocalised to the cell surface after staining with a Strep antibody. As its 
expression is hemocyte-enriched (Pinto et al., 2009), it is tempting to speculate that LRIM15 could 
be a PRR on the surface of circulating hemocytes, poised to recognise invaders in the hemolymph. 
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Furthermore, the intracellular region of LRIM15 is very small, which could be another strong 
indication. Little is known about the properties of Transmembrane LRIMs. Although membrane-
bound TLRs in mammals dimerise upon ligand binding (Botos et al., 2011), LRIM15 has been 
observed as a monomer in lysate from cultured cells (Michael Povelones, personal communication). 
Evidence presented in this Chapter has provided new insights into complex formation in the LRIM 
family. Whereas LRIM1 and APL1C form a disulphide-linked heterodimer (Baxter et al., 2010; 
Povelones et al., 2011), it was shown that LRIM4 forms a homodimer in vitro and in vivo. 
Interestingly, these three LRIMs are all Long subfamily members (Povelones et al., 2009). LRIM1 and 
APL1C are linked by a single intermolecular disulphide-bond between homologous cysteines located 
just upstream of the coiled-coil domains (Baxter et al., 2010; Povelones et al., 2011). LRIM4 lacks a 
cysteine in this position but has an additional cysteine at its extreme C-terminus, downstream of the 
coiled-coils (Waterhouse et al., 2010). Site-directed mutagenesis demonstrated that this additional 
cysteine residue is responsible for covalently-linking the LRIM4 homodimer (Povelones et al., 2011). 
This demonstrates an intrinsic flexibility in the position of the cysteine capable of bridging two LRIM 
molecules. It would be intriguing to determine how the three-dimensional structure of the LRIM4 
homodimer compares to the LRIM1/APL1C complex (Baxter et al., 2010). 
LRIM17 is secreted as a monomer in cell culture but its behaviour in the hemolymph is 
undetermined. LRIM17 lacks a terminal cysteine residue homologous to the bridging cysteine in 
LRIM1, APL1C or LRIM4 (Waterhouse et al., 2010), suggesting it is unlikely to form covalent 
interactions with other molecules. Nevertheless, it was shown that the disulphide bond between 
LRIM1 and APL1C is not essential for their heterodimerisation as they can form non-covalent 
complexes (Povelones et al., 2011). Therefore, LRIM17 could still be capable of forming non-covalent 
homo- and heterocomplexes. Interestingly, LRIM17 forms a weak band at the predicted size of a 
homotrimer after His purification in vitro, in addition to the predominant monomer. Perhaps LRIM17 
functions as a trimer when at very high concentrations, such as on pathogen surfaces. Although the 
coiled-coil domains are largely dispensable for LRIM1/APL1C heterodimer formation, the most C-
terminal coiled-coil domain seems to contribute to the specificity of their interaction (Povelones et 
al., 2011). Therefore, LRIM17 and the other coil-less LRIMs might be more promiscuous in their 
protein-protein interactions (Waterhouse et al., 2010).  
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7 Final discussion and conclusions 
 
This PhD thesis has provided new insights into the LRIM family in An. gambiae and its role in 
mosquito immunity. It has demonstrated that the LRIMs show differential transcriptional responses 
to various immune challenges, including blood feeding and infections with Plasmodium, bacteria, 
fungi and virus. Some LRIMs are induced by a wide variety of challenges and seem to play a core 
immune function, such as LRIM1 and APL1C in a complement-like pathway. In contrast, other LRIMs 
respond exclusively to specific challenges, including LRIM9, which was strongly induced by blood 
feeding. LRIM9 was discovered to be a novel antagonist of P. berghei infections of An. gambiae, with 
a putative role in parasite melanisation. We hypothesise that LRIM9 is induced in anticipation of 
blood-borne infections, which is an original concept in An. gambiae immunity. Finally, this project 
has increased our understanding of complex formation in the LRIM family. In particular, mutational 
studies using LRIM4 showed that there is intrinsic flexibility in the ability of LRIMs to form 
disulphide-bonded dimers. 
We propose that the LRIMs are a novel, mosquito-specific family of pathogen recognition proteins. 
LRR proteins are involved in pathogen sensing in many phyla, including TLRs and NLRs in mammals 
and NB-LRRs in plants (Istomin and Godzik, 2009; Padmanabhan et al., 2009; Sirard et al., 2007). 
They are hypothesised to link the mosquito complement-like system to pathogens, with different 
LRIMs responding to distinct pathogens and immune challenges. This thesis suggests that the LRIM 
family has diversified to respond to the wide variety of pathogens that mosquitoes encounter in 
their blood feeding lifestyle. The variability and structural flexibility of the LRR domains within the 
LRIM family could enable diverse interactions (Waterhouse et al., 2010). The LRIMs might directly 
interact with pathogen surfaces with their LRR domains. Those LRIMs that interact with TEP proteins 
via their coiled-coil domains might deliver their TEP cargo to the pathogen surface, opsonising the 
pathogen. Indeed, the LRIM1/APL1C complex is known to stabilise mature TEP1cut, promote its 
opsonisation of pathogen surfaces and prevent it from reacting with self-tissues (Fraiture et al., 
2009; Povelones et al., 2009). It remains to be determined whether other LRIM family members bind 
TEP proteins. Alternatively, the LRIMs might recruit other immune proteins and mediate pathogen 
recognition indirectly. The LRIMs do not possess known signalling domains and so they are probably 
not involved in immune signal transduction, unlike the TLR, NLR and NB-LRR proteins (Waterhouse 
et al., 2010). However, the existence of novel signalling domains cannot be ruled out. In particular, 
the Transmembrane LRIMs possess a small intracellular domain and seem the most likely candidates 
to play a signalling role. There remains much to learn about how LRIMs interact with each other in 
the hemolymph. As LRIM1/APL1C form a heterodimer and LRIM4 forms a homodimer (Povelones et 
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al., 2011), it can be predicted that other LRIMs form complexes, perhaps under different 
circumstances. 
The evolutionary history of the LRIMs is very interesting as it remains unknown how this mosquito-
specific family originated. To date, no LRIM-like genes have been discovered in the sequenced 
genome of any non-mosquito organism. Attempts to find LRIM orthologues or ancestral LRIM genes 
in other organisms have been hampered by the extensive amino acid sequence divergence in the 
LRIM family (Povelones et al., 2009; Waterhouse et al., 2010). A more thorough bioinformatic search 
might find the ancestor of mosquito LRIMs in another insect, although the characteristics of such a 
protein are unknown. It can be envisaged that a founder LRR protein gained a coiled-coil, or vice 
versa, and subsequently expanded. As LRR proteins and coiled-coil proteins are common, the 
original protein that gave rise to the LRIMs might not be identifiable, presuming it is still intact 
today. Although Drosophila has LRR proteins and coiled-coil proteins, the exact LRIM domain 
organisation is not present. Nevertheless, mosquitoes (Diptera: Culicidae) are lower Diptera, one of 
the earliest fly lineages, and are thought to have diverged from Drosophila (Diptera: Drosophilidae) 
approximately 250 million years ago (Waterhouse et al., 2007; Wiegmann et al., 2011). Therefore, an 
ancestral LRIM gene might be unrecognisable in Drosophila. It would be expected that the ancestral 
LRIM would be found in species more closely related to mosquitoes, such as sandflies (Diptera: 
Psychodidae). Very preliminary genome assemblies of the sandflies, Lutzomyia longipalpis and 
Phlebotomus papatasi, are becoming available but there is currently no evidence of LRIM-like genes. 
These sandflies are also blood feeders but, interestingly, hematophagy is thought to have arisen 
independently at least 12 times in Dipteran evolution (Wiegmann et al., 2011). 
It will be interesting to investigate how the orthologous LRIM proteins behave in Ae. aegypti and C. 
quinquefasciatus. In particular, it should be determined whether the role of LRIM9 is conserved, as 
LRIM9 exists as a single orthologue in these other mosquitoes (Waterhouse et al., 2010). Evidence 
suggests that the functional relationship between LRIM1, APL1C and TEP1 is conserved in Ae. aegypti 
as their orthologues are induced by Wolbachia infection (Kambris et al., 2009).  
Several LRIMs are involved in defence against the deadliest human malaria parasite, P. falciparum, 
which highlights the significance of the LRIM family. The mosquito complement-like pathway is 
thought to play an important role in P. falciparum defence, dependent on parasite infection 
intensity. TEP1 is consistently shown to be a major P. falciparum antagonist whereas LRIM1 and 
APL1C are known to be most effective at medium and low infection intensities, respectively (Dong et 
al., 2006a; Garver et al., 2012). Interestingly, several strains of P. falciparum have been 
demonstrated to evade the mosquito complement-like system to aid their transmission (Molina-Cruz 
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et al., 2012). Furthermore, LRIM17 has been reported to be a P. falciparum antagonist in the An. 
gambiae Keele strain, particularly at medium and low infection intensities (Dong et al., 2006a; 
Garver et al., 2012). The paralogues of APL1C have also been implicated in responses against P. 
falciparum. APL1A has been reported to influence the prevalence of P. falciparum infections (Mitri et 
al., 2009) and APL1B knockdown increases oocyst levels at medium infection intensities (Garver et 
al., 2012). It is possible that several LRIMs cooperate in P. falciparum defence responses or different 
LRIMs might take precedence in specific contexts. This PhD thesis has provided new candidate LRIMs 
for involvement in P. falciparum defence, such as LRIM4 and LRIM7. Although LRIM9 is not 
upregulated in response to P. falciparum, its suggested role in anticipatory immunity triggered by 
blood feeding may also be important during P. falciparum infections. TEP3 is another promising 
contender as it is a novel antagonist of P. berghei and interacts with the LRIM1/APL1C complex 
(Povelones et al., 2011). 
Hematophagous insects, like mosquitoes, are at high risk of infection from blood-borne pathogens, 
including parasites and viruses. The blood meal also promotes dramatic proliferation of midgut 
bacterial flora (Cirimotich et al., 2010; Kumar et al., 2010). The proposed theory of anticipatory 
immunity in mosquitoes would be a highly important defence mechanism against infections arising 
after blood feeding. By assuming every blood meal is infectious and inducing immune effectors, like 
LRIM9, in anticipation, the mosquito does not need to specifically recognise each pathogen but is 
prepared for imminent danger. Some pathogens, like viruses, can infect mosquito cells within hours 
of blood meal ingestion, which would allow little time for pathogen recognition and specific immune 
induction. Furthermore, anticipatory defence could even help kill pathogens evading immune 
recognition because the blood meal alone is sufficient to trigger the deployment of killing 
mechanisms. Anticipatory immunity has not, to our knowledge, been reported in the innate immune 
response of another organism. Innate immunity is traditionally considered to be poorly specific and 
non-anticipatory. However, the adaptive immune response of vertebrates has been previously 
proposed as “anticipatory”. In a distinct mechanism to mosquitoes, vertebrates generate diverse 
repertoires of T and B lymphocyte receptors by rearrangement of gene segments to enable 
recognition of any potential antigen (Pancer and Cooper, 2006). 
LRIM1 and APL1C function differently to LRIM9 as they constitutively circulate at high levels in the 
mosquito hemolymph poised to attack invaders, which has been described as basal immunity (Frolet 
et al., 2006). Unlike LRIM9, they are not specific to blood-borne infections because they are also 
involved in antibacterial defence and phagocytosis (Moita et al., 2005). Both the complement-like 
system discovered in An. gambiae and the proposed mechanism of anticipatory defence seem to be 
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mosquito-specific and involve LRIMs. Therefore, it can be postulated that the LRIM family is 
mosquito-specific because it evolved to defend against the distinct blood-borne pathogens faced by 
these insects. Importantly, many pathogens are only transmitted by mosquitoes, such as 
Plasmodium parasites, filarial worms and numerous viruses. In contrast to the LRIMs, the TEPs have 
ancient evolutionary origins and related proteins are found in many phyla, including the C3/C4/C5 
factors of the mammalian complement system (Blandin and Levashina, 2004). As well as mosquitoes, 
TEPs with complement-like activity have been discovered in horseshoe crabs (Tagawa et al., 2012; 
Zhu et al., 2005). We propose that the functions of TEP and LRIM proteins were combined to create 
the mosquito complement-like system whereas certain LRIMs, like LRIM9, have retained their 
ancestral function in blood-borne infections. It is unknown whether LRIM9 plays a generalised role 
or is specific to particular blood-borne pathogens. LRIM9 functions against P. berghei despite being 
transcriptionally unresponsive to malaria parasite infections, which demonstrates that 
transcriptional responses can be independent of protein activity. Therefore, LRIM9 should be 
investigated for RNAi phenotypes with other blood-borne pathogens, such as ONNV and filarial 
worms. Furthermore, other Short LRIMs with a similar induction post blood feeding (i.e. LRIM8A, 
LRIM8B and LRIM10) should also be examined for roles in defence against blood-borne infections. 
Understanding the mosquito immune system and how it interacts with Plasmodium parasites is an 
important challenge with exciting prospects for malaria control (Chen et al., 2008). The most 
successful malaria control strategies to date have all targeted the mosquito vector (Catteruccia, 
2007). The mosquito immune system could be exploited to create GM mosquitoes refractory to P. 
falciparum or P. vivax, which could be employed to replace wild mosquito populations 
(Christophides, 2005). Ideally, multiple Plasmodium antagonists could be overexpressed in the same 
GM mosquito to achieve 100% blockade of malaria transmission and reduce the risk of parasite 
resistance. The mosquito-specific LRIM family and the complement-like system are potential 
candidates for malaria control strategies and this PhD study has increased our understanding of the 
role of LRIMs in mosquito immunity. Future work is needed to elucidate precise mechanisms of 
parasite killing, the involvement of LRIMs and TEPs and immune evasion strategies used by P. 
falciparum. Furthermore, promoters of genes with blood feeding and/or female specific expression, 
potentially like LRIM9, are highly desirable for driving gene expression in GM mosquitoes. Finally, if 
members of the LRIM family are involved in limiting viral infections, as suggested by the 
transcriptional profiling in this study, the family could also be used to control arboviral disease. 
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9 Appendix 
 
9.1 Supplementary figures 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9.1  Evaluating LRIM9 peptide antibodies using blood fed hemolymph.  
Rabbit polyclonal antibodies were generated against two LRIM9 peptides: peptide 70 (α-LRIM9 Pep70; 
located at the C-terminus) and peptide 71 (α-LRIM9 Pep71; located between the LRRs and coiled-coil). 
Mosquitoes were injected with dsGFP or dsLRIM9 and, after 3 days, they were either sugar or blood 
fed. Hemolymph was collected 24 h later and analysed by non-reducing western blot, probing with α-
LRIM9 Pep70 (left panel) or α-LRIM9 Pep71 (right panel) followed by SRPN3 as a loading control. The 
red arrow shows the true LRIM9 band in the dsGFP blood fed lane. Molecular weight markers are 
indicated (kDa). 
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Figure 9.2  Temporal profiling of LRIM1/APL1C and TEP1 protein levels after E. coli bioparticle 
challenge in naïve mosquitoes.  
Non-reducing western blot was performed on hemolymph collected 15, 60, 120, 240 and 360 minutes 
after challenge with PBS or E. coli bioparticles. Blots were probed with antibodies against TEP1, the 
LRIM1/APL1C complex and SPCLIP1. SRPN3 was used as a control to ensure equal loading. Molecular 
weight markers are indicated (kDa). 
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9.2 Tables of primers 
 
Table 9.1  RNAi primer sequences. 
Gene Primer name Sequence 
Amplicon 
size (bp) 
GFP 
5' GFP1 T7 pove taatacgactcactatagggACGTAAACGGCCACAAGTTC 
535 
3' GFP1 T7 pove taatacgactcactatagggTGTTCTGCTGGTAGTGGTCG 
LRIM1 
LRIM1 T7 forward taatacgactcactatagggAATATCTATCTCGCGAACAATAA 
529 
LRIM1 T7 reverse taatacgactcactatagggTGGCACGGTACACTCTTCC 
APL1A 
APL1A_dsRNA_F taatacgactcactatagggCTACCACCTGCCGAAAGATG 
350 
APL1A_dsRNA_R taatacgactcactatagggTCTGGTCTTGTATAGTACAATGG 
APL1B 
APL1B_dsRNA_F taatacgactcactatagggACTCGCAAAGCTCAGCAAACAC 
224 
APL1B_dsRNA_R taatacgactcactatagggTGAGAACAAATAAGTTCAAAGTCC 
APL1C 
APL1C_dsRNA_F taatacgactcactatagggCCAAGAAGAACCGCAATCC 
241 
APL1C_dsRNA_R taatacgactcactatagggTCACAGTGATTTCAGGGTGTGC 
LRIM3 
LRIM2 A T7 F taatacgactcactatagggTGCAGAACTTCAACGACACC 
459 
LRIM2 A T7 R taatacgactcactatagggGTTGATCTCCTTGATGCGGT 
LRIM4 
LRIM4 f1 T7 F taatacgactcactatagggATCTGGAGCTGCACGAAAAT 
501 
LRIM4 f1 T7 R taatacgactcactatagggCCCCTCCTGAAGGCTTTTAC 
LRIM5 
LRIM5 R28 RNAi T7 F taatacgactcactatagggCATACGCACGTGTGGAAAGT 
279 
LRIM5 R28 RNAi T7 R taatacgactcactatagggTCATGCTAAACGAACGTGCT 
LRIM6 
AGAP006327 LRIM6 RNAi T7 F taatacgactcactatagggATATCCGCTTCCTAGTCGGG 
248 
AGAP006327 LRIM6 RNAi T7 R taatacgactcactatagggACAAACGCCAGCTTGTTCTT 
LRIM7 
AGAP007457 RNAi T7 F taatacgactcactatagggATCTGGCCGGTTGTGATAAG 
284 
AGAP007457 RNAi T7 R taatacgactcactatagggCGCTGCAGGGTGAGTATCTT 
LRIM8A 
AGAP007454 RNAi T7 F taatacgactcactatagggCCGAAGTGTGCAGAGTGAAG 
274 
AGAP007454 RNAi T7 R taatacgactcactatagggTAGCGTTATCTACCGCCGAT 
LRIM8B 
AGAP007456 RNAi T7 F taatacgactcactatagggATGGGCATTCGGAAGATGTA 
269 
AGAP007456 RNAi T7 R taatacgactcactatagggACGAGTCGAGTGCTACCTCC 
LRIM9 
AGAP007453 RNAi T7 F taatacgactcactatagggACTGGCAGAAAAGCTTCCAA 
323 
AGAP007453 RNAi T7 R taatacgactcactatagggTGGCATTTTCTCGAACACAG 
LRIM10 
AGAP007455 RNAi T7 F taatacgactcactatagggCAAAGATCCGCGGACTAAAG 
274 
AGAP007455 RNAi T7 R taatacgactcactatagggCAAGCTTTTGCTCCAACTCC 
LRIM11 
LRIM11 AGAP007034 T7 F taatacgactcactatagggGTACCGCTGGTGCTGCTC 
204 
LRIM11 AGAP007034 T7 R taatacgactcactatagggACGTCACTGCCGAGGTACAC 
LRIM12 
AGAP005496 LRIM12 RNAi T7 F taatacgactcactatagggGGCGTCCAAGACTTCAAAAC 
304 
AGAP005496 LRIM12 RNAi T7 R taatacgactcactatagggAAGTTCCTCCACCTCGTCG 
LRIM15 
AGAP007045 LRIM15 RNAi T7 F taatacgactcactatagggTCGATCGGATGATCCTCTTC 
302 
AGAP007045 LRIM15 RNAi T7 R taatacgactcactatagggTGAGCAGCAGTTATCGGAGA 
LRIM16A+B 
LRIM16A+B T7 F taatacgactcactatagggGCCTTGCAAAGCTAGCCAAT 
234 
LRIM16A+B T7 R taatacgactcactatagggCCGATTACCGTCCAGAAAGA 
LRIM17 
LRRD7 APL2 T7 F taatacgactcactatagggTCGGTGAGCAACAGTTTGAC 
397 
LRRD7 APL2 T7 R taatacgactcactatagggCTTCATTCCCGCTAATGCTC 
LRIM18 
LRIM18 AGAP010675 T7 F taatacgactcactatagggGCCTGTTGGGTTTTGACAAG 
218 
LRIM18 AGAP010675 T7 R taatacgactcactatagggGCACTCGTCCCCAGTTCA 
LRIM19 
LRIM19 AGAP011117 T7 F taatacgactcactatagggCGAGATGGAGTGCGAAATCT 
224 
LRIM19 AGAP011117 T7 R taatacgactcactatagggGATCTCGAGCTTCTCGGTCG 
LRIM20 
AGAP002542 LRIM20 RNAi T7 F taatacgactcactatagggGTTGGCCGACTGCAAAAT 
246 
AGAP002542 LRIM20 RNAi T7 R taatacgactcactatagggGTATCGAGCGTGTGGGAATG 
LRIM26 
AGAP005744 LRIM26 RNAi T7 F taatacgactcactatagggGGTGCTGGATGTGTCTGGTA 
240 
AGAP005744 LRIM26 RNAi T7 R taatacgactcactatagggCCACCAGCAGTTTGCAGTTA 
LRIM27 
LRIM27 T7 F taatacgactcactatagggACCCTGGCATTGGAGCTT 
257 
LRIM27 T7 R taatacgactcactatagggACAGGTCGAGCAGTTTCAGG 
TEP1 
TEP1 T7 F taatacgactcactatagggTTTGTGGGCCTTAAAGCGCTG 
435 
TEP1 T7 R taatacgactcactatagggACCACGTAACCGCTCGGTAAG 
TEP3 
TEP3 T7 F taatacgactcactatagggCGAGAAGGAACCCATTTAAGG 
321 
TEP3 T7 R taatacgactcactatagggGCTGCTGGAATGGCATAAGT 
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TEP4 
TEP4 T7 F Lav taatacgactcactatagggTCTTCTGGGAGGATGTTTGG 
410 
TEP4 T7 R Lav taatacgactcactatagggACGGTGGTCAATTGAAGAGG 
CTL4 
CTL4 T7 F taatacgactcactatagggTGGTTTGATGCCGTGTCCT 
342 
CTL4 T7 R taatacgactcactatagggAATAAATTGTCTCGGTTCATCATC 
 
Primer sequences used to amplify RNAi fragments from cDNA or plasmid template. T7 tags are shown 
in lower-case. Amplicon size includes the T7 tags. 
 
 
Table 9.2  qRT-PCR primer sequences. 
Gene Primer name Sequence Concentration (nM) 
S7 
AgS7 AGAP010592 qRT-PCR F GTGCGCGAGTTGGAGAAGA 300 
AgS7 AGAP010592 qRT-PCR R ATCGGTTTGGGCAGAATGC 900 
LRIM1 
AGAP6348 LRIM1 QPCR F CATCCGCGATTGGGATATGT 900 
AGAP6348 LRIM1 QPCR R CTTCTTGAGCCGTGCATTTTC 900 
APL1A 
APL1A_qPCRu_F CCATTTGCATGAGTTGGGTA 900 
APL1A_qPCRu_R TCCATCTGGTCCTTGAGCTT 300 
APL1B 
APL1B_qPCRi_F TGCAGATTCTGTTGAGACAGC 300 
APL1B_qPCRi_R AATTGCTTTATTTGTTGACGCTT 300 
APL1C 
APL1C_qPCRi_F CAGGCTGAGTTGAGACAGGA 300 
APL1C_qPCRi_R GCTTCACTTTTTGGCGCT 300 
LRIM3 
AGAP7037 LRIM2A QPCR F (LRIM3) GCAGATGGAGGAGATTGAGC 900 
AGAP7037 LRIM2A QPCR R (LRIM3) AGGTTGATGCAGTCCCAGTC 900 
LRIM4 
AGAP7039 LRIM4 QPCR F CTGTTTACCGTGCAGACCAC 900 
AGAP7039 LRIM4 QPCR R AGCACGGTCAGGAAGTTGTT 900 
LRIM5 
AgROB2-R28 QPCR F CTGTGCTGTTACGAGGGTCA 900 
AgROB2-R28 QPCR R CCCAAACTGTCCTCGTTCAT 900 
LRIM6 
AGAP6327 QPCR F CGTACTTCGGCAAGGACATT 300 
AGAP6327 QPCR R TGGTCACCGGTATGAACAGA 300 
LRIM7 
AGAP7457 QPCR F ATCTCGATACCGGACTGTGG 900 
AGAP7457 QPCR R AGCTCCTCCAGAAACGTCAA 900 
LRIM8A 
AGAP7454 QPCR F TAATCTCGCCCAATTTCCAG 900 
AGAP7454 QPCR R ACCATCAGCAACCACTCACA 900 
LRIM8B 
AGAP7456 QPCR F GGATTGATCGTGGTGGAGTC 300 
AGAP7456 QPCR R AAGCCAACGAGAGGTGCTTA 300 
LRIM9 
AGAP7453-2 QPCR F TTCAGCATGCACTGGAAAAG 900 
AGAP7453-2 QPCR R GTCGGTACCATCGGTTGACT 300 
LRIM10 
AGAP7455 QPCR F TCGGTCTGAAGGAGCTTTGT 300 
AGAP7455 QPCR R CACGTGCAGTGTCCTGATTC 300 
LRIM12 
AGAP5496 QPCR F CACGCTCGATCTTTGTGTGT 300 
AGAP5496 QPCR R GCCAGATTGTTGCTGGAAAG 300 
LRIM15 
AGAP7045 QPCR F ATCTGGAAGCCACCAATCTG 900 
AGAP7045 QPCR R ACACATCCAGCCAGGTAAGG 300 
LRIM16A 
AGAP7758-R42 QPCR F (LRIM16A) AGCAACATTGTGAGCACGAG 300 
AGAP7758-R42 QPCR R (LRIM16A) CAACCCTATTAGGACACAAAGCAT 300 
LRIM16B 
AGAP7758-R44 QPCR F (LRIM16B) ATAGGCTGCCAATCCATCAG 300 
AGAP7758-R44 QPCR R (LRIM16B) TTCCCATCATGAGACACATCAC 300 
LRIM17 
AGAP5693 LRRD7 APL2 QPCR F ATTCACTCACGGCGCTAAAC 900 
AGAP5693 LRRD7 APL2 QPCR R CTCGCGTCAATCAAATCAAA 900 
LRIM18 
AgLRIM18 QPCR F GCTACGGGAGCTAGATGTGC 300 
AgLRIM18 QPCR R AGCATCAGGGTCAGCAGTTT 900 
LRIM19 
AgLRIM19 QPCR F ACGCTCTACCTGGACGAGAA 300 
AgLRIM19 QPCR R CTGGTCCTCCGTGTCGTAGT 300 
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LRIM20 
AgLRIM20 QPCR F CCCGTACGAAAAGCTACGAA 900 
AgLRIM20 QPCR R AGCTCGATGTGGGTTAGCTG 900 
LRIM26 
AgLRIM26 QPCR F CGCAAGTGAAGGAAAAGGAG 300 
AgLRIM26 QPCR R AAACCGATCAAAAGCACCAC 300 
LRIM27 
AgLRIM27 QPCR F CTGTCCCAAATCGACCACTT 900 
AgLRIM27 QPCR R TGCCAAATTTTCTCCCTCAC 900 
TEP1 
TEP1 QPCR F AAAGCTGTTGCGTCAGGG 900 
TEP1 QPCR R TTCTCCCACACACCAAACGAA 300 
TEP3 
TEP3 QPCR F GGAAAGCATTGCGGATGTAT 300 
TEP3 QPCR R TTGGTAGCGATTCCCAGTTC 300 
TEP4 
TEP4 QPCR F GCTGAAGGCACTTACCAAGC 900 
TEP4 QPCR R CGCGAAACTCTTTCTTACGG 300 
 
After optimisation, gene-specific primers were used for qRT-PCR at the indicated final concentration. 3 
µM or 9 µM working primer stocks were prepared and used at 1/10 dilution in a 20 µL reaction. 
 
 
Table 9.3  NanoString probe sequences. 
Gene Target sequence 
S7 
GTGTACAAGAAGCTGACTGGCCGTGACGTTACGTTCGAATTCCCAGAGAACTACCTGTAAAATATAAGGGTTGCGTG
CTAGTGAATAGCCGAAGTTTGCA 
LRIM1 
CTCGAGCACTTTGACCTGCGCGGCAACGGGTTTCACTGTGGAACGTTGCGTGATTTCTTCAGCAAAAACCAACGCGT
GCAAACGGTCGCAAAACAAACCG 
APL1A 
CGCCGTATCACAAATAAGTGTAATTTTTTTAGCCTGTACCAACGGAGGACAGCCATCCTACAGGAGTCAGCCAATTTA
CGGAAATAAACAACGCTACTAC 
APL1B 
ACGCGCCGTATCTCTAATCAGTATGATCTTTTCAGCCAGTACCTACGGAGGACAGCTATCCTACAAAAGTATGCACTT
GACTCCTTTCACTTTGAGTGCT 
APL1C 
TCCAACCCATATAGGTCAAACAATCTACAGAAGTCAGCCAAATTACGGAGGTCAGCAACGCTACAACGCAAGACCAC
GACAGCTAGAATACAAATGCATT 
LRIM3 
CGAACATTAACAACATCTTCAAGTTCCGCAACCTGATCGAGCTGGACGTGTCGTACAACGAGCTGGTAACGCTGGAC
TTTGTCATCTTCGCCTTCATGAA 
LRIM4 
GCGTTCGATTTCGCTCTCGTGCGCAATATGCGCTCCCTGGTGACGTTGAATCTGGCGCACAATCGGCTGTTTACCGTG
CAGACCACCGGCGGTTCACCGC 
LRIM5 
AGGGCTGTGCTGTTACGAGGGTCAAGAGCCGTTTAATGAGCTGGACGGTGGTTTGGAGCGGGAGGCGAAAGGTGA
CGATGAACGAGGACAGTTTGGGAAG 
LRIM6 
GCCGGATTTTGCTTCATCGAGAATGTGCACCTGGACGTTTCCACCAACGGCATCGGGGGTGATTCGATACAGTTTCC
ACGCCACCCGACGCTGCTCATCA 
LRIM7 
CTCTTTACGCCACTCGCCCACGTTGAAAACCTGATGATCCATCGGCTGCAGATAGAGCAGCTCGATCTGGCCGGTTG
TGATAAGCTCGACATCCTGTTCG 
LRIM8A 
AAACAAGCTGCCCGGCATTTTCGACCTCACCGTCGATAAGTTGGGCATAGTGCAGCTCTTCATACGTCCTAGCCTGGT
GCATCTATCGGCGGTAGATAAC 
LRIM8B 
CTCGATCTATCGAACAATGATCTCTACCTACTGCTTGACGAGGCGCACCAGCTTGGTCAGTTCGGTGCACTGCTGGA
AGTTTCTTACGCCGGGAACGATT 
LRIM9 
TTCCAACAGTCGACAGTGAGCTACCGGATTTGTCCAAACGAACCACAGTGCGCATATTGGAAGGATCACTGGCCAAT
CTTACTGTGAAACTGGCAGAAAA 
LRIM10 
TGATTGCTTCTACCGTTAGTGAGCTATCACTTCCCGCCCTGAGTGTGCTGGCGCTCCAGAACAACACGCTGACCGTGT
TTGATCTGCGCACATGGTCATT 
LRIM11 
TCTGTAACTACGAAAAGTTCCACCTGTTCGACAGCATGTACCGGCCGCGGACGGACAACTTCTGCGTGTTTAACGAC
GTGTACCTCGGCAGTGACGTGAA 
LRIM12 
CGGCTGCTCGATCTTTCCAGCAACAATCTGGCGCTGGTGCGCAGCTCGATCGGTGCCGAGAAGCTTGCCTCACTGAC
AGTATTATATCTGAACGATAACC 
LRIM15 
ACGATCGACTTCCGGGAGACGGGCATCGAGAACATCAACAAGTTCACGTTCGAGAACGCCAAGCAGCTTCGGCATC
TGTTTCTGCGCCGCAACAAGCTTA 
LRIM16A 
AGCACGAGTGGTATGTTGGGGCAGGATCGGTTACTAGTCCATCAGAGTGCAGCACAAGTTGAAGGTAGCGGTGGA
AATGGCAATGGAGTGAATATTGCAG 
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LRIM16B 
GGTGCTGCTGGTATGTTGGGTCATGATAGGCTGCCAATCCATCAGAGTGCAGCACAAGTTGAAGTCAGCAGCGGAA
ATGGCAATGGGCTGATTATTGCAA 
LRIM17 
GTGTCCTCGGACGAGATTCTAACCACCACCTTTGCCAGCTCTAATCCCTCCACCCTATCCACCGTCCAGTTTGCACGCT
CTTCGCTCACCGGCATCCCAC 
LRIM18 
CACAGCCGGCGGTCCTCCAGCCAAAACGGACGATGGCCACAGCATGGCTTCGATGGCTCCGTTAGGCAACAGCTGG
CTGCTAGCCGGTCTGGCGGCGGTG 
LRIM19 
GTTTTCTAGTGACGGTTGCTTGCGGCGCCAGCGCCTACGGCCGAAAGCTGGAGTGCAGCGAGCACCGCGAGATGG
AGTGCGAAATCTCCAACTTTACCAT 
LRIM20 
TGTGACACTTACCAACGCGACCCTTTCCGCGATGGCTCAAACGGGCGGTGGCGGTGAACTCTCGCTCGACGGCTGCC
AGATTGACCACTTCGGGCCGGCA 
LRIM26 
AACTGTTTCTGCGTGACGCGAGCATGACGGATCTATCCGTAACGGACATCCGGCGTGACATGCCCGCCGTCAAGCGT
ATCCATCTCGGGGGTAACGATTT 
LRIM27 
CCGGCCGAACGTTACATGTGGACACCGACGCACGGTGTTCCCGGCAAGCAGGAAGAGCACGAGGAAGTTTGCATC
ATCGCGAGTGCCCGACTGAACAGCA 
TEP1 
TTGATGGGTTCCATGCAATCAATGAGAACGAGTTTGACATATTCCACAGCTTGGGTCTGTTCGCCAGGACATTGGAC
GATATCTTGTTCGACAGTGCAAA 
TEP2 
TATGTCAGCGTGGAGGTGAAATACCGTGGGAAGGATTATTATGTGCAAGGCATCACGAAACCTCGAGATTACGAGG
AAGCATTGATGAGAGTGCGGCTTT 
TEP3 
GCCCACAGTTCCGTCCGGGGACTCCTTTCAAGTGTACGCTAACGCTAATCTATCACGATGGCAGACCCGCTGGACAC
GTTCCCTTCTTTGTAAATGTCGA 
TEP4 
TCTCGAATCTTGGCTGTGGAAAACGGACAAAATTGGTTCCTCGGGAAGCGCAACGACCAAGGAGAGCGTTCCAGAT
ACGATCACAGCATGGCATTTGACA 
TEP5 
CCACACCGCAAGACTTAAGGAAGATTAAAATAACAGTTGAGGGTATTGGGGTTGGGCTCCTGGAGGTGATGTATAA
ATACAGATTGAATCTCGTGAACTT 
TEP6 
TTCGAATTATCGACTTCAGTATTCCGGATAGTCTGTCCTCTGGGAACTACAAAATTACCATTGATGGGCTGCAAGGTT
TCAACTTTCACGAGGAGGCAGA 
TEP9 
CAAGCTCAGATTCAATCCCAACTTACTTATCACCGTGAAGGACAACTTGAACGATATTCGCACTGATTGGAGTAGAT
GTAACGAAGGCATAAGAGGCACG 
TEP10 
TCGTTGTTCATGACTACCTGGTTGCCATTGGGTCAACACATCCATATGAATCCAACGATAATAAATGCATCAAATCCA
ATGGTTCATGGCGGAATCAGGT 
TEP11 
TTTTCATGGACTCGCACCAGAATCGAACGTTGTACCGTCCACGAGACGGAGGAGGCCATAGAAACTTACAGGATCA
AGAGCGATCGGGTTTAGAGTTAAT 
TEP12 
CACCGTGATATTGGAAGTCAGGTTTGGATTCTACCGTCAACCACACGGACGGTCAGCTTCACCATTGAAGGGACGAT
TTCGGGAGCGTTACGCATACACT 
TEP13 
CGTACAATCCGCGCACCTCGTTCGGCGAGCATCAGTTCTACATCTACCTGAACGCGCAGGACTCGACTAACGTGTAT
CTGCCGATCGTGCCGACACGGTT 
TEP14 
TGCTCGATGGCAACGAAGTATTCTATCCGGGGCTGGCGATGCGATTAATGGTGAAGCTTGCAACGATTGATGAGAA
ACCGCTTGTGAATCAACCTGTTAC 
TEP15 
TTATCGGGCCTAACCTTTAAGAACGAAACCGATTTGGAGTATCAGCAGAAGAGCTTCTCGGTATTTGTGCAAACGGA
CAAATCCATCTACAAGCCGGGCG 
Actin5C 
TCGGAGCGCGATTGCGCCGCCTATTATCATCTTTTCCCTATTGCGGCCACCTACTTCTGCGCAACAGAGAGGGTGAA
GGGTTATATGATGTCTGACGCTA 
Polyubiquitin 
GAAGGAATCCACCCTTCATCTGGTTCTCCGTCTGCGTGGTGGTATGCAGATTTTCGTGAAAACTCTGACCGGAAAGA
CCATCACTCTGGAAGTTGAGCCA 
 
100 bp of coding sequence for each gene was targeted using NanoString analysis. For each gene, one 
capture probe and one labelled reporter probe (~50 bp each) were used to target this 100 bp region. 
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Table 9.4  Ek/LIC cloning primer sequences. 
Gene Primer name Sequence 
LRIM4 
LRIM4 LIC for gacgacgacaagatgAAGCCATTGCAGTTTGCGTGC 
LRIM4 LIC rev gaggagaagcccggtttCTGAATAATGACCGTTTGTCC 
LRIM9 
gLRIM9 forA # TGCAATTTTCGATTCAGTGC 
tLRIM9 revA # AAAGGACCCACATCTCAACG 
LRIM9 LIC for gacgacgacaagatgGAGATTTCCAGCTCCGTGGTG 
LRIM9 LIC rev gaggagaagcccggtttGGCAGACGGTTCGGACGCCAC 
LRIM15 
LRIM15 LIC for gacgacgacaagatgGTCATCTATCAGTGCGATCATTAC 
LRIM15 LIC rev gaggagaagcccggtttCAAATCCTCGTGCAGTGCCGTTTG 
LRIM17 
LRIM17 LIC for gacgacgacaagatgAAGCAGCTGAGCTGCACAATG 
LRIM17 LIC rev gaggagaagcccggtttCGAGCAGCAAATGCCATCGATCAG 
TEP3 
TEP3C gst LIC F gacgacgacaagatgGGGATAAGGGCACTCGCCGCG 
TEP3C gst LIC R gaggagaagcccggtctaGTCGAGGTAGCTCTGGATATC 
TEP4 
TEP4Cnew gst LIC F gacgacgacaagatgGGGCTGAAGGCACTTACCAAG 
TEP4Cnew gst LIC R gaggagaagcccggtctaGTCGTCCACTTGGTACATCTT 
 
The open reading frames of LRIM4, LRIM9, LRIM15 and LRIM17 (without the endogenous signal 
peptides) were cloned into the pIEx-10 insect expression vector. C-terminal fragments of TEP3 and 
TEP4 were cloned into the pET41a(+) expression vector. Ek/LIC cloning overhangs are shown in lower-
case. All inserts were amplified by PCR from cDNA or plasmid template, except LRIM9, which was first 
amplified from genomic DNA using the primers marked # before LIC ends were added with the LIC for 
and rev primers. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
